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13Abstract
During normal testis development, SRY and SF1 up-regulate Sox9 expression
via its testis-speciﬁc enhancer element (TESCO), which is crucial for the es-
tablishment of the male supporting cell lineage, the Sertoli cells. In contrast,
during normal ovarian development, Sox9 expression needs to be down-regulated
in the female supporting cells and failure results in XX female-to-male sex rever-
sal. It was not known whether the repression of Sox9 expression is mediated via
the TESCO regulatory element in XX gonads. FOXL2 is a forkhead transcrip-
tion factor, expressed in the supporting cells of the ovary, but not testis, from
12.5 dpc onwards. Homozygous mutation of Foxl2 results in the up-regulation of
Sox9 and other testis-speciﬁc genes in postnatal gonads, suggesting that FOXL2
plays an important role in proper ovarian development by maintaining the re-
pression of Sox9. In this thesis, in vitro analyses demonstrate that FOXL2 can
repress TESCO activity (as can other candidate ovarian determining genes, such
as Dax1 and Sox4). The repressing eﬀect of FOXL2 is more severe in the pres-
ence of ER. Several forkhead factor binding sites and EREs are present in the
TESCO sequence, however mutation analyses showed that the repression eﬀect
is not mediated only through these. Moreover, FOXl2 can interact with SF1 and
interfere with its ability to activate TESCO in vitro. In vivo studies showed that
homozygous loss of Foxl2 results in the de-repression of TESCO activity in the
remaining granulosa-like cells in the XX gonads, which correlates with the ex-
pression of endogenous Sox9. However, this de-repression occurs only after birth,
getting more severe with age, suggesting that Foxl2 is the critical factor to re-
14press TESCO activity in the adult ovary. Moreover, evidence is provided that the
de-repression of Sox9 is independent from oocyte-depletion and solely due to the
loss of Foxl2 as targeted deletion of oocytes did not result in an up-regulation
of Sox9 expression. Further in vivo analyses indicate the involvement of Wnt
signalling in the repression of TESCO activity during embryonic development, as
TESCO becomes partially de-repressed in Wnt4 homozygous mutant mice before
birth.
15Chapter 1
Introduction
1.1 Mechanisms of sex determination
During evolution, the complex living organisms on earth have evolved through
generations of sexual reproduction, whereas asexual organisms mostly remain
primitive and simple. The beneﬁt of sexual reproduction comprises genetic vari-
ation, leading to the uniqueness of each individual, which is fundamental to the
success of the species.
The common precondition for sexual reproduction is the establishment of diﬀer-
ent sexes in one species. While in the majority of vertebrates all individuals are
phenotypically identical at the beginning of embryogenesis, each embryo has to
take the decision to develop into one sex, and not the other, at a speciﬁc time
point during its development. This event is called sex determination. Sex de-
termination happens in the gonads of the embryo, more precisely in the somatic
cells of the gonad, and describes the decision of the originally bi-potential gonad
to develop either into a testis or an ovary. Once this switch has been made, the
16course is set for the rest of the embryo to develop either as a male or a female
individual. However, many invertebrate species and some vertebrates, e.g. some
ﬁsh species, develop as hermaphrodites which can produce both sperm and eggs
either simultaneously or at successive life stages. In most species, sex determi-
nation is achieved during embryonic development, though there are examples of
individuals, e.g. in some ﬁsh species, which are able change their sexual pheno-
type during adult life.
The triggers through which sex determination is achieved in diﬀerent species are
manifold. The switch mechanism can dependent on either environmental or ge-
netic factors. Environmental sex determination (ESD) is based on the identical
genetic makeup of all individuals and environmental events triggering distinct
sexual phenotypes. In contrast, genetic sex determination (GSD) relies on the
diﬀerences in chromosomal constitution (or even in a single gene) between indi-
viduals, that is the presence of distinct sex chromosomes.
A well studied form of ESD is temperature dependent sex determination (TSD) in
which the temperature during a critical period of egg incubation determines the
sex of the oﬀspring, e.g. in crocodiles, alligators, most turtles and some lizards.
For example, the red-eared slider turtle (Trachemys scripta) develops as male at
an egg incubation temperature lower than 26◦C and as female at temperatures
higher than 31◦C. Between 26◦C and 31◦C both sexes can develop with the per-
centage of females increasing with rising temperature (Pieau et al., 1999). Other
ESD mechanisms have been described to depend on group dynamics including
visual and hormonal signals, e.g. in Clown ﬁsh (Amphiprion ocellaris) (for review
see Gilbert (2006)).
17In contrast to ESD, GSD is determined by the genetic content or chromosomal
constitution of each individual and has been found in, amongst others, worms,
insects and most vertebrate species. In some species, the development of distinct
sexual phenotypes depends on the presence of a haploid or a diploid genome (e.g.
in bees and ants). In others, speciﬁc sex chromosomes have evolved leading to
chromosomal diﬀerences between the sexes. Here, the sex determining switch can
be controlled by a dosage-dependent mechanism (DSD) or the presence of a dom-
inant gene on one of the sex chromosomes. DSD can be found in C. elegans and
D. melanogaster, in which the sex determination switch is controlled by the ratio
of X chromosomes to autosomes (although e.g. Drosophila has a Y chromosome
which is required for male fertility but not for sex determination). Sex determin-
ing mechanisms which rely on sex-speciﬁc chromosomes have been described in
the ZZ/ZW system (e.g. in some insects, ﬁsh, reptiles and birds) and the XX/XY
system (e.g. in some ﬁsh, amphibians, reptiles and all known mammals). In the
ZZ/ZW system, homogametic ZZ embryos develop as males whereas heteroga-
metic ZW embryos develop as females. For a long time, two possible mechanisms
of sex determination have been discussed in this system: a dosage-dependent
eﬀect of Z chromosome gene(s) and the activity of female-speciﬁc gene(s) from
the W chromosome. Recently, it has been shown in chick that the Z-linked gene
Dmrt1 is essential for male sex determination (Smith et al., 2009) supporting the
Z-dosage dependent hypothesis. However, it is still not known whether Dmrt1 is
suﬃcient to induce male development. Furthermore, it is also possible that the
role of Dmrt1 is to antagonise crucial gene(s) on the W chromosome which might
be necessary for female development. In the mammalian XX/XY system, the Y
18chromosome is the dominant male determinant and males are heterogametic XY
whereas females are homogametic XX. The ﬁrst hints for the importance of the
Y chromosome for mammalian sex determination came from studies in human
patients with Turner (45, X) and Klinefelter (47, XXY) syndrome, where XO in-
dividuals develop as females and XXY individuals develop as males (Ford et al.,
1959; Jacobs and Strong, 1959). The same correlations were found in studies in
mice (Welshons and Russell, 1959). These ﬁndings led to the proposal of the Y
chromosome as the male determinant in mice and men. The subsequent quest for
the speciﬁc testis determining factor (TDF) on the Y chromosome went on for 30
more years. Finally, in 1990, the analysis of several XX male patients led to the
discovery of a conserved 35 kb region on the Y chromosome. Within this region,
the male determining gene was identiﬁed by positional cloning and named SRY
for ”sex-determining region of the Y chromosome” (Sinclair et al., 1990; Gubbay
et al., 1990).
1.2 Overview of murine gonadogenesis
In mice, SRY stands at the top of a sex determination cascade, being the switch
between female and male development. Before going into detail about how the
presence or absence of SRY triggers the molecular events that will eventually
result in the formation of either a testis or an ovary, a closer look should be taken
at the morphology of the embryonic gonad as the place were primary sex de-
termination takes place. The morphological development of murine gonads can
be divided into two phases: the development of a bi-potential gonad which is
19morphological identical in both sexes and the subsequent sex-speciﬁc diﬀerentia-
tion into either a testis or an ovary following the time point of sex determination
around 11.5 dpc (days post coitum).
In the early embryo, the undiﬀerentiated genital ridge can be recognised as
a thickening of the coelomic epithelium adjacent to the mesonephros around
10.0 dpc. Shortly afterwards, primordial germ cells (PGCs) start to colonise the
gonads (Figure 1.1). PGCs emerge as a cluster in the region posterior to the
primitive streak at 7.25 dpc and then proliferate and migrate through the gut
mesentery to enter the genital ridge between 10 and 11 dpc (Ginsburg et al.,
1990). PGCs are indiﬀerent between the sexes when they enter the genital ridge,
and the special environment of the gonad is needed for adequate diﬀerentiation
into either spermatogonia or oogonia (Saitou et al., 2002). In the male, germ
cells then enter mitotic arrest in G0/G1 around 13.5 dpc until perinatal stage,
whereas in the female they enter meiotic prophase as oocytes around 13.5 dpc
and will then arrest in diplotene phase around the time of birth (McLaren, 1984).
While the germ cells originate outside of the genital ridge, the somatic cells of
the gonad are thought to arise from proliferation of the coelomic epithelium. The
somatic cells in the developing gonad are categorised into three major cell lin-
eages based on their cell fate after sex determination. Supporting cell precursors
develop into Sertoli cells in the male and follicle (granulosa) cells in the female.
This cell lineage was named after their function to support and maintain the germ
cells and is most crucial for gonad diﬀerentiation in both sexes. Steroidogenic
cell precursors develop into Leydig cells in the male and theca cells in the female.
20Finally, the connective cell lineages which are involved in the formation of the
organ as a whole show distinct testicular and ovarian patterns of diﬀerentiation.
At the time of sex determination in XY gonads, Sry is expressed exclusively in
supporting cell precursors, which originate from the coelomic epithelium, and
directs their fate to become Sertoli cells (Koopman et al., 1990; Karl and Capel,
1998). Directly after initiation of Sry expression, proliferation of coelomic epithe-
lial cells increases, a phenomenon speciﬁc to XY gonads (Schmahl et al., 2000).
During this male-speciﬁc proliferation, cells from the epithelium delaminate and
give rise to Sertoli cells and an interstitial cell population (Karl and Capel, 1998;
Schmahl et al., 2000). The diﬀerentiating Sertoli cells then enclose the germ
cells and form testis cords. These eventually give rise to the seminiferous tubules
characteristic of the testis (Figure 1.1) (Brennan et al., 2002).
Leydig cells diﬀerentiate in the interstitium between the testis cords around
12.5 dpc. The function of Leydig cells is to produce testosterone and thereby
guide the masculinisation of the whole embryo. In contrast to Sertoli cells, the
origin of fetal Leydig cells is not clear yet. Some evidence suggests that Ley-
dig cell precursors could arise from the coelomic epithelium (Brennan et al.,
2003), whereas other data suggests that Leydig precursor cells originate from
the mesonephros and migrate into the gonad before 11.5 dpc where they re-
main undiﬀerentiated until 12.5 dpc (Jeays-Ward et al., 2003). As cell division
is rarely detected among diﬀerentiated Leydig cells, it has been proposed that
the increase in the fetal Leydig cell population depends on an undiﬀerentiated
pool of progenitor cells in the gonadal interstitium which continuously prolife-
rates and diﬀerentiates (Orth, 1982). Recent studies strongly support this model
21and show that Notch signalling is involved in the regulation of the maintenance
of these fetal Leydig progenitor cells (Tang et al., 2008). Furthermore, signalling
molecules from Sertoli cells have been implicated to be involved in the diﬀerenti-
ation of fetal Leydig cells, such as Dhh (Desert hedgehog) and PDGF signalling
(Platelet-Derived Growth Factor) (Yao et al., 2002; Brennan et al., 2003; Schmahl
et al., 2008). The fetal Leydig cell population is lost at birth and replaced by an
adult population which forms from interstitial mesenchymal cells during puberty
(Davidoﬀ et al., 2004). It has been hypothesised that the adult Leydig cells might
diﬀerentiate from the same Leydig cell progenitor cell pool as the fetal Leydig
cells (Habert et al., 2001; Tang et al., 2008).
In the XY gonad, testis-speciﬁc peritubular myoid (PTM) cells can be found,
which surround the testis cords and thereby separate the cords from the inter-
stitium (Figure 1.1). Originally these cells were thought to emerge from the
mesonephros (Merchant-Larios and Moreno-Mendoza, 1998), but recent studies
have shown that the PTM cells do not migrate from the mesonephros into the
gonad between 11.5 dpc and 12.5 dpc (Cool et al., 2008; Combes et al., 2009). It
has then been hypothesised that PTM cells and other interstitial lineages (except
endothelial cells) are induced within the gonad.
Endothelial cells start migrating into the XY gonad from a large vascular plexus
in the mesonephros around 11.5 dpc (Coveney et al., 2008). These individual
cells migrate directly towards the coelomic epithelial domain of the gonad where
they aggregate and from the male-speciﬁc coelomic vessel around 12.5 dpc. The
migrating endothelial cells have been suggested to direct the formation of the
developing testis cords (Combes et al., 2009). It has also been suggested that
22testicular blood vessels promote eﬃcient export of testosterone out of the devel-
oping testis, as well as supplying oxygen to the rapidly growing tissue (Ross and
Capel, 2005).
In the XX gonad, supporting cell precursors diﬀerentiate into follicle (granulosa)
cells whereas the steroidogenic cell lineage gives rise to theca cells (Figure 1.1).
Both cell types are involved in the production of estrogens. Although endothelial
cells migrate from the mesonephric vascular plexus into the gonad from 11.5 dpc,
no vascular pattern is obvious in the XX gonad at 12.5 dpc (Coveney et al., 2008).
It has been suggested that the developing vasculature in XX gonads results from
proliferation and extension of the primordial gonadal vasculature (Coveney et al.,
2008). In the ovary, most of the morphological reorganisation occurs after birth.
However, some morphological changes already start at the time of the entry of the
germ cells into meiotic prophase around 13.5 dpc. At this time, oocytes become
associated in clusters which are called germ cell nests or cysts (Gomperts et al.,
1994; Pepling and Spradling, 2001). Each cluster of oocytes is surrounded by a
layer of pre-granulosa cells. The cysts break down around the time of birth and
while approximately two-third of the oocytes undergo programmed cell death,
the remainder individually become surrounded by somatic pre-granulosa cells
and form primordial follicles (Pepling and Spradling, 2001).
The internal reproductive tract and associated organs are derived from a pair
of genital ducts, the M¨ ullerian and Wolﬃan ducts, which are initially present
in both sexes (Figure 1.1). The Wolﬃan ducts develop from the intermediate
mesoderm and are completed by 10.5 dpc. In XY mice, they diﬀerentiate into
23vas deferens, epididymis and seminal vesicles, whereas they regress in XX. The
M¨ ullerian ducts start to develop around 11.5 dpc. They give rise to oviduct,
uterus and the upper parts of the vagina in XX mice, whilst they degenerate
in XY due to the presence of anti-M¨ ullerian hormone (AMH) made by Sertoli
cells. It has been reported that the M¨ ullerian duct needs the presence of the
Wolﬃan duct to form (Gruenwald, 1941). However, the Wolﬃan duct does not
contribute cells to the M¨ ullerian duct, but is thought to provide essential (though
still unknown) signals to guide its development (Orvis and Behringer, 2007).
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Figure 1.1: The early development of testis and ovary.
(a) The genital ridge forms as a thickening of the coelomic epithelium around
10.0 dpc and primordial germ cells (pink) enter between 10.0 and 11.0 dpc. Both,
the M¨ ullerian and the Wolﬃan duct form initially in the mesonephros underly-
ing the bi-potential gonad. In XY gonads, Sry is expressed between 10.75 and
12.5 dpc and initiates testis development: diﬀerentiation of supporting cell pre-
cursors to Sertoli cells (green) which, together with the peritubular myoid cells
(orange), encircle the germ cells (purple) to form testis cords. In between the
testis cords develop the male steroidogenic cell lineage: the Leydig cells (blue).
The male-speciﬁc vasculature (red) forms and vessels branch between the testis
cords. In contrast, no signiﬁcant morphological changes are visible in XX gonads
during this period. Adapted from Ross and Capel (2005). (b) The distribution
of germ cells (purple, marked by STELLA) and supporting cells (green, marked
by FOXL2 in XX gonads and SOX9 in XY gonads) in the embryonic gonad at
13.5 dpc. Scale bar = 100m
251.3 Early gonadal development
In the indiﬀerent gonad, several genes are expressed in both sexes from 9.5 dpc
onwards, including Wilms’ tumour suppressor gene 1 (Wt1), steroidogenic fac-
tor 1 (Sf1), LIM homeodomain protein 9 (Lhx9), M33 and Emx2. In mice,
functional mutations of these genes cause gonadal agenesis, indicating that they
are required for the early formation of the bi-potential gonad prior to the time of
sex determination.
Wt1 was originally identiﬁed as a gene involved in infant kidney cancer and
mutations and deletions of the gene are associated with WAGR (Wilms’ tu-
mour/aniridia/genitourinary abnormalities/mental retardation), DDS (Denys-
Dash syndrome) and FS (Frasier syndrome). The gene is composed of ten exons,
which undergo alternative splicing and show diﬀerent translational start sites, re-
sulting in a total of 24 diﬀerent protein isoforms (Reddy and Licht, 1996; Sharma
et al., 1994), which share a characteristic domain of four zinc ﬁngers in the C-
terminus. Of particular interest for gonadal development are two splice variants
which diﬀer in the insertion or omission of the three amino acids KTS between
the third and fourth zinc ﬁnger (+KTS and -KTS isoforms). The two protein
isoforms vary in their DNA binding activity in vitro (Laity et al., 2000) and only
the +KTS isoform is able to bind and stabilise RNA (Bor et al., 2006). Unlike
human patients, mice with a heterozygous null mutation of Wt1 do not show
any gonadal phenotype. Mice with homozygous Wt1 null mutations die between
13 dpc and 15 dpc, due to a failure of kidney development, and lack both go-
nads and adrenal glands (Kreidberg et al., 1993). Targeted deletion of either the
26+KTS or -KTS isoforms revealed their distinct function during gonadal develop-
ment. While WT1(+KTS) seems to be more important in testis development,
WT1(-KTS) is required for formation and survival of the gonadal primordium in
both sexes, as WT1(-KTS∆=∆) mice show an increased number of apoptotic cells
in the early gonad (Hammes et al., 2001).
Steroidogenic factor 1 (Sf1, Nr5a1) is a member of the nuclear receptor fam-
ily and was ﬁrst identiﬁed as an activator of genes involved in steroidogenesis
(Parker and Schimmer, 1997). SF1 contains a DNA-binding domain composed
of highly conserved zinc ﬁngers and recognises (C/T)CAAGG(T/C)(C/T) and
(A/G)(A/G)(A/G)AGGTCA DNA sequences (Morohashi et al., 1992). In hu-
man patients, heterozygous mutation of SF1 is associated with primary adrenal
failure, XY male-to-female sex reversal including diﬀerent degrees of gonadal dys-
genesis and persistent M¨ ullerian structures (for review see Lin and Achermann,
2008). In contrast to humans, mice with a heterozygous mutation of Sf1 do not
display any gonadal phenotype (Luo et al., 1994). Mice carrying a homozygous
null mutation of Sf1 (Sf1−=−) start to develop the genital ridge correctly and
migration of PGCs appears normal. However, somatic cells undergo apoptosis
around 11 - 11.5 dpc, which results in the complete lack of gonads and adrenals,
indicating an essential role for Sf1 in regulating the survival and proliferation of
the adrenal and somatic gonadal cells (Luo et al., 1994).
Lhx9 is a member of the LIM homeobox transcription factor family with two N-
terminal LIM domains and a homeobox domain. The LIM domain is a cysteine-
rich domain consisting of two zinc ﬁngers which mediates protein-protein inter-
27actions, whereas the homeobox domain is involved in DNA binding. Mice with a
homozygous null mutation of Lhx9 (Lhx9−=−) show failure of somatic cell prolif-
eration in the genital ridge, resulting in the absence of gonads (Birk et al., 2000).
Sf1 expression is signiﬁcantly reduced in Lhx9−=− mice, indicating that LHX9
modulates Sf1 activation. Indeed, it has been shown in vitro that LHX9 and
WT1(-KTS) interact and cooperatively activate the Sf1 promoter (Wilhelm and
Englert, 2002).
The M33 gene (also known as Cbx2) is a member of the polycomb (PC) group
of proteins which were ﬁrst identiﬁed in Drosophila melanogaster. Mice with
homozygous deletion of the M33 C-terminus (M33cterm=cterm), which is highly
conserved among Drosophila Pc proteins (Pearce et al., 1992), show retardation
in the formation of the genital ridge in both sexes (Katoh-Fukui et al., 1998).
In adult XX M33cterm=cterm mice, ovaries are either small or residual, whereas
XY M33cterm=cterm mice show varying degrees of male-to-female sex reversal with
the appearance of ovarian-like structures containing follicles. Further analyses of
the M33 mutant mice indicated a reduced expression of Sf1 (Katoh-Fukui et al.,
1998). Moreover, M33 directly binds to the Sf1 gene locus in vitro, suggesting
that M33 may be involved in the regulation of Sf1 expression (Katoh-Fukui et al.,
2005). Recently mutations in CBX2 were identiﬁed in a human patient with XY
male-to-female sex reversal (Biason-Lauber et al., 2009).
Emx2 is a homeobox gene which was ﬁrst identiﬁed due to its homology to the
Drosophila gene empty spiracles (Simeone et al., 1992). Mice carrying a homozy-
gous null mutation of Emx2 (Emx2−=−) show a complete absence of gonads due
28to a failure in thickening of the coelomic epithelium at 11.5 dpc. Moreover, the
genital tract system is absent in both sexes in the Emx2−=− mice as the M¨ ullerian
ducts never form and the Wolﬃan ducts start to degenerate around 11.5 dpc in
XY Emx2−=− mice (Miyamoto et al., 1997).
In summary, before 11.0 dpc the gonad is indistinguishable between XY and XX
embryos. In both sexes, the same set of regulatory genes is expressed setting the
stage for the changes to come and the gonad bears the potential to diﬀerentiate
into either a testis or an ovary. And then along comes Sry and activates a
cascade of gene activity which will eventually lead to the establishment of testis
development in XY gonads.
1.4 Taking the route towards testes
1.4.1 Testis determination: Sry
SRY was shown to be critical for male sex determination through both loss- and
gain-of-function studies. Analysis of human XY sex-reversed female patients dis-
covered a de novo frameshift mutation in the Y-linked gene SRY, which indicated
that it was necessary for testis development (J¨ ager et al., 1990). Subsequently,
many XY females have been found with point mutations in Sry (for review see
Sekido, 2010). Parallel studies conﬁrmed the importance of Sry for testis de-
termination in mice. Loss-of-function (LoF) experiments demonstrated that XY
mice with a 11 kb deletion of Sry, which results in a lack of a functional Sry
gene, develop ovaries and become female (Gubbay et al., 1990). Gain-of-function
29(GoF) studies showed that XX mice carrying a Sry transgene develop testes and
become male, although they are infertile (Koopman et al., 1991). These data
demonstrate that Sry is both suﬃcient and necessary for testis development and
therefore is only gene on the Y chromosome required for male development.
Studies in chimeric mice demonstrated that more than 90% of Sertoli cells in the
testes were XY, in contrast to other cells which did not show any bias, suggesting
that Sry acts in the male supporting cell lineage (Palmer and Burgoyne, 1991b).
However, some of the cells were XX indicating that a non-cell autonomous factor
can recruit XX cells to become Sertoli cells. By variation of the XX:XY cell ratio
in the chimeric mice, a threshold level of 20% Sry-expressing cells was found to
be suﬃcient for testis development (Burgoyne and Thornhill, 1993). Subsequent
studies conﬁrmed that Sry expression is restricted to cells that diﬀerentiate into
Sertoli cells (Sekido et al., 2004; Wilhelm et al., 2005). These data substantiate
the idea that the critical role for SRY in sex determination is to establish the
Sertoli cell fate decision in the supporting cell lineage in the early gonad.
In the mouse, Sry is expressed in the Sertoli cell precursors of the XY gonad in a
centre to pole wave (Bullejos and Koopman, 2004; Sekido et al., 2004; Albrecht
and Eicher, 2001). Both mRNA and protein analyses showed that Sry is only
present during a narrow time window between 10.75 dpc and 12.5 dpc in the
nucleus of Sertoli cell precursors (Koopman et al., 1990; Sekido et al., 2004). Sry
expression needs to reach a critical threshold per cell and also in a suﬃcient num-
ber of cells in order to initiate and maintain Sertoli cell diﬀerentiation (Palmer
and Burgoyne, 1991a; Burgoyne and Thornhill, 1993). Recently, ex vivo studies
30showed that XX gonads carrying an inducible Sry transgene only initiate correct
Sertoli cell diﬀerentiation and thus testis development when the transgene was
expressed in a 6 hour time window between 11.0 dpc and 11.25 dpc (Hiramatsu
et al., 2009). These data show that if Sry is expressed at a critical time during
gonadal development, it acts as a genetic switch to shift the development of the
bi-potential gonad towards to male pathway.
Several factors have been proposed to be involved in the activation of Sry ex-
pression in the XY gonad, including SF1, WT1(+KTS), GATA4/FOG2, M33
and members of the insulin receptor (IR) family (Figure 1.2). Cell fate mapping
analyses showing that Sry-expressing Sertoli precursor cells indeed originate from
Sf1-expressing coelomic epithelial cells, suggests the importance of SF1 in Sry reg-
ulation and Sertoli cell diﬀerentiation (Schmahl et al., 2000). In support of this
hypothesis, it has been shown that SF1 binds and activates both human and pig
Sry promoters in vitro (de Santa Barbara et al., 2001; Pilon et al., 2003) and Sry
expression can not be detected in gonads of XY Sf1−=− mice (S. Guioli, unpub-
lished). FS patients lacking the WT1(+KTS) isoform also show XY sex reversal
(Gubler et al., 1999). Recently, it has been shown that WT1(+KTS) is involved
in the cell-autonomous regulation of Sry expression as gonads of XY (+KTS∆=∆)
mice show reduced Sry expression per cell as well as reduced proliferation of
somatic cells and failure of Sertoli cell diﬀerentiation (Bradford et al., 2009).
Mice carrying a homozygous null mutation of the zinc ﬁnger transcription factor
Gata4 (Gata4−=−) die before 10.5 dpc due to severe defects in heart development
(Molkentin et al., 1997). However, a hypomorphic mutation of Gata4 (Gataki)
which abolishes the interaction between GATA4 and its co-factor FOG2, or the
31null mutation of Fog2 (Fog2−=−), both resulting in embryonic lethality after the
time of sex determination, cause XY male-to-female sex reversal (Tevosian et al.,
2002). Sry transcript levels are signiﬁcantly decreased in XY Fog2−=− gonads
(Tevosian et al., 2002). Recent studies revealed that GATA4 interacts with both
WT1 isoforms (+KTS and -KTS) to activate the mouse, human and pig Sry pro-
moters in vitro (Miyamoto et al., 2008). Combined triple deletions of IR genes,
including IR itself, insulin-related receptor (IRR) and insulin-like growth factor 1
receptor (IGF1R), also result in a reduction of the Sry transcript level, associated
with XY sex reversal (Nef et al., 2003). It is thought that this phenotype is due to
a reduced proliferation of the somatic cells resulting in fewer Sry-expressing cells.
However, an alteration of Sry transcription itself cannot be excluded. Recently,
the involvement of MAPK (mitogen-activated protein kinase) signalling in the
regulation of Sry expression has been described (Bogani et al., 2009). Loss of
MAP3K4 activity results in XY sex reversal due to a failure in the up-regulation
of Sry expression. However, it is not clear yet whether this failure of proper Sry
expression is due to transcriptional regulation of Sry by the MAP3K4-signalling
pathway or due to insuﬃcient numbers of Sertoli cell precursors. Taken together,
although a lot of genes have been implicated in Sry activation, little is still known
about the exact transcriptional regulation of Sry.
Recent studies on the evolution of Sry have revealed that the 5’ sequence up-
stream of Sry is partially conserved in human, pig, bovine and goat, including
conserved binding sites for transcription factors, whereas the mouse sequence was
found to be considerably diﬀerent (Ross et al., 2008). In contrast to the tran-
sient expression of Sry in mouse, the expression of human and pig Sry persists
32throughout later stages of development, which might suggest diﬀerent regulatory
mechanisms (Hanley et al., 2000; Daneau et al., 1996).
SRY proteins usually consist of three diﬀerent regions: N-terminal domain, HMG
box and C-terminal domain (Sekido, 2010). Interestingly, mouse SRY has a more
unusual structure compared to other species. Due to a very short N-terminal
domain, the HMG box is essential N-terminal. Moreover, the protein contains
a large glutamine (Q) repeat region at the C-terminus which is connected to
the HMG box by a bridge domain. In vitro SRY binds to the DNA consensus
sequence (A/T)ACAA(T/A) via its HMG box and thereby bends DNA up to an
angle of 90◦ (Ferrari et al., 1992; Giese et al., 1994). Outside the highly conserved
HMG box domain, the conservation of the protein sequence is poor amongst
mammals. The vast majority of point mutations in SRY in cases of human XY
male-to-female sex reversal occur within the HMG box which suggests that this
is the most critical part of the protein (Sekido, 2010). However, both the N-
and C-terminal domains might play a role in Sry function, as point mutations in
these regions have been found in a few cases of XY sex reversal (Shahid et al.,
2004). The importance of the mouse-speciﬁc Q-stretch in male sex determination
was suggested in transgenic mouse experiments, as Sry constructs lacking the Q-
stretch were not able to induce testis development in XX embryos (Bowles et al.,
1999). However, it was not possible to ascertain whether any mutant protein was
actually made or stable in these mice. In contrast, the SRY proteins from M. mus.
domesticus (Y DOM) or M. mus. poschiavinus (Y POS) contain a truncation of this
Q-stretch. When Y DOM or Y POS chromosomes were transferred onto the M. mus.
musculus background C57BL/6, ovarian tissue developed, indicating that these
33Y chromosomes function as weak alleles, possibly due to the reduction of the
Sry Q-stretch (Eicher et al., 1982). Recent studies indicated the involvement of
the Q-stretch in interference with the female-promoting Wnt/-catenin pathway
(see later) (Tamashiro et al., 2008). In contrast to mouse SRY, human SRY
seems to be unable to inhibit the Wnt/-catenin, possibly due to the lack of
the C-terminal Q-stretch domain. However, human SRY fused to the murine
Q-stretch domain is able to interfere with this pathway (Tamashiro et al., 2008).
Interestingly, even though human and mouse SRY are distinct in their C-terminus,
hSRY expressed under the control of mouse regulatory sequences, can still induce
testis development in the mouse (Lovell-Badge et al., 2002), as does the expression
of goat Sry (Pannetier et al., 2006b).
Both human and mouse SRY is able to directly interact with other proteins,
such as SRY-interacting protein (SIP-1) and Kr¨ uppel-associated box only protein
(KRAB-O). SIP-1 was identiﬁed by an in vitro screen for human SRY interacting
proteins (Poulat et al., 1997). Subsequent analyses revealed that SIP-1 interacts
with the bridge domain between the HMG box and the Q-stretch of mouse SRY
and with a speciﬁc motif (TKL-motif) at the C-terminus of human SRY (hu-
man SRY does not contain a bridge domain) (Thevenet et al., 2005). KRAB-O
interacts with the bridge domains of mouse SRY and a domain adjacent to the
C-terminus of the human SRY HMG box, but no clear motif has been identiﬁed
(Oh et al., 2005). A recent study showed that ablation of KRAB-O expression
in vitro via RNAi, results in a failure to up-regulate the SRY target gene Sox9
(see later) (Polanco et al., 2009). However, targeted deletion of KRAB-O in
mice did not impair testis development in vivo, which might be due to a possible
34redundancy between members of the large KRAB gene family.
Interestingly, in the adult mouse testis, a circular Sry transcript has been found
(Capel, 1998). This circular RNA is not translated and no function has been
associated with it so far. It has not been found in humans or other mammals
and might represent a mouse-speciﬁc mechanism to disable Sry function in the
adult.
In summary, Sry must be expressed at the right time of development and in
the right place in order to act as a molecular switch by activating downstream
target genes which ensure that the supporting precursor cells become Sertoli cells
and thereby setting the development of the bi-potential gonad towards testis
development.
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Figure 1.2: Model of genetic interactions during testis development.
Possible genetic interactions in the XY gonad resulting in the establishment of
Sox9 expression in the supporting cell lineage. The testis-determining genes
also have to ensure the inhibition of the ovarian-determining genes in order to
maintain the Sertoli cell fate XY gonads.
351.4.2 Testis diﬀerentiation: establishment of Sertoli cells
As SRY acts only transiently in testis development, other genes, which act down-
stream of SRY, must be involved in the establishment of Sertoli cells. Several
studies indicated the autosomal gene Sox9 (Sex determining region Y, box 9) as
the a crucial downstream target of SRY in testis development (Chaboissier et al.,
2004; Sekido et al., 2004; Sekido and Lovell-Badge, 2008). Sox9 is an Sry-related
gene belonging to the Sox E family of HMG box proteins (together with Sox8
and Sox10). Like SRY, SOX9 can bind and bend DNA but it also contains a
transactivation domain at the C-terminus, suggesting a role as a transcriptional
activator (Bell et al., 1997; Lefebvre et al., 1997; S¨ udbeck et al., 1996). In con-
trast to SRY which is found only in mammals, SOX9 is highly conserved amongst
vertebrates.
Human patients with SOX9 haploinsuﬃciency display a severe skeletal malfor-
mation syndrome, Campomelic dysplasia (CD), which is associated with XY
male-to-female sex reversal in about 75% of all cases (Foster et al., 1994; Wagner
et al., 1994). On the other hand, duplication of the chromosomal region contain-
ing SOX9 (17q23-24) results in XX female-to-male sex reversal (Huang et al.,
1999). In the mouse, homozygous null mutation of Sox9 (Sox9−=−) is embryonic
lethal around the time of sex determination (Bi et al., 2001). However, when gen-
ital ridges from 11.5 dpc XY Sox9−=− mice were cultured in vitro, they neither
formed testis cords nor expressed Amh (Chaboissier et al., 2004). Conditional
deletion of Sox9 via the Cre/LoxP system, using Sf1:Cre to delete Sox9 speciﬁ-
cally within the gonad (Sox9∆=∆), can result in XY male-to-female sex reversal
36(Chaboissier et al., 2004; Barrionuevo et al., 2006). Moreover, misexpression of
Sox9 in XX mice induces female-to-male sex reversal (Bishop et al., 2000; Vidal
et al., 2001). These results mimic the LoF and GoF studies of Sry, respectively,
implying that Sox9 is the only critical downstream target of SRY and thereby is
both necessary and suﬃcient for normal testis development (Figure 1.2). How-
ever, a possible functional redundancy between Sox9 and other members of the
SoxE family, such as Sox8 or Sox10, has been suggested in testis diﬀerentiation
(Chaboissier et al., 2004; Barrionuevo et al., 2006).
Sox9 is initially expressed at low levels in the gonad of both sexes around 10.5 dpc,
and thus before the onset of Sry expression (Morais da Silva et al., 1996). Fur-
thermore, Sox9 expression persists in Sertoli cells throughout life after transient
Sry expression has ceased, indicating that other factors are involved besides Sry
in regulating Sox9 expression. Several studies have suggested that Sf1 is par-
ticularly important for testis diﬀerentiation and might be involved in the early
regulation of Sox9 expression. Indeed, early sex-independent expression of Sox9 is
abolished in the gonads of XY Sf1−=− mice (Sekido et al., 2004). Moreover, ubiq-
uitous misexpression of Sry in XX gonads only results in the initiation of Sox9
expression in SF1 positive cells (Kidokoro et al., 2005). Recently, the regula-
tory element responsible for the testis-speciﬁc expression of Sox9 has been iden-
tiﬁed 13 kb upstream of the transcription start site, and named testis-speciﬁc
enhancer of Sox9 (TES) including a 1.3 kb core region (TESCO) (Sekido and
Lovell-Badge, 2008). This element is highly conserved between mouse, rat, dog
and human. Chromatin immunoprecipitation (ChIP) analyses demonstrated that
both SF1 and SRY bind to the TESCO enhancer sequence, conﬁrming Sox9 as
37a direct target of SRY. Subsequent analyses with transgenic mice carrying mu-
tations in either SRY or SF1 binding sites showed little eﬀect on the enhancer
activity but simultaneous mutation of all the binding sites completely abolished
TESCO activity (Sekido and Lovell-Badge, 2008). In vitro co-transfection exper-
iments demonstrated that SF1 on its own can activate TESCO weakly, whereas
the combination of SF1 and SRY results in a stronger activation. These results
indicate that SF1 can indeed initiate TESCO (and therefore Sox9) expression on
its own and the synergistical eﬀect of SF1 and SRY results in the up-regulation
of its expression. Moreover, the ChIP assays revealed that SOX9 itself can bind
to TESCO via the same binding sites as SRY or via fragments containing SF1
binding sites (Sekido and Lovell-Badge, 2008). This result suggests that SF1 and
SOX9 might physically interact to regulate TESCO activity. Indeed, a direct
interaction between the N-terminal domain of SOX9 and the C-terminal region
of SF1 was previously described for the regulation of the Amh promoter (De
Santa Barbara et al., 1998). Subsequent in vitro co-transfection assays showed
that the TESCO element can be activated robustly by the combination of SF1
and SOX9, indicating a positive feedback mechanism in which SOX9 ensures the
maintenance of its own expression. All these data led to the proposal of a new
model of Sox9 regulation via the TESCO element: (i) SRY-independent initia-
tion, (ii) SRY-dependent up-regulation and (iii) SRY-independent maintenance
(Sekido and Lovell-Badge, 2008) (Figure 1.3).
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Figure 1.3: Model for Sox9 regulation via TESCO in XY gonads.
Sox9 expression in the developing XY gonad is regulated via the TESCO element
in three phases: (i) SF1 is binding to the enhancer at 10.5 dpc and initiates a
low expression of Sox9, (ii) Sry is activated around 11.5 dpc and up-regulates
Sox9 expression (iii) SOX9 itself can bind to its own enhancer and maintains its
expression via this autoregulation and other feedback loops involving FGF9 and
PGD2 signalling.
A number of other factors have been implicated to be involved in the regulation
Sox9 expression. For example, Sox9 expression is lost in both Gataki and Fog2−=−
XY gonads (Tevosian et al., 2002), indicating that the GATA4/FOG2 complex
might be required directly for Sox9 transcription. Recent ﬁndings also show that
FGF9 (ﬁbroblast growth factor 9) plays an important role in maintaining Sox9
expression (Figure 1.2). Fgf9 is originally expressed in the gonad of both sexes
and then becomes XY speciﬁc in Sertoli cells after Sry expression (Colvin et al.,
2001). In XY mice carrying a homozygous null mutation of Fgf9 (Fgf9−=−), the
expression of Sry is not aﬀected and Sox9 starts to be expressed normally at
11.5 dpc, which suggests that FGF9 is not involved in the initial up-regulation of
Sox9 expression (Kim et al., 2006b). However, SOX9 is not detectable anymore
in the XY mutant gonads after 12.5 dpc which results in XY male-to-female sex
reversal, indicating that FGF9 is involved in maintaining Sox9 expression. This
correlates with the ﬁnding that the misexpression of Fgf9 alone does not result in
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Fgf9−=−, mice carrying a homozygous null mutation in the main receptor of FGF9
signalling, FGF receptor 2 (Fgfr2−=−), show XY sex reversal due to a loss of Sox9
expression after 11.5 dpc (Kim et al., 2007; Bagheri-Fam et al., 2008). Moreover,
human patients with a deletion of the region containing FGFR2 (10q26) display
XY sex reversal (Wilkie et al., 1993). All these data suggests the importance
of FGF9/FGFR2 signalling in the maintenance of Sox9 expression. Moreover, it
has been shown that conditional XY Sox9∆=∆ mice have decreased levels of Fgf9
at 11.5 dpc (Kim et al., 2006b), indicating that SOX9 is, in turn, necessary for
Fgf9 expression. Taken together, FGF9/FGFR2 signalling seems to be crucial for
normal testis development by acting on Sox9 expression via a positive feedback
loop.
Another target of SOX9 is the prostaglandin D synthase gene (Ptgds) which
is involved in the synthesis of Prostaglandin D2 (PGD2). SOX9 can directly
bind and activate the Ptgds promoter whereas active PGD2 signalling in turn
enhances import of SOX9 from the cytoplasm into the nucleus in an autocrine and
paracrine manner (Wilhelm et al., 2005). Moreover, ex vivo analyses have shown
that addition of PGD2 to XX gonads resulted in up-regulation of Sox9 expression
and partial masculinisation (Adams and McLaren, 2002; Wilhelm et al., 2005).
This suggests that PDG2 signalling is suﬃcient to up-regulate Sox9 expression
in cells which did not express Sry. This Prostaglandin signalling pathway might
be involved in the recruitment of XX cells to become Sertoli cells as seen in
XX-XY chimeric mice (Palmer and Burgoyne, 1991b). On the other hand, mice
carrying a targeted homozygous null mutation for Ptgds do not show any signs
40of sex reversal indicating that PGD2 signalling is a back-up mechanism to ensure
eﬃcient Sertoli cell diﬀerentiation of all cells of the supporting cell lineage (Moniot
et al., 2009).
In summary, SOX9 is the crucial factor which deﬁne Sertoli cell phenotype and
function. This includes the direct or indirect repression of genes characteristic
of the supporting cell precursors of the bi-potential gonad, as well as the repres-
sion of genes involved in ovarian development (see later). Thus, maintenance of
Sox9 expression is indispensable in the XY gonad in order to develop as a fully
functional testis.
1.5 Determined to develop as female
1.5.1 Ovarian determining or anti-testis genes
Female development in mammals has often been considered as the default path-
way of development (Jost, 1952). The bi-potential gonad develops into an ovary
in the absence of Sry, suggesting the testis pathway to be the active pathway of
gonadal formation. However, it has also been proposed that a gene in XX gonads
(the Z gene) acts as a negative regulator of male sex determination (McElreavey
et al., 1993). Although no exclusive female-determining gene has been found so
far, several cases of partial XX female-to-male sex reversals have been described
in the absence of Sry, in both mice and humans. In some cases the relevant
genes have been identiﬁed, for example in LoF mutations in Wnt4 (a member
of the wingless family of genes), Rspo1 (R-spondin1) and Foxl2 (forkhead box
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necessary for normal ovarian development, rather than this depending entirely
on a passive default pathway. Indeed, is seems that a ”battle of the sexes” is
happening in the developing gonad with diﬀerent genes involved in tipping the
balance either towards testis and male development or towards ovary and female
development. The genes involved in this battle would activate other genes in their
developmental pathway and simultaneously repress genes which are important for
the opposite pathway.
The ﬁrst signiﬁcant molecular event happening in XX gonads is the down-regula-
tion of Sox9 expression in the precursors of the supporting cell lineage shortly
before 11.5 dpc. Thereupon, these cells diﬀerentiate into female granulosa cells
instead of male Sertoli cells. An important question is therefore which genes
are directly responsible for the repression of Sox9 at this stage and for main-
taining its repression throughout life in granulosa cells. A number of genes have
been proposed to act as anti-testis or ovarian-determining genes, including Wnt4,
Rspo1, -catenin, Dax1 (Dosage-sensitive sex-reversal (DSS) adrenal hypoplasia
congenita (AHC) critical region on the X-chromosome, gene 1), Sox4, Foxl2 and
ERs (estrogen receptors).
The Wnt family (Wingless-type MMTV integration site family) is a conserved
group of secreted glycoproteins, which was named after the Drosophila segment
polarity gene (wingless) and the ﬁrst discovered vertebrate homolog (integrated).
The extra-cellular WNT ligand can stimulate diﬀerent intra-cellular transduction
cascades: the canonical -catenin dependent pathway and two non-canonical
42pathways (planar cell polarity pathway and Wnt/Ca2+ pathway). In the canon-
ical pathway, WNT ligands bind to the transmembrane receptor frizzled (Fz)
and the co-receptors LDL-receptor related protein 5 and 6 (Lrp5/6) and the
signal is then transduced to the cytoplasmic protein Dishevelled (Dsh). In the
absence of WNT ligand -catenin is phosphorylated by a multiprotein complex
which leads to its ubiquitination and subsequent degradation via the proteo-
some. Upon binding of WNT, Dsh prevents -catenin degradation by disrupting
the protein complex needed for its phosphorylation. Stabilised -catenin translo-
cates into the nucleus and interacts with T-cell factor/Lymphocyte enhancer
factors (TCF/LEF). This protein complex then binds to cis-regulatory elements
of target genes and thereby activates Wnt-responsive genes (for a more detailed
review see Komiya and Habas, 2008). On the other hand, it has been shown that
LEF/TCF proteins can physically interact with co-repressors, such as Groucho
and CtBP, which leads to the repression of their target genes (Roose et al., 1998).
Wnt4, is particularly crucial for female development. In human patients, a du-
plication of the chromosomal region including WNT4 (1p35) has been associated
with XY sex reversal (Wieacker et al., 1996), whereas a point mutation within
the WNT4 coding region (E226G) has been reported as a LoF mutation which
causes masculinisation in an XX patient (Biason-Lauber et al., 2004). In the
mouse, Wnt4 expression starts in the early gonad in the mesenchyme along the
length of the mesonephros from 9.5 dpc onwards. At 11.0 dpc it is expressed in
the mesenchyme of the indiﬀerent gonad in both sexes and then becomes female-
speciﬁc due to its down-regulation in the XY gonad around 11.5 dpc. Wnt4
is strongly expressed in the mesenchymal cells of the developing M¨ ullerian duct
43but not the Wolﬃan duct (Vainio et al., 1999). XX embryos carrying a targeted
null mutation of Wnt4 (Wnt4−=−) show partial masculinisation of the gonad,
including some Leydig cell diﬀerentiation and the formation of a coelomic ves-
sel. Moreover, the Wolﬃan duct is maintained in these embryos, whereas the
M¨ ullerian duct is absent (Vainio et al., 1999; Jeays-Ward et al., 2004). However,
misexpression of Wnt4 in XY transgenic embryos (Sf1:Wnt4) does not cause
male-to-female sex reversal, although it does interfere with the normal formation
of the coelomic blood vessel (Jeays-Ward et al., 2003; Jordan et al., 2003) (more
detailed discussion of the Wnt4 mutant phenotype in Chapter 6).
R-spondin 1 (R-SPO1) belongs to a family of secreted ligands and can interact
with Fz/Lrp receptors via its two furin-like domains (Kim et al., 2006a). It might
activate the same intracellular canonical pathway as WNT ligands, leading to a
stabilisation of -catenin (Kazanskaya et al., 2004). Thus, RSPO1 is thought
to potentiate canonical WNT signalling although it could also act independently
to achieve a similar eﬀect. In human patients, homozygous LoF mutation of
R-SPO1 (R-SPO1−=−) can lead to complete XX female-to-male sex reversal in
the absence of SRY (Parma et al., 2006). R-SPO1 does not seem to be neces-
sary for testis diﬀerentiation because XY R-SPO1−=− patients develop normal
and functional testes (Micali et al., 2005). In the mouse, Rspo1 is expressed in
somatic cells of the indiﬀerent gonad in both sexes at 10.5 dpc and then becomes
female-speciﬁc around 12.5 dpc (Parma et al., 2006). Mice with a targeted null
mutation of Rspo1 (Rspo1−=−) show partial XX female-to-male sex reversal with
formation of the male-speciﬁc coelomic vessels and the appearance of several sem-
iniferous tubules (Chassot et al., 2008; Tomizuka et al., 2008). Moreover, adult
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talia and persistence of both, Wolﬃan and M¨ ullerian ducts. However, expression
of testis diﬀerentiation markers such as Sox9, Fgf9 and Dhh cannot be detected
in the mutant embryos at the time of sex determination, although expression
of ovary diﬀerentiation marker genes, such as Wnt4, Fst and Bmp2, is reduced
(Chassot et al., 2008; Tomizuka et al., 2008). Epistatic analysis showed that
Axin, a known target gene of -catenin is not expressed in XX Rspo1−=− em-
bryos, while misexpression of a stable form of -catenin rescues the XX Rspo1−=−
phenotype (Chassot et al., 2008). These data indicates that Rspo1 acts upstream
of -catenin. On the other hand, Rspo1 expression is not aﬀected in Wnt4−=−,
suggesting that Rspo1 acts either upstream of, or in parallel to, Wnt4 (Chassot
et al., 2008). Taken together, these data suggest that both Wnt4 and Rspo1 play
an important role in female sex determination by ensuring appropriate levels of
stable -catenin.
Stabilised -catenin, as the downstream eﬀector of WNT4 signalling and perhaps
RSPO1, has been shown to rescue the phenotype of Wnt4−=− gonads in organ
culture and the gonadal phenotype of R-spo1−=− mutant mice in vivo (Maatouk
et al., 2008; Chassot et al., 2008). In XY gonads from a transgenic mouse carrying
a dominant stabilised form of -catenin (Catnbex3), Sry and early Sox9 expres-
sion are unaﬀected and both the formation of the coelomic vessels and the early
proliferation of the coelomic epithelium, which is speciﬁc for XY gonads, occur
normally. However, Sox9 expression rapidly decreases after 12.5 dpc resulting in
a disruption of testis cord formation and up-regulation of female-speciﬁc markers
(Bmp2, Foxl2, Dax1, Wnt4, Fst) in somatic cell lineages, indicating the transi-
45tion from male to female development (Maatouk et al., 2008; Chang et al., 2008).
On the contrary, Sertoli cell-speciﬁc deletion of -catenin, by either Amh:Cre or
Sf1:Cre, does not lead to any abnormalities in testis development, implying that
it is not essential for Sertoli cell diﬀerentiation (Chang et al., 2008; Liu et al.,
2009). However, in XX gonads, conditional deletion of -catenin in SF1-positive
somatic cells results in the appearance of testis-speciﬁc vasculature, maintenance
of the Wolﬃan duct and loss of germ cells, closely resembling the phenotype of
both Wnt4−=− and R-SPO1−=− mutant mice (Liu et al., 2009). Taken together,
the data suggest that the role of -catenin is to antagonise testis development
and to maintain rather than initiate female development. It has been shown in
chondrocyte diﬀerentiation that SOX9 and -catenin are able to repress each oth-
ers eﬀects on transcriptional activation in a DNA binding independent manner.
As the C-terminal transactivation domain of Sox9 physically can interact with
the Armadillo repeats in -catenin, SOX9 can compete with LEF/TCF factors
for binding to -catenin. The resulting SOX9/-catenin complex is eventually
degraded via the proteosomal machinery (Akiyama et al., 2004). Therefore, Sox9
can act as a de-stabiliser of -catenin causing a reduction in the expression of -
catenin target genes or vice-versa. Similarly, there is some evidence that human
SRY is able to inhibit -catenin by direct protein interaction in vitro (Bernard
et al., 2008). It is not known which part of the SRY protein mediates the inter-
action with -catenin, only that the SRY HMG-box on its own is not suﬃcient.
Other studies indicate a role of -catenin in estrogen production in granulosa
cells where -catenin is able to directly interact with SF1 and thereby modulate
SF1 activity, e.g. in the regulation of Cyp19A1 in vitro (Parakh et al., 2006).
46Dax1 (also known as Nr0b1) is an X-linked gene encoding an unconventional
member of the nuclear receptor (NR) superfamily. It lacks the classic zinc ﬁnger
DNA binding domain of NRs and instead contains three and a half repeats of a
novel domain composed of the LXXLL-motif (Ito et al., 1997), which appears to
be involved in interactions between DAX1 and other NRs. DAX1 binds to SF1
through this motif and represses SF1 activity by the recruitment of a nuclear
co-repressor NcoR (Ito et al., 1997; Crawford et al., 1998). On the other hand,
the Dax1 promoter contains binding sites for SF1 and mutation of these sites
abolishes Dax1 expression. Moreover, Dax1 expression is signiﬁcantly reduced
in Sf1−=− mice (Hoyle et al., 2002) implying that Dax1 is regulated by SF1 in
the developing gonad. Thus, the two genes interact in a complex fashion which
is not yet fully understood. A consensus DNA binding sequence for DAX1 has
not yet been described. It might bind DNA directly, like other nuclear receptors
(e.g. SF1), but it has also been suggested that DAX1 binds to DNA secondary
structures (Zazopoulos et al., 1997) or that it does not bind to DNA, but to
RNA (Lalli et al., 2000). Human XY patients with duplications of a region of
Xp21, containing the DAX1 gene, display a male-to-female sex reversal (Bardoni
et al., 1994). This suggested that DAX1 can act as an anti-testis gene and that
it might be is important in ovary development. In mice, Dax1 is expressed in
the indiﬀerent genital ridge of both sexes and is down-regulated in XY gonads
during testis development (by 12.5 dpc) whereas the expression persists in the
somatic cells of XX gonads throughout ovarian development (Swain et al., 1996).
Misexpression of Dax1 in mouse strains carrying a weak Sry allele (Y POS) or with
a delayed onset of Sry expression causes XY sex reversal (Swain et al., 1998).
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(Meeks et al., 2003). On the other hand, mice carrying this Dax1 deletion show
XY male-to-female sex reversal in the presence of Y POS (Meeks et al., 2003) or
on a speciﬁc genetic background (C57BL/6HJ) (Bouma et al., 2005), indicating
that Dax1 is required for testis development. This is in contrast to the human
cases where LoF mutations in DAX1 do not aﬀect testis development in XY
AHC patients (Zanaria et al., 1994; Muscatelli et al., 1994). The molecular
mechanisms underlying this paradox are not understood yet, but it is possible
that Dax1 is needed for both testis and ovarian development depending on timing
and dosage of its expression. It is possible that the deletion might not be a
true null mutation as only the second of the two Dax1 exons was deleted and
a truncated DAX1 protein (containing only the N-terminal region) could still
retain some functional activity (Ludbrook and Harley, 2004). It might interact
with SF1 via its remaining N-terminus and could act as a dominant negative with
respect to SF1 activity (maybe by reducing the pool of SF1 protein available to
activate the male pathway).
Sox4 belongs to the SOX family of transcription factors (Gubbay et al., 1990),
subgroup C, together with Sox11. Sox4 is expressed in a number of tissues in-
cluding neural tissue, heart, lung and thymus (van de Wetering et al., 1993).
Moreover, in mice Sox4 has been found to be expressed speciﬁcally in the ovary
and not in the testis at the time of sex determination (P. Koopman, personal
communication) suggesting a potential role in ovarian development. Mice with a
homozygous null mutation of Sox4 (Sox4−=−) die at 14.0 dpc due to heart malfor-
mation (Schilham et al., 1996) but the gonadal phenotype of those mutant mice
48has not yet been analysed. It is known that SOX proteins are transcriptional reg-
ulators that can activate or repress target genes according to the cellular context
(Chew and Gallo, 2009). Hence, it is possible that SOX4 could act as a repressor
of Sox9 expression in the developing XX gonad. Moreover, it has been shown
that SOX4 directly interacts with -catenin and TCF/LEF proteins and that
SOX4 can enhance -catenin activity in colon carcinoma cells in vitro (Sinner
et al., 2007).
Foxl2 encodes for a member of the forkhead family of transcription factors. It
was originally identiﬁed as a candidate for a gene involved in ovarian development
in goats. In these animals, an 11.7 kb deletion 200 kb upstream of the Foxl2 gene
causes a dominant hornless phenotype that is associated with a recessive XX
female-to-male sex reversal, known as polled/intersex syndrome (PIS) (Vaiman
et al., 1996). In human patients, LoF mutations of FOXL2 cause the dominant
disorder blepharophimosis/ptosis/epicanthus inversus syndrome (BPES), charac-
terised by small palpebral ﬁssures (blepharophimosis), drooping eyelids (ptosis),
a small skinfold inwards from the lower lid (epicanthus inversus) and a broad
nasal bridge (Crisponi et al., 2001). Two distinct types of BPES have been de-
scribed: BPES type I which is associated with premature ovarian failure (POF) in
female patients and BPES type II where patients remain fully fertile. Mutations
within the coding sequence of FOXL2 resulting in a truncated FOXL2 protein
cause BPES type I, while frameshifts or duplications further downstream in the
sequence produce an extended protein which is associated with BPES type II.
Some BPES patients show intact coding sequences for Foxl2, but carry mutations
about 100 kb upstream of the gene itself (Uhlenhaut and Treier, 2006). In the
49mouse, Foxl2 is, amongst other tissues, expressed in the granulosa cells of ovarian
follicles. The gonadal expression is female-speciﬁc and starts in the supporting
cell precursors of the ovary around 12.5 dpc and is maintained in adult granu-
losa cells (Schmidt et al., 2004). Foxl2 is also expressed in some theca cells in
the adult ovary (Uhlenhaut et al., 2009). Mice with a heterozygous mutation of
Foxl2 display no phenotype, whereas homozygous loss of Foxl2 results in a num-
ber of defects resembling the human BPES condition (Uda et al., 2004; Schmidt
et al., 2004). This includes XX infertility and the postnatal up-regulation of
testis-speciﬁc genes (more detailed description of the Foxl2 mutant phenotype
in Chapter 5). Only a few target genes of FOXL2 have been described so far,
including the gonadotrophin releasing hormone receptor (GnRHR), the human
steroidogenic acute regulatory gene (StAR), which is involved in the rate-limiting
step of steroidogenesis, and Cyp19 which encodes for an aromatase involved in
converting androgens into estrogens (more detailed discussion of FOXL2 target
genes in Chapter 4). Moreover, it has been reported that forkhead factors can
compete with TCFs for interaction with -catenin in vitro and direct interaction
of forkhead factors and -catenin leads to the enhancement of forkhead transcrip-
tional activity (Hoogeboom et al., 2008).
Estrogen receptors (ERs) are members of the nuclear receptor superfamily which
transmit 17-estradiol (E2) signals into the nucleus and activate target genes by
binding to estrogen response elements (ERE). EREs are palindromic sequences
of the estrogen receptor half site GGTCA (Klinge, 2001). Two ERs have been
identiﬁed in mammals which are expressed in many tissues including the ovaries,
where ER is expressed in stroma, theca and granulosa cells and ER is expressed
50predominantly in granulosa cells (Fitzpatrick et al., 1999). Single mutations
of either ER or ER cause distinct defects. In XX ER−=− mice, follicular
development is partially arrested and follicular maturation occurs at reduced
eﬃciency resulting in smaller ovaries and sub-fertility whereas XY males are
fully fertile (Krege et al., 1998). XX ER−=− mice are infertile with a block
of folliculogenesis and a decrease in granulosa cell proliferation, severe uterine
and vaginal hypoplasia and unovulatory adult ovaries with accumulation of large
cystic follicles. Moreover XY ER−=− mice are infertile indicating that estrogens
might play an important role in male as well as in female development (Lubahn
et al., 1993; Dupont et al., 2000). Mice carrying double homozygous mutations
of both estrogen receptors (ER−=−) display a more severe phenotype than the
single mutants (Couse et al., 1999; Dupont et al., 2000). Similar to ER−=−
males, XY ER−=− mice are infertile due to reduced numbers of sperm, while
the reproductive tract appears normal. XX ER−=− mice are also infertile and
show vaginal hypoplasia, large ovarian cysts, absence of mature corpora lutea
and proliferation defects in granulosa and theca cell layers. These mice also
show partial sex reversal with appearance of seminiferous tubule-like structures
and Sertoli-like cells expressing Sox9 and Amh. However, this phenotype only
occurs after puberty (Couse et al., 1999). It has also been shown that forkhead
transcriptional regulators are essential for estrogen receptor DNA binding, e.g. in
breast cancer cell lines (Carroll et al., 2005), suggesting a possible link between
FOXL2 and ERs.
511.5.2 Ovarian development
The germ cells in the XX genital ridge enter meiotic prophase at 13.5 dpc and
arrest in diplotene at the time of birth. It has been proposed that they follow an
intrinsic clock to enter meiosis, as even germ cells assembled in lung aggregates
enter meiosis about 13.5 dpc in vitro (McLaren and Southee, 1997). However,
it has also been shown that not all germ cells in the ovary enter meiosis at the
same time but in an anterior-to-posterior pattern (Menke et al., 2003; Bullejos
and Koopman, 2004). Moreover, there is now substantial evidence that suggests
that retinoic acid, synthesised by the mesonephros, diﬀuses into the early ovary
to trigger entry of the germ cells into meiosis, probably by induction of Stra8 ex-
pression (Bowles et al., 2006; Koubova et al., 2006). In the early testis, CYP26B1,
which is produced by Sertoli cells and probably a target of Sox9, degrades retinoic
acid and thus prevents meiosis (Bowles et al., 2006; Koubova et al., 2006).
Morphological changes in XX gonads are not obvious until late gestation when
the ovary can be divided into two main regions: the cortex and the medulla.
Around 16.5 dpc many germ cells in the medulla undergo apoptosis resulting in
an accumulation of germ cells in the cortex (Yao et al., 2004). The germ cell loss
correlates with the breakdown of germ cell cysts and the start of folliculogenesis
(Pepling and Spradling, 2001). At this stage, the pre-granulosa cells extend cy-
toplasmic processes and enclose individual oocytes in a single layer of squamous
cells, forming primordial follicles (Figure 1.4). Oocytes express Fig (factor in
germ line ), which is involved in the recruitment of pre-granulosa cells. Although
germ cells of mice with a homozygous null mutation in Fig enter meiosis cor-
52rectly, they fail to form primordial follicles resulting in the depletion of oocytes
directly after birth (Soyal et al., 2000). During normal ovarian development, the
primordial follicles enlarge after birth due to an increase in the size of the oocyte
and the transition of the squamous granulosa cells into cuboidal granulosa cells,
resulting in the formation of primary follicles (Hirshﬁeld, 1991). The granulosa
cells then proliferate to form multiple layers around the oocyte and thereby form
pre-antral follicles, which are enclosed by an outer layer of theca cells. During
the following antral stage, the granulosa cells secrete follicular ﬂuid (containing
serum proteins and steroid hormones) which ﬁlls the emerging antral cavity. Most
of the antral follicles will undergo atresia, but the ones remaining will become
pre-ovulatory follicles under the inﬂuence of follicle-stimulating hormone (FSH).
After ovulation, the remaining granulosa and theca cells form the corpus luteum
which secretes steroid hormones to promote implantation of the embryo. In the
adult ovary, follicles of each stage can be found, which is due to some primor-
dial follicles entering a temporary state of quiescence to ensure the continuous
production of ovulatory follicles (Figure 1.4).
The function of the female steroidogenic cell lineage, the theca cells, is the pro-
duction of estrogens. Theca cells express Cyp11a, 3-HSD (HSD3B2) and Cyp17
which are required for the conversion of cholesterol into androgens. Granulosa
cells express Cyp19 and 17-HSD (HSD17B1) which converts these androgens
into estradiol. Thus, both cell types are required for estrogen production in the
ovary (Magoﬃn, 2005).
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Figure 1.4: Model of ovarian follicle development.
(a) Folliculogenesis starts in the embryo with a pool of germ cells and somatic
cells (granulosa and theca cells). The model shows the development of primordial
follicles which grow to primary, pre-antral and antral stages before they become
pre-ovulatory follicles. The granulosa cells (green) surround the oocyte (pink)
and proliferate to several layers of supporting cells. The theca cells (blue) start
to surround the follicles at the pre-antral stage. The antral cavity which contains
the follicular ﬂuid is shown in yellow. Adapted from Barnett et al. (2006). (b)
H+E staining illustrating the morphology of an adult ovary. Scale bar = 100m.
541.6 Outline of this thesis
Sox9 plays an essential role during embryonic development as its presence or
absence determines the fate of the gonadal supporting cell lineage and thereby
controls the establishment of either a testis or an ovary. The aim of this thesis
is to investigate the eﬀect of potential ovarian-promoting or anti-testis genes
on the expression of Sox9 via the TESCO element, both in vitro and in vivo.
Therefore, the repressing potential of DAX1, SOX4, FOXL2, ER and WNT4-
signalling on TESCO activity was individually analysed in transfection assays in
vitro. Subsequently, the consequences of loss of either Foxl2 or Wnt4 individually
or in combination was assessed in vivo, focusing on the potential de-repression
of TESCO and the male pathway in XX gonads during embryonic development
and adult stages. Finally, diﬀerent possible mechanisms by which FOXL2 could
mediate repression of TESCO were examined in vitro.
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Figure 1.5: Model of distinct Sox9 regulation in XX and XY gonads
during early development.
In the bi-potential gonad, SF1 binds to the TESCO enhancer of Sox9 and initi-
ates a low Sox9 expression in both sexes. In XY gonads, SRY binds to TESCO
and up-regulated Sox9 expression, which is maintained by SOX9 itself and other
factors such as FGF9 and PGD2 signalling. In contrast, the initial Sox9 expres-
sion is actively down-regulated in XX gonads and the repression is maintained
throughout life. Several anti-testis or ovarian-determining genes have been pro-
posed to be involved in this regulation of Sox9 expression, although no direct
interactions have been shown yet.
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Materials and Methods
2.1 Sequence analysis
TESCO sequences from diﬀerent species were compiled from the Ensemble data-
base (http://www.ensembl.org): mouse sequence (ENSMUSG00000000567),
rat sequence (ENSRNOG00000002607), human sequence (ENSG00000125398)
and dog sequence (ENSCAFG00000004374). The mouse TESCO sequence was
analysed for potential transcription factor binding sites using the MatInspector
program (http://www.genomatix.de). To analyse the homology between the
TESCO elements of diﬀerent species, sequences were aligned and compared us-
ing the BLAST software from NCBI (http://www.blast.ncbi.nlm.nih.gov/
Blast.cgi).
572.2 Luciferase Assay
2.2.1 Cloning of constructs
To analyse the eﬀect of several candidate genes in co-transfection assays, the
cDNAs of those genes were individually cloned into a CMV expression vector
(for plasmid maps see Appendix). Existing plasmids containing the cDNA of
interest were cut by enzymatic digestion following standard protocols. For Foxl2,
the gene was ampliﬁed from whole ovarian DNA by PCR (KOD Hot Start Poly-
merase, Novagen) following standard protocols. The DNA fragments were then
puriﬁed using the Geneclean II kit (Qbiogene) and ligated into the linearised
pcDNA3 vector (Invitrogen) for 30 minutes at 16◦C. Subsequently, constructs
were transformed into chemically competent TOP-10 cells (Invitrogen) by adding
the ligation mix to 50l of TOP-10 cells, incubating on ice for 20 minutes fol-
lowed by an incubation at 42◦C for 1 minute. After resting for 5 minutes on ice,
500l of LB medium was added to the cells, which were then incubated at 37◦C
for 1 hour. 100l of transformed cells were streaked onto LB plates containing
ampicillin (50g/ml) and incubated at 37◦C overnight. The next day, single bac-
terial colonies were picked and incubated in 2ml LB broth containing ampicillin
(100g/ml) at 37◦C in a Brunswick Scientiﬁc Shaking Incubator for 6 hours at
350rpm. Plasmid DNAs were extracted via Miniprep following standard proto-
cols and successful cloning was determined by restriction digest. For large-scale
DNA preparations, 100ml LB broth containing ampicillin (100g/ml) were in-
oculated with 100l of the remaining Mini-culture from the correct clones and
incubated overnight at 37◦C. The plasmid DNAs were extracted via Maxipreps
58using the Nucleobond Xtra kit (Macherey-Nagel) and stored at 4◦C. From each
clone, 1ml of culture was kept and 0.5ml 50% glycerine was added to generate
glycerine stocks which were stored at -80◦C.
For analyses of transcription factor binding, several base pairs were mutated in
the TESCO element. This was done using modiﬁed oligonucleotides in a PCR
ampliﬁcation of the TESCO sequence using the KOD polymerase, resulting in
speciﬁc point mutations at the sites of interest. The TESCO sequence with all
FOX/ERE sites mutated was generated by de novo DNA synthesis (GENEART,
Germany). The altered TESCO sequences were then cloned into the Luciferase
vector (p51LUCII) between BamHI and SalI. All constructs were sequenced
(Cogenics) and analysed to determine the accuracy of the mutations and cloning.
2.2.2 Cell culture
COS7 cells (ATTC #CRL-1657) were cultured in Dulbecco’s modiﬁed Eagle
medium (DMEM, Sigma) with 10% fetal calf serum (FCS, Gibco), 1% L-glutamine
(Gibco) and 1% Penicilin/Streptomycin (Gibco) at 37◦C and 5% CO2. When the
cells were 70-80% conﬂuent, they were washed with PBS (calcium and magne-
sium free, Gibco) and incubated with Trypsin-EDTA (Gibco) until they detached
from the bottom of the ﬂasks. Culture medium was added to stop trypsinisation
and the cells were centrifuged at 1000rpm for 5 minutes at 4◦C. The cell pellet
was then resuspended in fresh culture medium and the cells re-plated at a lower
density. For stock freezing, cells were re-suspended in 0.5ml of DMEM containing
20% FCS and 10% DMSO (Sigma) and stored in liquid nitrogen.
592.2.3 Transfection assays
COS7 cells were plated in normal culture medium at 5x104 cells per well in 24-well
plates 24 hours before transfection. The cells were then transfected with 0.5g
Luciferase vector containing the TESCO element (either wild-type or with in-
serted point mutations) and 0.1g of the expression vectors containing Sf1, Sox9
or Sry to activate Luciferase activity. To analyse potential repression eﬀects, the
same amount of expression vectors containing Foxl2, ER, Dax1, Sox4, -catenin,
Tcf1, Tcf3, Tcf4 or Lef1 were added individually in diﬀerent co-transfection as-
says. To determine dosage-dependent eﬀects, increasing amounts of these eﬀector
genes were transfected (20ng, 60ng, 180ng, 540ng). The amount of expression
vector was equalised by adding pcDNA3 vector, the amount of DNA was adjusted
using pBluescript vector. For normalisation 0.3g pmiwZ (Suemori et al., 1990)
was added. The DNA and 4g Lipofectamine (Invitrogen) were mixed in serum-
free OptiMEM (Gibco), incubated at room temperature for 20 minutes and then
added to the cells in fresh DMEM. Luciferase activity was measured 48 hours
after transfection using the Luciferase assay system (Promega) and normalised
to -galactosidase activity using 2.5g of o-Nitrophenyl--D-galactopyranosid
substrate (ONPG, Sigma) per ml of LacZ buﬀer (10mM KCl, 1mM MgCl2 ,
40mM NaH2PO4, 60mM Na2HPO4, 1mM DTT). All co-transfection assays were
performed in triplicates, error bars indicate the standard deviation from three
biological replicates and p-values were calculated using the GraphPad Software
t-test calculator (www.graphpad.com/quickcalcs/ttest1.cfm).
602.3 Mouse Lines
2.3.1 Husbandry
Animals were kept on a 12 hour light-dark cycle, water and food were provided
ad libitum. For embryonic studies, the morning of vaginal plug (VP) detection
was deﬁned as 0.5 days post coitum (dpc), assuming the time of conception
was in the middle of the dark phase. For postnatal studies, the day when pups
were born was deﬁned as postnatal day zero (P0), followed by the ﬁrst day post
partum (dpp). All experiments were carried out in accordance with the Animals
(Scientiﬁc Procedures) Act 1986 under the project licence 80/1949A and the
personal licence 80/10095.
2.3.2 Genotyping
Ear pieces were lysed overnight at 55◦C in lysis buﬀer (0.5M Tris-HCl pH 8.5,
5mM EDTA, 0.1M NaCl, 2,5% SDS) with 1mg/ml proteinase K (Roche). The
DNA was then puriﬁed by Phenol extraction using an equal amount of Phenol-
Chloroform-Isoamylalcohol (25:24:1) followed by precipitation with NaOAc (1/10
volume) and Isopropanol (1x volume). Finally, the DNA was resuspended in 50l
TE and used in PCRs. For genotyping of embryos or newborn pups, a small piece
of tail was used and the DNA extracted as described above.
612.3.3 Mouse lines
TESCO:CFP
The 1.3 kb TESCO sequence was cloned into the Asshsp68LacZpA vector, con-
taining the hsp68 minimal promoter and in which the LacZ gene had been re-
placed by ECFP. The TESCO element drives CFP expression speciﬁcally in Ser-
toli cells of the testis (Sekido and Lovell-Badge, 2008). The mice were kept on
an MF1 background and the presence of the transgene was detected by standard
PCR with primers located in the ECFP: 5’-GACCCTGAAGTTCATCTGCAC-3’
and 5’-GTGGCTGATGTAGTTGTACTC-3’ (for protocol see Appendix 8.2).
TESCO
pA ECFP hsp68
Foxl2LacZ
Foxl2LacZ mice were originally generated and described by Schmidt et al. (2004).
Foxl2 is a single exon gene and encodes for a protein of 375 amino acids. Upon
homologous recombination at the Foxl2 locus, the amino acids 62 to 375 were re-
placed by the LacZ gene, generating a functional null allele (see diagram below).
The mice were ﬁrst kept on a C57BL/6 background, but later bred onto an MF1
background. Homozygous oﬀspring were obtained by inter-crossing heterozygous
males and females. The Foxl2LacZ mice were genotyped by detecting the wild-type
Foxl2 allele with the primer set (5’-CAGATGATGGCCAGCTACCCCGAGC-3’
and 5’-GTTGTGGCGGATGCTATTCTGCCAGCC-3’) and the mutant allele
62with a third primer (5’-GTAGATGGGCGCATCGTAACCGTGC-3’) which is
located within the LacZ sequence and the forward primer described above (for
protocol see Appendix 8.2).
ATG 183
Chr9,  Foxl2 Locus
LacZ Foxl2
Wnt4neo
Wnt4neo mice were originally generated and described by Stark et al. (1994). Ho-
mologous recombination at the Wnt4 locus resulted in a deletion of about 2.2 kb
including the coding sequence for the WNT4 amino acids 106 to 196 and replace-
ment by a PGK-neo selection cassette, resulting in a functional null allele (see dia-
gram below). The mice were kept on an 129/Sv background and homozygous oﬀ-
spring were generated by inter-crossing heterozygous mice. The wild-type Wnt4
allele was detected with the primers 5’-CTTCACAACAACGAGGCTGGCAGG-3’
and 5’-CACCCGCATGTGTGTCAAGATGG-3’, whereas the targeted Wnt4neo
allele was identiﬁed by a primer located within the sequence of the PGK-neo
cassette 5’-GCATTGTCTGAGTAGGTGTCATTC-3’ and the reverse primer de-
scribed above (for protocol see Appendix 8.2).
Chr4,  Wnt4 Locus PGK−neo E5 E2 E1
ATG TGA
63R26DTA
R26DTA mice were originally generated by Ivanova et al. (2005) and contain a
GFP/PGK-neo cassette between two LoxP sites followed by the diphtheria toxin
fragment A (DTA) in the ROSA26 locus. In the absence of Cre recombinase, GFP
is expressed and DTA is not active. Upon Cre recombination, the GFP/PGK-
neo cassette located between the two LoxP sites (pink triangles in the diagram
below) is excised resulting in the activation of DTA. When expressed, the subunit
A of the diphtheria toxin mediates the termination of all protein synthesis which
eventually leads to apoptosis of the cell (Maxwell et al., 1986), therefore result-
ing in cell depletion speciﬁcally in the cell type expressing the Cre. Homozygous
R26DTA mice were kept on the C57BL/6 background and bred to mice carrying
a Cre recombinase under the control of the oocyte-speciﬁc promoter of the zona
pellucida 3 gene (Zp3:Cre, Fvb background) to generate Zp3:Cre, R26DTA mice.
The presence of the Zp3:Cre allele was detected by PCR using the primer set
5’-GGCGGATCCGAAAAGAAAA-3’ and 5’-CAGGGCGCGAGTTAGTAGC-3’
(for protocol see Appendix 8.2).
ROSA26 Chr6, locus
ROSA26 Chr6, locus
pA DTA
GFP PGK−neo pA DTA pA
After ZP3cre recombination
642.3.4 Harvesting of gonads
For the analysis of embryonic gonads, pregnant mice were harvested using a
schedule 1 method at diﬀerent time points after VP. Embryonic gonads (including
the mesonephros at stages earlier than 16.5 dpc) were then dissected into PBS
and cleaned from all other tissues. In addition, a small piece of embryo tail
was collected and used for genotyping. For analyses of postnatal stages, pups
and adult mice were harvested at diﬀerent ages using a schedule 1 methods and
ovaries and testes were then dissected into PBS as described above.
2.4 Immunohistochemistry
2.4.1 Preparation of samples
Embryonic gonads were ﬁxed in 4% PFA (w/v in PBS) for 30 minutes (from
12.5 dpc to 14.5 dpc ) or 1 hour (from 16.5 dpc to P0) at 4◦C. Postnatal gonads
were ﬁxed overnight at 4◦C. After ﬁxation, gonads were washed with PBS and
equilibrated in 30% sucrose (w/v) at 4◦C overnight. Samples were then embedded
in OCT compound (VWR) in Dispomoulds and frozen using dry ice. Frozen sam-
ples were sectioned at a thickness of 8m using a Leica cryostat (model CM3050S)
and the sections were then collected onto Superfrost Plus slides (Thermo Scien-
tiﬁc). Slides were stored at -80◦C until further processing.
652.4.2 Histology
For Haematoxylin-Eosin (H+E) staining, postnatal gonads were ﬁxed in Bouin’s
solution (Sigma) overnight at 4◦C. After ﬁxation, samples were washed in 70%
ethanol and then stored in fresh 70% ethanol at 4◦C. Samples were subsequently
embedded in wax, sectioned at a thickness of 5m and processed for H+E staining
(Histology Service, NIMR).
2.4.3 Immunostaining
Cryosections were thawed at room temperature and then washed twice with PBS
to remove the remaining OCT compound. Adult samples were additionally ﬁxed
in 4% PFA for 10 minutes at room temperature and then washed again twice with
PBS. Afterwards, sections were blocked with 1% normal donkey serum (Sigma)
in PBS/0.05% triton for 1 hour at room temperature. Subsequently, sections
were incubated with primary antibodies diluted in blocking solution in a humid-
iﬁed chamber overnight at 4◦C. The following day, sections were washed three
times with PBS/0.1% triton and then incubated for 1 hour with the appropriate
ﬂuorescent secondary antibody (Molecular probes) diluted in blocking solution
in a humidiﬁed chamber in the dark at room temperature. After the slides were
washed with PBS/0.1% triton three times, sections were incubated with DAPI
solution (Sigma, 1:10000 v/v in PBS) at room temperature for 5 minutes. Finally,
sections were rinsed with PBS, air dried and mounted with Aqua PolyMount so-
lution (Polysciences).
For co-staining, sections were washed three times in PBS/0.1% triton after incu-
66bation with the secondary antibody and then ﬁxed again in 4% PFA for 10 min-
utes at room temperature. After rinsing with PBS, sections were blocked for
1 hour at room temperature and the second primary antibody was added in
blocking solution and incubated overnight at 4◦C. The following day, sections
were processed as described for single staining.
Primary antibodies
Protein Host Dilution Source
GFP Rabbit 1:500 Invitrogen
GFP Goat 1:500 Abcam
SOX9 Goat 1:250 R&D systems
SOXE Rabbit 1:1000 Morais da Silva et al. (1996)
FOXL2 Goat 1:500 Imgenex
-galactosidase Mouse 1:500 Promega
Secondary antibodies
Antibody Fluorescence Dilution Source
Goat anti-rabbit Alexa-488 1:500 Molecular Probes
Donkey anti-goat Alexa-488 1:500 Molecular Probes
Donkey anti-goat Alexa-555 1:500 Molecular Probes
Goat anti-mouse IgG2 Alexa-594 1:500 Molecular Probes
672.4.4 Imaging
Pictures of H+E stainings were obtained with a light microscope (Leica CTR-
MIC) using a 40x lens and OpenLab software (Improvision, UK). Immunoﬂuores-
cent pictures were taken with a Leica SP5 confocal using a LAS software (Leica,
Germany). Images were taken with either 40x or 100x lenses and processed using
Adobe Photoshop 5.5 (Adobe Systems).
2.5 Protein interaction assays
2.5.1 In vitro translation of 35S-SF1
35S-labelled SF1 was generated following the instructions of the TNT coupled
reticulocyte lysate system from Promega. The pcDNA3-Sf1 plasmid was used as
DNA template (0.5g/l). For the reaction mix, 25l TNT rabbit reticulocyte
lysate, 2l TNT reaction buﬀer, 1l RNA Polymerase T7, 1l 1mM amino acid
mixture (without methionine), 1l RNase Inhibitor, 2l DNA template and 1l
[35S]methionine (10.25mCi/ml) were incubated in a total volume of 50l at 30◦C
for 90 minutes. The reaction was then stopped by transfer to ice and a fraction
of the in vitro translated protein was subsequently analysed on a 6% acrylamide
gel whereas the remaining sample was aliquoted and stored at -80◦C. The gel was
run at 170V for 2-3 hours, dried afterwards and the presence of radioactivity was
detected by ﬁlm (Kodak) exposure overnight at -80◦C.
682.5.2 Preparation of GST-FOXL2
The Foxl2 cDNA was cloned into the GST gene fusion vector pGEX-2T (Ad-
dgene) via BamHI and EcoRI. The construct was transformed into bacterial cells
and the following day clones were picked and inoculated in 5ml LB broth at 37◦C
overnight. Cultures were then transferred to 150ml fresh LB broth and further
incubated at 30◦C until it reached an OD between 0.5 - 1.0 after approximately
4 hours. Protein production was induced by adding 0.2mM IPTG followed by in-
cubation at 30◦C for 2 hours. Subsequently, cultures were centrifuged at 5000rpm
for 10 minutes at 4◦C. Pellets were resuspended in 5ml PBS (including 100M
ZnCl2, 1mM PMSF) and sonicated (duty cycle 30%, output control 5, 30 seconds
on, 1 minute oﬀ, 7 cycles). Afterwards Tween-20 and DTT were added to a
ﬁnal concentration of 1% and 4mM, respectively. Samples were then centrifuged
at 4000rpm for 15 minutes at 4◦C. The supernatant was incubated with 0.25ml
Glutathione Sepharose-4B beads (Pharmacia, 50% w/v in PBS) by mixing gen-
tly for 10 minutes at 4◦C. The beads were then washed three times with PBS
(containing 100M ZnCl2, 1mM PMSF) and centrifuged at 800rpm for 2 min-
utes at 4◦C. Afterwards, the beads were resuspended in buﬀer G (50mM Tris-HCl
pH9.5, 5mM Glutathione S-transferase (Sigma)) and mixed gently for 15 minutes
at 4◦C. Finally, the beads were collected by a short spin up to 5000rpm at room
temperature and the supernatant was transferred into a dialysis tube. The pro-
tein extracts were dialysed against 10mM Tris-HCl pH 8.0, 100mM ZNSO4, 1mM
PMSF overnight at 4◦C. The ﬁnal protein extracts were aliquoted and stored at
-80◦C.
692.5.3 Co-Immunoprecipitation
5l 35S-SF1 and either 3g GST-FOXL2 or GST control protein were incubated
in CoIP buﬀer (20mM HEPES pH7.9, 100mM KCl, 10% Glycerol, 0.1% Triton,
1mM DTT, 1mM PMSF) at 4◦C for 2 hours. Samples were subsequently incu-
bated with 20l Glutathione Sepharose-4B beads (50% w/v in PBS) for 30 min-
utes at 4◦C. The beads were then washed three times with CoIP buﬀer and cen-
trifuged at 800rpm for 2 minutes at 4◦C. Afterwards, the beads were resuspended
in 20l 2x protein sample buﬀer (Invitrogen) and boiled at 95◦C for 5 minutes.
10l of each sample and 5l input control (35S-SF1 protein) were run on 4-12%
pre-made gels (Invitrogen) for 1 hour at 170V and 70mA. Afterwards, the gels
were dried for 30 minutes and the presence of radioactive sample was detected
by ﬁlm exposure overnight at -80◦C.
2.5.4 Nuclear protein extract
COS7 cells were plated at a density of 5x104 cells per 10 cm2 dish and incu-
bated at 37◦C and 5% CO2. The following day, 24g of either pcDNA-Foxl2 or
pcDNA-Sf1 were transfected using 60 g Lipofectamine in fresh medium. After
48 hours, the cells were washed twice with PBS and then centrifuged for 15 sec-
onds at 13000rpm at 4◦C. The cells were resuspended in 600l ice cold buﬀer A
(10mM HEPES pH7.9, 10mM KCl, 0.1mM EDTA, 0.1mM EGTA, 1mM DTT,
1x proteinase inhibitor cocktail) and incubated on ice. After 15 minutes, 37.5l
10% NP-40 were added to the cells, which were vortexed for 10 seconds and then
centrifuged for 30 seconds at 13000rpm at 4◦C. The supernatant, which contains
70the cytoplasmic proteins, was removed and the pellet resuspended in 50l ice cold
buﬀer C (20mM HEPES pH7.9, 400mM NaCl, 1mM EDTA, 1mM EGTA, 1mM
DTT, 1x proteinase inhibitor cocktail). After incubation at 4◦C for 15 minutes,
the samples were centrifuged for 5 minutes at 13000rpm at 4◦C. The supernatant
containing the nuclear cell extract was then aliquoted and stored at -80◦C.
2.5.5 Electrophoretic Mobility Shift Assay (EMSA)
Two complementary DNA sequences of a length of 43 nucleotides, each containing
a 5’ overhang including a GTP, were annealed to form a double strand. 600pmol of
each oligonucleotide (MWG) were incubated in 100l STE (100mM NaCl, 10mM
Tris-HCl pH8.0, 1mM EDTA) for 10 minutes at 95◦C, followed by 30 minutes
at 65◦C, 1 hour at 37◦C and overnight at 4◦C. The double stranded sequences
were then labelled by ﬁlling the 3’ gaps of each strand with nucleotides including
[-32P]dCTP by Klenow polymerase in a total volume of 50l for 30 min at 37◦C
(50ng DNA, 5l 10xbuﬀer, 1l 5mM d(GAT)P, 2l d32P-CTP (10mCi/ml),
1l Klenow DNA polymerase I (5U/l)). The reaction was stopped by phenol-
chloroform extraction and 50l STE were added before the labelled probes were
puriﬁed over a Sephadex G50 column. The radioactive incorporation was de-
termined via the Cherenkov method and samples with greater than 106cpm/g
DNA were used in subsequent shift assays. Binding reactions for SF1 and FOXL2
using nuclear protein extracts were carried out in DNA binding buﬀer (20 mM
HEPES pH 7.9, 50 mM KCl, 1 mM EDTA, 20% Glycerol, 1 mM DTT, 50 g/ml
poly dI-dC, 2.5 g/ml salmon sperm DNA, 50 g/ml BSA) using 1 l 32P end-
71labelled probe and 1 l nuclear protein extract in a total of 20l for 30 minutes
at room temperature. The incubations were stopped by transfer to ice and 2l
10x loading dye (0.2M HEPES pH7.9, 0.5M KCl, 10mM EDTA, 0.25% BPB)
were added to each sample. 10l of each sample was subsequently run on 6%
acrylamide gels in 0.5x TBE for 4 hours at 100V. The gels were then dried for
30 minutes and analysed by ﬁlm exposure overnight and for 1 week at -80◦C.
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TESCO modulation by ovarian
determining genes in vitro
3.1 Introduction
The key element in the early gonad for ovarian development is the down-regulation
of Sox9 expression in the supporting cell lineage by 11.5 dpc. If Sox9 fails to be
down-regulated and is instead maintained, XX female-to-male sex reversal occurs.
This has been shown in XX human patients with duplication of the chromosomal
region containing SOX9 (17q23-24) and by transgenic misexpression of Sox9 in
XX mice (Huang et al., 1999; Bishop et al., 2000; Vidal et al., 2001). However,
it was not known which gene(s) are responsible for the initial down-regulation
of Sox9 expression in XX gonads and the maintenance of this repressed state
throughout adult life. Several genes have been proposed to act as ovarian pro-
moting or anti-testis genes and might be involved in the initial down-regulation
of Sox9 and/or in the maintenance of its repression in the XX gonad.
Recently, the 1.3 kb enhancer sequence TESCO was identiﬁed as the regulatory
73element for sex-speciﬁc Sox9 expression in the XY gonad (Sekido and Lovell-
Badge, 2008). Moreover, in vitro studies in COS7 cells using a reporter assay
approach in which the mouse TESCO element drove the expression of a Luciferase
reporter gene, showed that TESCO could not be activated by SRY or SOX9 by
themselves. However, it could be activated about 5-fold by SF1, about 10-fold by
combination of SF1 and SRY and a robust activation (30-fold) was detected by a
combination of SF1 and SOX9 (Sekido and Lovell-Badge, 2008). When the con-
sensus binding sites for both SF1 and SOX proteins were mutated in the TESCO
sequence, no activity could be detected in the co-transfection assays, furthermore
indicating a synergistic eﬀect between SF1 and SRY/SOX9 in regulating TESCO
activity. Studies in mice carrying a CFP reporter transgene under the control of
the TESCO element showed that the enhancer activity recapitulates the gonadal
expression of Sox9 in vivo. While high levels of TESCO activity could only be
detected in the presence of endogenous SOX9, some reporter activity was also
seen in the absence of SOX9 at 11.5 dpc in vivo, indicating that SRY is required
for TESCO activation. Furthermore, corresponding to the in vitro results, mu-
tation of the SF1 and SOX binding sites abolished TESCO:CFP expression in
the transgenic mice (Sekido and Lovell-Badge, 2008). All these data let to the
proposal that the TESCO element is necessary to activate and maintain Sox9
expression in the XY gonad.
On the other hand, it is also possible that the TESCO element plays a role in the
regulation of Sox9 in the XX gonad, either in its initial down-regulation and/or
the maintenance of its repression. This hypothesis raises the question whether any
of the proposed ovarian determining or anti-testis genes could be involved in the
74regulation of TESCO activity in the XX gonad. These genes have been suggested
to be important for ovarian development due to their sex-speciﬁc expression in
XX gonads both during the time of sex determination and in the adult. Thus,
the aim of the study presented in this chapter was to analyse whether the ovarian
promoting genes could indeed regulate TESCO activity.
To determine whether DAX1, SOX4, -catenin, FOXL2 and ER could possibly
repress Sox9 expression via the TESCO element, the TESCO sequence was ﬁrst
analysed for potential binding sites of the proposed transcription factors. Subse-
quently the individual eﬀect of each factor on the TESCO element was analysed
by in vitro co-transfection assays.
753.2 Results
3.2.1 Sequence analysis of TESCO
The 1.3 kb TESCO sequence was analysed for putative binding sites of forkhead
factors (FOXL2), EREs, nuclear receptors (DAX1) and LEF/TCF factors (as
eﬀectors of Wnt4-signalling) using the MatInspector program (Quandt et al.,
1995).
The search revealed two possible forkhead factor binding sites, three ERE half
sites, two LEF/TCF binding sites and three nuclear receptor sites (Figure 3.1).
In addition to the sites identiﬁed in this study, the TESCO sequence also con-
tains six SF1-speciﬁc binding sites and three sites for SOX proteins (Sekido and
Lovell-Badge, 2008). From the Ensemble database, the TESCO sequences were
compiled for mouse (ENSMUSG00000000567), rat (ENSRNOG00000002607), hu-
man (ENSG00000125398) and dog (ENSCAFG00000004374) and then analysed
by the NCBI-BLAST software. A comparison between those species showed high
conservation for most of the predicted binding sites (see Appendix 8.3), suggest-
ing a potential role for these sites in Sox9 regulation.
To test if FOXL2, ER, DAX1, SOX4 or the -catenin/LEF/TCF complex could
indeed exert a repressive eﬀect on the TESCO element, in vitro co-transfection
assays were carried out.
76        1 CATATGTCAC ATACCTAAGG TGAAAATATA CGAGCCCTGT CTAAATCGGA ACTCCAACCA 
       61 TGTACCATTT TCCTTAAGGC CCCACAGGAA GAAAAAGGGA AAAAGAGAGA GAGACCGACT 
      121 CTATTGTTGA ATTACTGTTA GCAGAACTCA GCTGTAATAC AGAACCATTT GAAAGGAATG 
      181 CCAATTGAGT TCTGCCCAGC CTGAAGAAGA CCCAGCCTCG GCCTTTGTTC CTAACCTGGG
      241 CGGTTTTCAC AAAATAACAA TGCCTTCTTT CAGAAACTTT AGGGCTAAGA AAGAGAAGAC 
      301 TCCACTCTCG CAGATAAGGG CTGGCAGAAG AGGTGGCAGA TACCAACTAC AGGGAGGTGG 
      361 CTGCAGGAGT TCCCAGGGTC AAACACAAGT GCCTGGCTTC TTGGTGAGAG GAATTAGACA
      421 AGGAAGGGCC TTGCTCCCAG GAACTGAAAA CCCCCCACCC CCACTCCCTG TGCCCATACA 
      481 GAAGAAGTCC AAGGATCTCT GAAAACATCT CCTTCACATT CTGGGTATGT TTGCAGTTGG 
      541 GGGCTATCTC TACAGCTGAC TTCTTCCAAG ACTCTGCGGT TTAGAGTTTG AGTGAGCTTG 
      601 GTGGCTGGCC TTTCTCTCTC TTACCTTTTT ATTCAAAGTT TCCAACACAC AAAGCGCTTG 
      661 AGAGTATCCA TGGAAACTTC CATAGCCACG GACTCAGAAT GAGGCTGTGA GCAAAGTGTC 
      721 AGCAGCCTGG AAGTCACCCC AAGAGCATCA AGTCCCGGTG GCATGAATGT GTCACTTTCT 
      781 CTTTTTCTAA TGGGGCCACG GGGTGCCATT TCTTTGCAAA GGACCACACC GACATGAGCC 
      841 CAGCTAAAAA GGGGGTAGCT ACTGATAGGA TGAACTCGGA CTGCGGTTGC ATTTGGACTG 
      901 GTAAATGTGG TCAGTCACAT AGCAAGGCAG GACTCAGACA CTGCAGAAAT GCACTGCCCT
      961 TGCTTGAAGG CCTTGTTGAC CCTGATAAAG CTTGTGGCCC TTCTAGAAGA GGTGTATCCT 
     1021 TGTCCCACCT CCCACCTCCA GCCTTCCTGG CTTCCTGAGA GCAATCTGTG CTCAGGGCCA 
     1081 GTCCACACAG TGTGCTACTG AGTTGAATGA CCTTGTCCTC TCGAACTCCC CTGTCCCCAT 
     1141 TCAGTACACC ATTGTTCTGC AATCTCCACC AGCATTGGTT CAAGGACCCT CTATAGCTAC 
     1201 AAAAGTCCAG GGACACCCAA GTCTCATATA AAACAGCATG GTGTGTGCAC AGAACTAATG 
     1261 ATAATTCCCA TGTGGTGTTA ATTGTCTGTT AAC
xxx FOXL2 binding sites G/A T/C C/A A A C/T A 
xxx Estrogen response half site GGTCA
xxx TCF/LEF-1 binding sites C/T C T T T G A/T A/T 
XXX SF1 binding sites T/C A A G G T/C C G/A 
XXX SOX binding sites A G A A C A A T G G
xxx possible DAX1 binding sites secondary structure 
Figure 3.1: Sequence analysis of TESCO.
The TESCO sequence contains several binding sites for forkhead factors
(FOXL2), EREs, nuclear receptor sites (DAX1) and binding sites for LEF/TCF
factors, as well as SF1 and SOX binding sites.
773.2.2 Repression of TESCO in vitro
To investigate the possible repressive eﬀects of DAX1, SOX4, WNT4, FOXL2
and ER, each of the genes was cloned into the same expression vector used for
SF1 and SRY. Each construct was then expressed in COS7 cells together with
the TESCO reporter construct and combinations of SF1, SF1 + SOX9 and SF1
+ SRY, respectively. Dosage-dependent eﬀects were analysed by co-transfection
of diﬀerent amounts of the candidate gene upon TESCO activation by SF1 +
SOX9.
Addition of DAX1 resulted in 74% reduction of TESCO activation when acti-
vated with SF1, 85% when activated with SF1 + SOX9 and 86% when activated
with SF1 + SRY (Figure 3.2a). Increasing amounts of DAX1 showed a dosage-
dependent reduction of TESCO activity down to background levels (Figure 3.2b).
Addition of SOX4 did not have any signiﬁcant eﬀect on TESCO activation by
SF1, but co-transfection of SOX4 with SF1 + SRY or SF1 + SOX9 resulted in a
reduction of around 10% (Figure 3.3a). Increasing amounts of SOX4 correlated
with a greater repression of TESCO activity, up to a reduction of about 60% of
the original activation by SF1 + SOX9 (Figure 3.3b).
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Figure 3.2: Repression of TESCO by DAX1 in vitro.
SF1, SF1 + SOX9 or SF1 + SRY mediated TESCO activation was robustly re-
pressed in vitro by co-transfection of DAX1 (a). This eﬀect was dosage-dependent
as higher amounts of Dax1 resulted in a greater repression of TESCO (b). As-
says were performed in triplicate, bars indicate the standard deviation of three
biological replicates, asterisks show signiﬁcance with * p < 0:05, ** p < 0:01,
*** p < 0:001.
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Figure 3.3: Repression of TESCO by SOX4 in vitro.
SOX4 did not have any signiﬁcant eﬀect on the activation of TESCO by SF1
alone, but in combination with SF1 + SOX9 or SF1 + SRY resulted in a mi-
nor repression of TESCO activation (a). Increasing amounts of SOX4 revealed
a dosage-dependent repression eﬀect on SF1 + SOX9 mediated TESCO activa-
tion (b). Assays were performed in triplicate, bars indicate the standard devi-
ation of three biological replicates, asterisks show signiﬁcance with * p < 0:05,
** p < 0:01, ns = not signiﬁcant.
80The co-transfection assays with FOXL2 were ﬁrst done using an EGFP-Foxl2 N-
terminal fusion plasmid (gift from M. Treier). These assays showed a reduction of
TESCO activity by 32% when activated with SF1, by 35% when activated with
SF1 + SOX9 and a reduction by 43% when activated with SF1 + SRY (Figure
3.4a). This eﬀect was dosage-dependent as higher amounts of FOXL2 resulted
in greater TESCO repression, up to a reduction of about 72% of the original
activation by SF1 + SOX9 (Figure 3.4b). However, because EGFP can dimerise
and this might compromise the activity of the linked FOXL2, the co-transfection
assays were repeated using a diﬀerent construct containing only the Foxl2 gene.
The same results were obtained: reduction of TESCO after activation by SF1,
SF1 + SOX9 or SF1 + SRY and a dosage-dependent repression eﬀect (data not
shown).
To investigate a possible interaction between FOXL2 and estrogen receptors dur-
ing sex determination, the eﬀect of ER on TESCO activity was analysed on its
own and in combination with FOXL2. ER alone showed no signiﬁcant eﬀect
on TESCO activation by SF1 + SOX9. However, when ER was co-transfected
with FOXL2 it enhanced the FOXL2-mediated repression of TESCO activation,
down to around 10% of the original activation by SF1 + SOX9. This synergistic
repression eﬀect of ER seemed to be independent of the amount used (Figure
3.5).
810
5
10
15
20
25
30
35
40
1.4 Sox9  SF1 SF1 +Foxl2 SF1 + Sox9 SF1 + Sox9 + Foxl2 SF1 + SRY Sf1 + Sry + Foxl2 −
−
−
Sf1 + + + + +
Sox9 − − + − −
Sry − − − + +
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
Foxl2 − − + − + − +
+
+
−
*
***
**
(a)
0
5
10
15
20
25
30
35
+
+
−
+
+
+
+
+
+
+
+
F
o
l
d
 
a
c
t
i
v
a
t
i
o
n
Sf1 −
Sox9 −
Foxl2 −
**
***
**
**
(b)
Figure 3.4: Repression of TESCO by FOXL2 in vitro.
TESCO activation was repressed in vitro by co-transfection of FOXL2 to SF1,
SF1 + SOX9 or SF1 + SRY, respectively (a). This eﬀect was dosage-dependent
as higher amounts of Foxl2 resulted in a greater repression of TESCO (b). As-
says were performed in triplicate, bars indicate the standard deviation of three
biological replicates, asterisks show signiﬁcance with * p < 0:05, ** p < 0:01,
*** p < 0:001.
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Figure 3.5: Repression of TESCO by ER in vitro.
ER on its own did not have any eﬀect on SF1 + SOX9 mediated activation
of TESCO, but it enhanced the repression eﬀect mediated by FOXL2. This
enhanced repression was independent of the amount of ER used. Assays were
performed in triplicate, bars indicate the standard deviation of three biological
replicates, asterisks show signiﬁcance with *** p < 0:001, ns = not signiﬁcant.
83Next, the eﬀect of WNT signalling on TESCO activation was assessed. WNT4 it-
self did not activate the WNT-reporter plasmid TOPﬂash (Molenaar et al., 1996)
in COS7 cells (data not shown), which suggests that the WNT4 signalling path-
way is not active in this cell line. Thus, the eﬀectors of the signalling pathway,
such as -catenin and LEF1, TCF1, TCF3, TCF4 were used in the co-transfection
assays to test the implication of WNT signalling on TESCO activity. As the -
catenin/LEF/TCF complex usually acts as a transcriptional activator, it was
theoretically possible that this complex could activate TESCO on its own or en-
hance the activation mediated by SF1 or SF1 + SOX9. However, co-transfection
assays with -catenin alone or in combination with any LEF/TCF factor did not
activate TESCO in the absence of SF1 + Sox9 (Figure 3.6a). Moreover, TESCO
activation by SF1 + Sox9 was not signiﬁcantly altered by addition of -catenin
alone, any of the LEF/TCF factors on their own or by combinations of -catenin
and any of the LEF/TCF factors (Figure 3.6a). For both assays, the results are
shown for TCF3 though the same results were obtained for TCF1, TCF4 and
LEF1 (data not shown). Even using increasing amounts of -catenin did not
result in any eﬀect on TESCO activation by SF1 or SF1 + SOX9 (Figure 3.6b).
Next, the possible enhancement of forkhead transcriptional activity by interaction
with -catenin was analysed. As FOXL2 represses TESCO activation, the pres-
ence of -catenin could result in a stronger repression. However, co-transfection
assays showed that addition of -catenin did not have any eﬀect on the FOXL2-
mediated repression of TESCO activity (Figure 3.7).
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Figure 3.6: Eﬀect of -catenin and LEF/TCFs on TESCO activation in
vitro.
-catenin did not activate TESCO on its own or with TCF3. Activation of
TESCO by SF1 + SOX9 was not aﬀected by addition of -catenin, TCF3 or
both (a). Increasing amounts of -catenin did not result in any eﬀect on either
SF1 or SF1 + SOX9 mediated activation of TESCO (b). Assays were performed
in triplicate and bars indicate the standard deviation of three biological replicates.
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Figure 3.7: Eﬀect of -catenin on FOXL2 mediated repression of TESCO
in vitro.
-catenin did not have any signiﬁcant eﬀect on FOXL2 mediated repression of
TESCO. Assays were performed in triplicate, bars indicate the standard deviation
of three biological replicates, asterisks show signiﬁcance with *** p < 0:001,
ns = not signiﬁcant.
863.3 Conclusions
In the early XX gonad, Sox9 expression is down-regulated in the supporting cell
lineage at 11.5 dpc and this repression is maintained throughout life. Although
a number of genes have been proposed as ovarian promoting or anti-testis genes,
such as Wnt4, -catenin, Dax1, Sox4, Foxl2 and ER, it is not known if any
of these genes has a primary role in the repression of Sox9. In the XY gonad,
Sox9 expression is regulated via the TESCO enhancer element (Sekido and Lovell-
Badge, 2008), it is possible that the down-regulation in the XX gonad is mediated
via this element as well. To determine whether the proposed ovarian genes have
the potential to repress Sox9 expression by modulating TESCO activity, in vitro
co-transfection assays were performed.
In the WNT signalling pathway, LEF/TCFs are the executive factors in Wnt
canonical pathways, which lead, in association with -catenin, to the activation of
downstream target genes. On the other hand, it has been shown that LEF/TCF
proteins can physically interact with co-repressors, such as Groucho and CtBP
and thereby lead to the repression of their target genes (Roose et al., 1998).
Moreover, TCF3 has been demonstrated to act as a repressor in the absence
of stabilised -catenin (Merrill et al., 2004). Thus, there are several diﬀerent
possibilities as to how -catenin and LEF/TCF factors could be involved in
Sox9 regulation: -catenin in combination with any LEF/TCF factor could act
as an activator of Sox9 expression via the TESCO element or TCF3 could act
as a repressor in the absence of -catenin. However, the co-transfection assays
showed that -catenin does not aﬀect TESCO on its own or in combination
87with any LEF/TCF factor, indicating that these eﬀectors are not contributing
to the activation of the TESCO element. Moreover, SF1 + SOX9 mediated
activation of TESCO was not aﬀected by TCF3, arguing against the hypothesis
that TCF3 might at as a repressor of Sox9 in the absence of -catenin. It has been
reported that forkhead factors can compete with TCFs for the interaction with
-catenin. The formation of a forkhead/-catenin complex has been shown to
enhance forkhead transcriptional activity (Hoogeboom et al., 2008). However, the
results obtained in this thesis show that addition of -catenin did not signiﬁcantly
aﬀect FOXL2 mediated repression of TESCO activity. Taken together, none of
the tested eﬀectors of the WNT signalling pathway had any signiﬁcant eﬀect
on TESCO activation in the in vitro co-transfection assays. This could imply
that WNT signalling is not aﬀecting Sox9 transcription or that it is not acting
simply through the TESCO element but possibly via other regulatory elements.
However, it is also possible that necessary co-factors involved in the signalling
process or in SOX9--catenin degradation (like Groucho or CtBP) are missing
in this type of in vitro assay system and therefore no eﬀect can be seen due
to the limitations of the system. Another intriguing possibility is that WNT-
signalling could aﬀect Sox9 expression only indirectly, e.g. via DAX1. It has
already been demonstrated that Dax1 expression is signiﬁcantly decreased in
XX Wnt4-deﬁcient mice and that Dax1 transcription is activated by -catenin
(in cooperation with SF1), indicating that Dax1 is a downstream target gene of
Wnt4. Therefore, it is possible that Wnt4 signalling might act solely through -
catenin mediated activation of Dax1 (Mizusaki et al., 2003) in sex determination.
All other candidate genes tested in the in vitro co-transfection assays in this
88chapter did have an eﬀect on TESCO expression. Dax1 was able to repress
TESCO activation in a dosage-dependent manner. The repression eﬀect of Dax1
was the strongest of all genes analysed. It is already known that DAX1 can form
heterodimers with SF1, which results in a decrease of SF1 activity (Ito et al., 1997;
Crawford et al., 1998). Since SF1 is required for TESCO activation, a reduction
in SF1 activity in the presence of DAX1 could cause the observed repression of
TESCO. However, the detailed mechanism as to how DAX1 represses TESCO
activation, whether by direct binding to the TESCO sequence or by interaction
with SF1, remains to be investigated.
SOX4 also repressed TESCO activation, though it had the weakest repressor
eﬀect of all genes analysed. Interestingly, SOX4 did not have a repressive eﬀect
on TESCO activation mediated by SF1 alone, but was able to repress both SF1
+ SOX9 and SF1 + SRY mediated TESCO activation. The TESCO sequence
contains multiple SOX binding sites, which are crucial for its activation by SRY
and SOX9. SOX4 contains the same, highly conserved, DNA binding domain
(HMG-box) as other SOX proteins and probably binds to the same sites in the
DNA. Thus, it is possible that SOX4 competes with SOX9 and SRY for binding
to the TESCO enhancer sequence. It could be speculated that SOX4 and SOX9,
as members of diﬀerent groups of SOX proteins, exhibit diﬀerent eﬀects on the
TESCO element: SOX9 (belonging to the SOXE group) activates TESCO while
SOX4 (belonging to the SOXC group) might act as a repressor or just reduces
the amount of SOX9 bound to TESCO.
FOXL2 was able to repress TESCO activity in a dosage-dependent manner,
89whereas ER had no eﬀect on TESCO activation. Interestingly, the repressive
eﬀect of FOXL2 was even more severe in the presence of ER, suggesting a syn-
ergistic eﬀect of the two proteins on TESCO activation. However, this synergistic
repressive eﬀect seems to be independent of the amount of ER available.
In summary, the proposed ovarian promoting genes Dax1, Sox4 and Foxl2 (on
its own or in combination with ER) are able to repress the activation of the
TESCO element in vitro. This suggests that they might indeed be involved in
the regulation of Sox9 expression in vivo via the TESCO element. Moreover,
the result that FOXL2 can repress TESCO activity provides the ﬁrst direct link
between FOXL2 and Sox9 regulation. To gain more insight into FOXL2 mediated
repression of TESCO, possible mechanisms of this regulatory eﬀect were analysed
in vitro.
90Chapter 4
Possible mechanisms of TESCO
modulation by FOXL2
4.1 Introduction
FOXL2 is able to repress Sox9 expression via the TESCO enhancer element in
vitro. However, it is important to further determine how FOXL2 interacts with
TESCO and how exactly the repression is mediated.
FOXL2 is a member of the forkhead gene family of transcription factors (Crisponi
et al., 2001) and members of this family are characterised by a DNA binding
domain consisting of a helix-turn-helix core element of three -helices ﬂanked
by two loops or wings (Figure 4.1). The recognition Helix 3 interacts with the
major groove of DNA and Wing 2 with the minor groove. The sequence of this
forkhead domain (FHD) is highly conserved, indicating a similar 3D structure
and DNA recognition within the forkhead factor family, whereas regions outside
the forkhead domain are poorly conserved between family members (Carlsson and
Mahlapuu, 2002). Forkhead proteins bind DNA as monomers to the consensus
91binding site (A/G)(C/T)(A/C)AA(A/T)A (Kaufmann et al., 1995) and in doing
so bend the DNA up to an angle of 80-90◦(Pierrou et al., 1994). This property
is unusual as most transcription factors do not induce such a distortion in DNA.
However, the HMG boxes of SOX proteins are also known to bend the DNA
up to 90◦by binding to the minor groove (Sekido and Lovell-Badge, 2008). The
ﬂanking regions on both sides of the consensus sequence are important for the
protein binding aﬃnity to the DNA. Forkhead factors have been shown to act
as both transcriptional activators and repressors (Carlsson and Mahlapuu, 2002)
and can be found in a variety of vertebrate and non-vertebrate species indicating
a conserved mechanism of action (Mazet et al., 2003).
FOXL2 is a nuclear protein and contains the arginine/lysine-rich sequence of the
classical nuclear localisation signal (NLS) at the C-terminus of the forkhead do-
main (Figure 4.1). In addition, FOXL2 also comprises a non-conventional NLS
(KGNYWTLDPACEDMFEKGNY) just prior to the classical motif (Moumn´ e
et al., 2008). The C-terminal part of the FOXL2 protein contains two polyA and
one polyP stretch (Figure 4.1). About 30% of all reported human FOXL2 muta-
tions are attributed to expansion of the polyA tract from the normal 14 alanines
to up to 24 (Moumn´ e et al., 2008). In vitro analyses have shown that expansion
of the polyA stretch results in mislocalisation and cytoplasmic aggregation of the
protein. FOXL2 is normally exclusively localised in the nucleus and therefore cy-
toplasmic aggregation results in loss of its activity. On the other hand, a patient
with primary amenorrhea carrying a 30 bp deletion in the FOXL2 ORF resulting
in a reduction of the polyA tract down to 4 alanines, was able to naturally deliver
two healthy babies (Harris et al., 2002; Gersak et al., 2004).
92      Helix1 
  1 MMASYPEPED TAGTLLAPES GRAVKEAEAS PPSPGKGGGT TPEKPDPAQK PPYSYVALIA
Helix2            Helix3 -strand    Wing1 
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-strand    Wing2 
121 GNYWTLDPAC EDMFEKGNYR RRRRMKRPFR PPPAHFQPGK GLFGSGGAAG GCGVPGAGAD 
PolyA
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Figure 4.1: The FOXL2 protein.
The FOXL2 protein consists of 375 amino acids, the forkhead domain (FHD)
ranges from amino acid 50 - 150 and includes three helices, two -strands and
two loop (or wing) structures. FOXL2 contains a classical and an additional
nuclear localisation sequence (NLS) at the C-terminal end of the FHD. Outside
the FHD are two poly-A stretches and one poly-P stretch.
Only a few target genes for FOXL2 have been described so far. The ﬁrst di-
rect target to be identiﬁed was the promoter of murine gonadotrophin releasing
hormone receptor (GnRHR). In vitro assays demonstrated that FOXL2 together
with SMAD3/4 activated the GnRHR activating element (GRAS) (Ellsworth
et al., 2003). Another FOXL2 target gene is Cyp19 which encodes aromatase,
the enzyme that converts androgens into estrogens. In the goat, FOXL2 and
CYP19 co-localise in somatic cells of the XX gonad (Pannetier et al., 2006a) and
Cyp19 expression is drastically decreased upon FOXL2 loss in XX foetuses car-
rying the PIS mutation (Pailhoux et al., 2001). Moreover, FOXL2 was able to
bind and activate the goat Cyp19 promoter in vitro, suggesting that it is involved
in the regulation of estrogen production in the female gonad (Pannetier et al.,
932006b). FOXL2 could also directly bind to the promoter of human steroidogenic
acute regulatory gene (StAR), which controls the rate-limiting step in steroido-
genesis, and repress its transcription (Pisarska et al., 2004). StAR is expressed in
diﬀerentiated granulosa cells and repression by FOXL2 is thought to prevent ac-
celerated follicular development mediated by an increase of StAR activity, which
would ultimately lead to premature ovarian failure (POF). FOXL2 transcripts
with a truncation of the C-terminal domain resulting in the loss of the polyalanine
tracts, failed to repress StAR activity in vitro (Pisarska et al., 2004). Recently
it has been shown that the activity of FOXL2 as a transcriptional repressor of
the StAR gene depends on sumoylation. Indeed, FOXL2 and the E2-conjugating
enzyme Ubc9 are co-expressed in granulosa cells of small and medium follicles of
the developing ovary and FOXL2 is sumoylated at lysine-25 via Ubc9-mediated
sumoylation (Kuo et al., 2009). FOXL2 was also able to repress the rat Dmrt1
promoter in in vitro co-transfection assays. The Dmrt1 promoter contains sev-
eral forkhead factor binding sites and removal of these sites, by shortening of the
promoter sequence, resulted in the loss of repression mediated by FOXL2 (Lei
et al., 2009). A bioinformatic screen using the human steroidogenic granulosa-like
cell line KGN, identiﬁed new potential FOXL2 target genes, which suggest the
involvement of FOXL2 the regulation of a number of diﬀerent genes, including
immunomodulators (e.g. IFNB1, IL12A), transcription factors (e.g. NFATC2,
NR5a2) and regulators of apoptosis (e.g. BCL2A1, IER3) (Batista et al., 2007).
Forkhead factors have been described to act as co-repressors on their target genes
by directly interacting with other proteins: for example, FOXG1 interacts with
androgen receptor (AR) and thereby acts as an AR co-repressor (Obendorf et al.,
942007) and FOXP1 interacts with SMRT to repress the diﬀerentiation gene c-fms
in monocytes (Jepsen et al., 2008). FOXL2 has been found to directly interact
with few proteins so far. It has been shown to interact with the dead box protein
DP103 resulting in an increase in apoptosis in vitro (Lee et al., 2005). More-
over, FOXL2 interacts with SMAD3 to regulate the transcription of Follistatin
in vitro (Blount et al., 2009) and in tilapia, FOXL2 and SF1 interact to acti-
vate Cyp19 gene expression (Wang et al., 2007). Direct interaction has also been
demonstrated between FOXL2 and ER in co-immunoprecipitation experiments
in vitro (Uhlenhaut et al., 2009; Kim et al., 2009).
The results presented so far, have shown that FOXL2 can repress TESCO ac-
tivity in vitro. The TESCO element contains forkhead factor binding sites sug-
gesting that FOXL2 could directly bind to the TESCO element. Indeed, chro-
matin immunoprecipitation assays have demonstrated that FOXL2 can bind to
the TESCO enhancer element of Sox9 (Uhlenhaut et al., 2009). In this chapter,
possible mechanisms of how FOXL2 is mediating its repressive eﬀect on TESCO
was analysed in more detail in vitro.
954.2 Results
4.2.1 Analyses of mutations in TESCO binding sites
The TESCO element contains two highly conserved consensus forkhead factor
binding (FOX) sites (Figure 3.1) through which the repression eﬀect of FOXL2
could be mediated. Each of these binding sites was mutated individually as
well as in combination, by replacing the FOX sites with SacI restriction sites, to
determine their importance for FOXL2 binding. The mutated TESCO sequences
were then cloned into the luciferase vector and their activities were analysed
in co-transfection assays with SF1 + SOX9 and SF1 + SOX9 + FOXL2 using
COS7 cells, respectively. Neither individual nor combined mutations of those
sites resulted in a statistically signiﬁcant loss of FOXL2 mediated repression of
TESCO activity (Figure 4.2).
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Figure 4.2: Eﬀect of FOXL2 on TESCO with 2 mutated FOX sites.
TESCO activation by SF1 + SOX9 could be repressed by addition of FOXL2,
even after mutation of the highly conserved forkhead factor binding sites (#1:
bp 528-534 and #2: bp 974-980) either individually or simultaneously. Assays
were performed in triplicates, bars indicate the standard deviation of three bio-
logical replicates.
96It was possible that FOXL2 could still repress TESCO activity after mutation
of these two consensus binding sites because the TESCO element might contain
other forkhead factor binding sites which had not been picked up by the initial
search with the MatInspector program. Thus, the TESCO sequence was searched
manually for the core sequence of forkhead factor binding sites (C/A)AA(C/T)A.
The search revealed 10 possible binding sites, including the two sites found in the
original search, evenly distributed over the TESCO sequence (Figure 4.3).
To determine the importance of these sites, several mutation constructs of the
TESCO sequence were analysed in co-transfection assays. These constructs con-
tained 200 - 250 bp deletions in diﬀerent parts of the TESCO sequence: deletion
of bp 72 to 335 including two possible FOX sites (∆C4), deletion of bp 354 to
548 including three possible FOX sites (∆C5), deletion of bp 564 to 829 including
one possible FOX site (∆C6), deletion of bp 847 to 1054 including one possible
FOX site (∆C7). Another construct contained a shorter version of TESCO, lack-
ing 200bp at the 3’-end which included one possible FOX site (1.0 kb). For a
detailed sequence map see Appendix Figure 8.4. All of the constructs (except
∆C6) also contained established binding sites for SF1 and/or SOX9. Due to the
reduced number of activation sites, the overall activation potential of these dele-
tion constructs was diminished when co-transfected with SF1 + SOX9. However,
repression of TESCO activity upon addition of FOXL2 was found in all these
constructs. A slight reduction in repression ability of FOXL2 could be seen in
the assays with the ∆C6 and ∆C7 constructs, but these diﬀerences were not
statistically signiﬁcant (Figure 4.4).
97        1 CATATGTCAC ATACCTAAGG TGAAAATATA CGAGCCCTGT CTAAATCGGA ACTCCAACCA 
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      721 AGCAGCCTGG AAGTCACCCC AAGAGCATCA AGTCCCGGTG GCATGAATGT GTCACTTTCT 
      781 CTTTTTCTAA TGGGGCCACG GGGTGCCATT TCTTTGCAAA GGACCACACC GACATGAGCC 
      841 CAGCTAAAAA GGGGGTAGCT ACTGATAGGA TGAACTCGGA CTGCGGTTGC ATTTGGACTG 
      901 GTAAATGTGG TCAGTCACAT AGCAAGGCAG GACTCAGACA CTGCAGAAAT GCACTGCCCT
      961 TGCTTGAAGG CCTTGTTGAC CCTGATAAAG CTTGTGGCCC TTCTAGAAGA GGTGTATCCT 
     1021 TGTCCCACCT CCCACCTCCA GCCTTCCTGG CTTCCTGAGA GCAATCTGTG CTCAGGGCCA 
     1081 GTCCACACAG TGTGCTACTG AGTTGAATGA CCTTGTCCTC TCGAACTCCC CTGTCCCCAT 
     1141 TCAGTACACC ATTGTTCTGC AATCTCCACC AGCATTGGTT CAAGGACCCT CTATAGCTAC 
     1201 AAAAGTCCAG GGACACCCAA GTCTCATATA AAACAGCATG GTGTGTGCAC AGAACTAATG 
     1261 ATAATTCCCA TGTGGTGTTA ATTGTCTGTT AAC
XXX SF1 binding sites T/C A A G G T/C C G/A 
XXX SOX binding sites A G A A C A A T G G
XXX FOXL2 core binding site G/A T/C C/A A A C/T A 
Figure 4.3: Additional consensus FOX sites in the TESCO sequence.
The TESCO sequence was manually searched for the core sequence of fork-
head factor binding sites (C/A)AA(C/T)A, which revealed 10 possible FOX sites
evenly distributed over the TESCO sequence.
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Figure 4.4: Repression eﬀect of FOXL2 on TESCO deletion constructs.
Five constructs with deletions of diﬀerent parts of TESCO were analysed in co-
transfection assays. Addition of FOXL2 after activation by SF1 + SOX9 resulted
in a repression similar to the wild-type TESCO construct. Assays were performed
in triplicates, bars indicate the standard deviation of three biological replicates.
Next, the all ten putative FOX sites in the TESCO element were mutated simul-
taneously by replacement of the essential central AA motif with a GC motif. The
mutated TESCO sequence was then cloned into the luciferase vector and anal-
ysed in vitro as described before. The construct was activated by SF1 + SOX9
in co-transfection assays and addition of FOXL2 still resulted in repression of the
TESCO activity (Figure 4.5). The combined mutation of all FOX sites and all
estrogen response elements (EREs) still resulted in repression of TESCO activity
by FOXL2, but interestingly the previously observed synergistic repression eﬀect
of ER together with FOXL2 was abolished (Figure 4.6).
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Figure 4.5: Repression eﬀect of FOXL2 on TESCO with mutations in
all consensus FOX sites.
The ten possible consensus FOX sites found in the TESCO sequence were mu-
tated and the construct used in co-transfection assays. Addition of FOXL2 after
activation by SF1 + SOX9 resulted in a repression of the mutant TESCO simi-
lar to the wild-type TESCO element. Assays were performed in triplicates, bars
indicate the standard deviation of three biological replicates.
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Figure 4.6: Repression eﬀect of FOXL2 + ER on TESCO with all
FOX/ERE sites mutated.
All FOX and ERE sites found in the TESCO element were mutated and the
construct used in co-transfection assays. Addition of FOXL2 after activation by
SF1 + SOX9 resulted in a repression of the mutant TESCO similar to the wild-
type TESCO element. However, the synergistical eﬀect of ER in enhancing
FOXL2 mediated repression was lost. Assays were performed in triplicates, bars
indicate the standard deviation of three biological replicates.
100In all the mutation constructs analysed in the above co-transfection assays, ad-
dition of FOXL2 resulted in a similar level of repression of TESCO activity.
Thus, it could be possible that the repression eﬀect seen by FOXL2 might be
due to a non-speciﬁc eﬀect of FOXL2 on the luciferase vector backbone. To rule
out this possibility, increasing amounts of the original luciferase vector (with-
out the TESCO sequence) were added in co-transfection assays to the wild-type
TESCO-luciferase construct which was activated by SF1 + SOX9 and repressed
by addition of FOXL2, as described before. If FOXL2 was indeed binding to
cryptic binding sites in the vector backbone, excess amounts of Luciferase vec-
tor would deplete the available FOXL2, thereby reducing the amount of FOXL2
accessible to repress TESCO activity. However, even with increasing amounts of
Luciferase vector, no signiﬁcant decrease in the FOXL2-mediated repression of
TESCO activity was found (Figure 4.7). It might be worth noting that, due to
the large excess of the original luciferase vector used in this assays, the cumula-
tive amount of DNA was more than double the amount used in the assays before,
which might interfere with the transfection eﬃciency.
Taken together, all these results suggest that the identiﬁed FOX binding sites
within the TESCO enhancer are not crucial for FOXL2 to repress TESCO activ-
ity. It is possible that the TESCO element contains additional forkhead factor
binding sites, through which the repression eﬀect of FOXL2 is mediated and
which might diﬀer from the known consensus binding site. Another possible ex-
planation is that the repression eﬀect of FOXL2 is not mediated through binding
to the TESCO sequence but through a diﬀerent mechanism, e.g. by acting as a
co-repressor in association with another protein.
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Figure 4.7: Eﬀect of excess amounts of vector on FOXL2 mediated re-
pression of TESCO.
Increasing amounts of empty Luciferase vector (not containing the TESCO se-
quence) did not result in a dosage-dependent loss of FOXL2 mediated repression.
This shows that FOXL2 is not binding to cryptic binding sites in the backbone
of the vector. Assays were performed in triplicates, bars indicate the standard
deviation of three biological replicates.
4.2.2 Analyses of interactions between FOXL2 and SF1
Experiments in tilapia suggest that FOXL2 and SF1 can physically interact
(Wang et al., 2007). A similar interaction could be occurring in the developing
mouse gonad, resulting in a repression of SF1-mediated transcriptional activation
of TESCO. To test this hypothesis, a synthetic sequence element containing only
SF1 binding sites and no FOX sites, was cloned into the luciferase vector (Figure
4.8a). This luciferase reporter construct was indeed activated in co-transfection
assays by SF1 and addition of FOXL2 resulted in a dosage dependent repres-
sion (Figure 4.8a). This result was similar to the FOXL2-mediated repression
of TESCO (Figure 3.4b). As no forkhead binding sites are present in this syn-
102thetic element, the repression cannot be due to FOXL2 binding to FOX sites but
must be mediated through a diﬀerent mechanism, e.g. direct interaction between
FOXL2 and SF1.
To analyse this hypothesis, a GST-FOXL2 fusion protein and a 35S-labelled SF1
protein were generated. Co-immunoprecipitation assays with the two proteins
were performed, showing that FOXL2 and SF1 can indeed directly interact (Fig-
ure 4.9). No interaction could be detected in the controls with 35S-SF1 on its
own or 35S-SF1 together with the GST control.
Next, the eﬀect of FOXL2 on the DNA-binding ability of SF1 was analysed. The
synthetic SF1-binding sequence, which contained SF1 but no FOX binding sites,
was radioactively labelled. This probe was then incubated with SF1 and increas-
ing amounts of FOXL2 (Figure 4.10). As expected, binding of SF1 to the DNA
was clearly visible. Interestingly, a weak interaction could also be detected in
the sample where only FOXL2 (and not SF1) was added to the DNA, indicating
that FOXL2 might be able to bind to DNA containing SF1 binding sites. In-
creasing amounts of FOXL2 resulted in an attenuation of the band representing
SF1 bound to DNA. This suggests that FOXL2 competes with SF1 for binding
to SF1 binding sites. As the DNA contains more than one SF1 binding site, it is
possible that several SF1 and FOXL2 proteins could simultaneously bind to the
sequence. The formation of such multimers could result in the an even higher
bandshift and possibly explain the upper bands seen in this assay.
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Figure 4.8: Eﬀect of FOXL2 on SF1-mediated activation.
A synthetic sequence containing only SF1 binding sites was cloned into the Lu-
ciferase vector (a). In co-transfection assays, this construct was activated by SF1.
Addition of increasing amounts of FOXL2 resulted in a repression in a dosage-
dependent manner (b). Assays were performed in triplicates, bars indicate the
standard deviation of three biological replicates.
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Figure 4.9: Direct physical interaction between FOXL2 and SF1.
Co-Immunoprecipitation of GST-FOXL2 and 35S-SF1 showing an interaction be-
tween the two proteins.
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Figure 4.10: FOXL2 interferes with SF1 binding to DNA.
A radioactively labelled probe containing only SF1 binding sites was incubated
with SF1 or FOXL2 or both proteins. SF1 was able to bind to its binding sites
as indicated by the band shift. When FOXL2 was added on its own a weak band
appears indicating the possibility of FOXL2 binding to the SF1 site. Increasing
amounts of FOXL2 resulted in a decrease of SF1 bound to DNA and an increase
of FOXL2 bound to DNA, suggesting a competition for binding between the two
proteins.
1054.3 Conclusions
It has been shown so far that FOXL2 represses TESCO activity in vitro. In
this chapter, it was assessed how FOXL2 mediates this repression eﬀect. As
FOXL2 is a transcription factor which can activate or repress its target genes
by binding to its consensus DNA binding sites, the analysis ﬁrst asked whether
FOXL2 represses TESCO activity by binding to possible binding sites in the
TESCO sequence. Mutation of the ten putative forkhead factor binding sites
in the TESCO sequence did not abolish the repression mediated by FOXL2 in
co-transfection assays. However, it is possible that the TESCO element contains
additional forkhead factor binding sites which diﬀer from the consensus forkhead
binding site. It is known that some groups of forkhead factors indeed bind to
sequences which only partially match the consensus site (Carlsson and Mahlapuu,
2002). Thus, FOXL2 could still be repressing TESCO activity via potential non-
consensus binding sites in the in vitro assays.
FOXL2 and ER were found to physically interact with each other in co-immuno-
precipitation assays (Uhlenhaut et al., 2009; Kim et al., 2009). While the com-
bined mutation of all FOX sites and EREs found in the TESCO element still
resulted in repression of TESCO activity by FOXL2, it abolished the synergistic
repression eﬀect of ER together with FOXL2 in vitro. Similarly, simultane-
ous mutation of all FOX and ERE sites in the TESCO:CFP reporter construct,
resulted in in a de-repression of TESCO activity in adult ovaries in vivo (Uh-
lenhaut et al., 2009). These results indicate an involvement of both factors in
the repression of TESCO and the importance of forkhead factors for estrogen
106receptor function. However, the exact mechanism of how FOXL2 and ER re-
press TESCO remains to be investigated. Furthermore, it is possible that the
mutated TESCO sequence still contains some minor interaction sites for FOXL2,
which do not play an important role in the normal physiological environment in
vivo. However, due to the artiﬁcial system of the co-transfection assays in vitro,
the excessive amount of FOXL2 available might still repress the TESCO element
via these sites. Thus, the repression of the mutated TESCO element in vitro
in contrast to the de-repression seen in vivo might be due to a dosage eﬀect of
FOXL2.
Interestingly, deletion of diﬀerent parts of the TESCO element resulted in the
same level of repression by FOXL2 as the wild-type TESCO sequence. These re-
sults suggest that FOXL2 could be additionally repressing TESCO activation via
a diﬀerent mechanism. Co-immunoprecipitation analysis revealed that FOXL2
and SF1 are able to physically interact with each other. Thus, it is possible
that FOXL2 could mediate its repression eﬀect via SF1, by repressing the SF1-
mediated transcriptional activation of TESCO. Recently, a paper was published
which identiﬁed a new FOXL2-speciﬁc DNA binding site GTCAAGG(T/C)CA
(Benayoun et al., 2008) which shows close similarity to the SF1-binding site
(T/C)(T/C)AAGG(T/C)C(G/A). This suggests the possibility that FOXL2 might
be able to bind to the SF1 DNA site. Indeed, gel mobility shift assays showed
that FOXL2 can bind to a DNA sequence containing only SF1-binding sites and
no FOX sites. Moreover, increasing amounts of FOXL2 resulted in a decrease
of SF1 bound to its DNA binding site. Likewise, increasing amounts of FOXL2
led to a dosage-dependent repression of an luciferase reporter construct contain-
107ing the same DNA sequence in co-transfection assays. These results suggest a
mechanism involving competition between FOXL2 and SF1 for binding to the
SF1 site. In this hypothesis, binding of SF1 could result in TESCO activation
whereas binding of FOXL2 might result in TESCO repression.
In summary, these results suggest a cooperation of FOXL2 and ER in repress-
ing TESCO activity. It is possible that the two proteins interact as a functional
unit which can either bind to FOX sites or EREs to repress the TESCO ele-
ment. However, the data obtained here also suggest the possibility of a second
mechanism of FOXL2-mediated repression involving SF1. There could be several
hypotheses: (i) FOXL2 might physically interact with SF1 and thereby reduce
the amount of SF1 available to activate TESCO, (ii) FOXL2 might interact with
SF1 which is bound to its DNA binding site in the TESCO element, thereby in-
hibiting its activation capability and (iii) FOXL2 might be competing with SF1
for binding at the TESCO element, resulting in a repression of TESCO rather
than is activation.
The results obtained in this thesis so far have provided evidence that FOXL2 can
repress TESCO activity in vitro and might therefore be involved in the regulation
of Sox9 in the XX gonad in vivo. To investigate this further, the repressing eﬀect
of FOXL2 on TESCO activity was analysed next in vivo.
108Chapter 5
The eﬀect of Foxl2 on TESCO
activity in vivo
5.1 Introduction
The female-speciﬁc expression pattern of Foxl2 in the gonad is highly conserved
amongst vertebrates, and also in species with very distinct mechanisms of sex
determination. For example, in the red-eared slider turtle (Trachemys scripta),
in which the sex of the oﬀspring is dependant on the egg incubation temperature,
the Foxl2 transcript levels are higher at female promoting temperatures than
at male promoting temperatures (Loﬄer et al., 2003). In the tilapia ﬁsh (Ore-
ochromis niloticus), Foxl2 is highly expressed in XX individuals at the critical
period of sex determination (between 5 to 6 days after hatching) whereas it is
barely detectable in XY individuals (Ijiri et al., 2008). In rainbow trout (On-
corhynchus mykiss), XY ﬁsh treated with estrogens up-regulate Foxl2 expression
and become feminised, whereas XX ﬁsh treated with androgens show signs of
masculinisation and down-regulate Foxl2 expression (Baron et al., 2004). In frog
109(Xenopus laevis), Foxl2 expression is higher in the female ZW gonad than in the
male ZZ gonad (Okada et al., 2009). A similar sexual dimorphic pattern is also
observed in the chick, where Foxl2 is speciﬁcally expressed in the ZW gonad from
the beginning of sex determination (Loﬄer et al., 2003). In the mouse, Foxl2 is
expressed in the somatic cells of the XX gonad from 12.5 dpc onwards, whereas
it is not detected in XY gonads (Uda et al., 2004). The conserved female-speciﬁc
expression pattern of Foxl2 in the developing gonad suggests the potential of this
gene to act as a conserved factor in ovarian development. However, the molecu-
lar mechanisms explaining how the transcription factor FOXL2 regulates ovarian
development and diﬀerentiation are not yet fully understood.
Mice heterozygous for a null mutation of Foxl2 display no phenotype, whereas
homozygotes mutant mice (Foxl2−=−) are born with open necrotising eyes, eyelid
hypoplasia, craniofacial defects and smaller body size, which are features compa-
rable to human BPES (Uda et al., 2004). In addition, XX Foxl2−=− mice show
hypoplastic uterine tubes and are infertile, whilst XY Foxl2−=− mice remain fully
fertile and testis development is unaﬀected. The same phenotype was found in
mice carrying a LacZ gene insertion into the Foxl2 locus (Foxl2LacZ) resulting in
a null allele (Schmidt et al., 2004). Directly after birth the numbers of primordial
follicles and oocytes are similar between wild-type and Foxl2−=− mutant ovaries,
but 2 weeks postnatally, when secondary follicles are normally surrounded by two
cuboidal granulosa cell layers in the wild-type ovary, the mutant follicles contain
only one layer of granulosa cells. Moreover, these cells have not yet completed the
transition from squamous to cuboidal type. At 8 weeks, mutant ovaries are sig-
niﬁcantly smaller than wild-type and mutant follicles contain signiﬁcantly fewer
110granulosa cells due to decreased proliferation. In addition, no quiescent primor-
dial follicles are found indicating a depletion of the primordial follicle pool (Uda
et al., 2004). The expression of Sox9 and some other markers of testis diﬀerenti-
ation such as Fgf9, Fgfr2, Dhh, Wt1, Sf1, Gata4 is up-regulated in the mutant
ovary 1 week after birth (Ottolenghi et al., 2005).
Recently, our collaborators Henriette Uhlenhaut and Mathias Treier, have gener-
ated a mouse line carrying a conditional Foxl2 allele (Foxl2flox=flox). To determine
Foxl2 function in the adult ovary, an ubiquitously expressed inducible Cre recom-
binase allele (Rosa26:CreERT2) was bred into this line to allow the deletion of
Foxl2 upon administration of tamoxifen (thus giving Foxl2∆=∆). Analysis 3 weeks
after the tamoxifen administration to 8 week old mice, revealed XX gonadal sex
reversal (Uhlenhaut et al., 2009). The gonads of these mice contained structures
resembling seminiferous tubules with Sertoli-like cells as indicated by tripartite
nucleoli and veil-like cytoplasmic extensions pointing towards the lumen. The
tubule-like structures were also surrounded by a prominent basal lamina. One
week after tamoxifen administration, the morphology of the follicles and the
oocytes in Foxl2∆=∆ gonads were still intact, but the granulosa cells surround-
ing the oocytes were expressing Sox9. These cells started to transdiﬀerentiate
into Sertoli-like cells despite the presence of an oocyte, suggesting that gran-
ulosa cells undergo cell autonomous reprogramming into Sertoli-like cells upon
loss of Foxl2. A number of other Sertoli cell markers were also up-regulated in
these cells, including Gata1, Tif2, Dmrt1 and Dhh. Leydig cell markers, such as
Hsd17b3 (the rate-limiting enzyme in testosterone production in the testis) were
also up-regulated in the XX Foxl2∆=∆ gonads. Moreover, Hsd17b3 was found
111to be expressed in a similar pattern to adult testis, suggesting the presence of
Leydig-like cells. Furthermore, similar levels of testosterone were detected in the
blood of XX Foxl2∆=∆ mice compared with XY wild-type littermates. Looking at
events immediately after tamoxifen administration revealed that FOXL2 protein
was still present 2 days after whereas SOX9 was not yet expressed. However,
SOX9 was detected already at high levels 4 days after tamoxifen administration,
by which time FOXL2 expression had disappeared. No evidence could be found
of any overlap, suggesting that expression of FOXL2 and SOX9 are mutually
exclusive.
All the evidence suggested that FOXL2 is required in granulosa cells of the post-
natal ovary to antagonise Sox9 expression and actively prevent Sertoli cell diﬀer-
entiation and subsequent masculinisation of the gonad. The data presented in the
previous chapters of this thesis showed that FOXL2 can repress Sox9 expression
in vitro via the TESCO enhancer element (see Chapter 3).
To test whether the same mechanism occurs in vivo Foxl2LacZ mice, which were
generated by the replacement of most of the Foxl2 coding region by -galactosidase
(Schmidt et al., 2004), were crossed to a transgenic mouse line expressing a
CFP reporter under the control of the TESCO enhancer element (TESCO:CFP)
(Sekido and Lovell-Badge, 2008). The expression of CFP in the TESCO:CFP
line correlates with the expression of endogenous SOX9: in XY gonads CFP is
expressed in Sertoli cells from 11.5 dpc until adult stages, whereas in XX gonads
CFP is not expressed at all in granulosa cells (Figure 5.1). If FOXL2 represses
Sox9 expression via the TESCO element in vivo, loss of Foxl2 in the XX go-
112nad should lead to a de-repression of TESCO and therefore activation of CFP
expression in the XX TESCO:CFP; Foxl2LacZ=LacZ ovary.
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Figure 5.1: CFP expression in the TESCO:CFP reporter line in vivo.
Immunohistochemistry showing CFP expression in XY, but not XX gonads, of
the TESCO:CFP reporter line at 13.5 dpc, equates to the expression pattern of
Sox9. Scale bar = 100m; insert shows 2.5x higher magniﬁcation.
1135.2 Results
5.2.1 De-repression of TESCO in Foxl2 mutant mice
In the original paper describing the Foxl2LacZ=LacZ phenotype, it was reported
that homozygotes are born at the expected Mendelian ratio, although about 95%
of the mutant animals die before weaning (Schmidt et al., 2004). However, after
being bred onto a C57BL/6 background for several generations, it was not possible
to ﬁnd any homozygous mutant mice amongst the litters born or even amongst
the embryos harvested at 12.5 dpc (a total of 207 mice and 114 embryos were
generated from heterozygous Foxl2 matings on the C57BL/6 background). As the
original mutation was maintained on a mixed background (129/BlackSwiss/CD1),
this result suggests a variable penetrance of the Foxl2 mutation in diﬀerent mouse
strains and a high sensitivity of the C57BL/6 background for the Foxl2 mutation.
To circumvent this problem, the Foxl2 mutant mice were ﬁrst bred onto an MF1
hybrid background, which resulted in the appearance of live born mutant mice
after four generations. These Foxl2[MF1] homozygous mutant mice were smaller
than wild-type and heterozygous littermates and they were born with open eyes
and craniofacial defects as described in Schmidt et al. (2004). The Foxl2[MF1]
mice were then bred with TESCO:CFP reporter mice to generate the desired
TESCO:CFP; Foxl2LacZ=LacZ genotype.
To determine the possible de-repression of TESCO activity, XX TESCO:CFP;
Foxl2LacZ=LacZ gonads were collected and compared to control gonads from XY
TESCO:CFP; Foxl2LacZ=wt and XX TESCO:CFP; Foxl2LacZ=wt mice at diﬀerent
time points during embryogenesis (12.5 dpc to 18.5 dpc) and after birth (P0 to
1148 weeks). The gonads were then sectioned and analysed for CFP expression.
Ovaries of XX heterozygous and homozygous Foxl2 mutant mice are indistin-
guishable directly after birth (P0). However, from 7 dpp onwards morphological
diﬀerences could be found between the two genotypes and the ovarian dysgenic
phenotype of XX homozygous mutants became more prominent with age. From
4 weeks onwards, it was clearly evident that oocytes (asterisks) in Foxl2LacZ=LacZ
ovaries are surrounded by fewer layers of granulosa cells (arrows), compared to
several layers of granulosa cells in the Foxl2LacZ=wt ovaries (Figure 5.2), as de-
scribed in the original paper (Schmidt et al., 2004).
As expected, during embryonic development, CFP was expressed in the Sertoli
cells within the testis cords in XY TESCO:CFP; Foxl2LacZ=wt gonads, whereas
it was absent in XX TESCO:CFP; Foxl2LacZ=wt gonads between 12.5 dpc and
18.5 dpc. No CFP expression could be detected in the gonads of XX TESCO:CFP;
Foxl2LacZ=LacZ mice at any stage during embryogenesis. However, just after birth
(P0) a very few CFP-positive cells were found (Figure 5.3).
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Figure 5.2: Morphology of XX Foxl2LacZ=LacZ gonads.
H+E staining of XX Foxl2LacZ=wt and Foxl2LacZ=LacZ gonads at diﬀerent time
points after birth and during adulthood. No morphological diﬀerence could be
seen at P0. From 4 weeks of age it was evident that fewer layers of granulosa cells
(arrows) surround the oocytes (asterisks) in Foxl2LacZ=LacZ ovaries. Scale bar =
50m.
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Figure 5.3: TESCO activity in TESCO:CFP; Foxl2LacZ=LacZ gonads dur-
ing embryogenesis.
Cryosections of XY and XX gonads of TESCO:CFP mice, with heterozygous
and homozygous loss of Foxl2, at diﬀerent time points during embryogenesis and
just after birth (P0). Immunostaining shows DAPI in blue and CFP in green.
TESCO:CFP expression could be detected in Sertoli cells in the XY gonads (left
panel), whereas it was absent in XX TESCO:CFP; Foxl2LacZ=wt gonads (mid-
dle panel). No de-repression of TESCO activity was found in XX TESCO:CFP;
Foxl2LacZ=LacZ gonads during embryogenesis, but a few CFP-positive cells could
be detected just after birth (right panel). Scale bar = 50m; insert shows 2.5x
higher magniﬁcation of CFP-positive cells in ovary with homozygous loss of Foxl2.
117At postnatal stages, CFP expression was detected in the Sertoli cells of all XY
TESCO:CFP; Foxl2LacZ=wt gonads from 7 dpp until 8 weeks of age. During this
time frame the normal reorganisation of the testis cords could be observed, in-
cluding the migration of Sertoli cells towards the centre of the cords just after
birth, the migration of the Sertoli cell nuclei back to the basal area of the semi-
niferous tubules after puberty and the ﬁnger-like cytoplasmic extension of adult
Sertoli cells from the basal to the adluminal compartment of the seminiferous
tubules (Figure 5.4). In XX TESCO:CFP; Foxl2LacZ=wt gonads, no CFP expres-
sion was seen before 4 weeks of age, except for a non-speciﬁc staining in oocytes.
However, at 4 and 8 weeks of age, CFP expression was detected in some theca
cells surrounding the follicles. It has been reported that Sox9 is expressed in
the inner layer of theca cells in the adult ovary but does not coincide with the
expression of the steroidogenic markers P450 and 3HSD, suggesting that the
SOX9-positive cells are a subpopulation of non-steroidogenic theca cells (Notar-
nicola et al., 2006). In the XX TESCO:CFP; Foxl2LacZ=LacZ mice, CFP expression
was detected in all gonads from 7 dpp to 8 weeks of age (Figure 5.4). The CFP-
positive cells in the homozygous Foxl2 mutant gonads were mostly found in the
remaining layer surrounding the oocytes.
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Figure 5.4: TESCO activity in postnatal TESCO:CFP; Foxl2LacZ=LacZ
gonads.
Cryosections of XY and XX gonads of TESCO:CFP mice, with heterozygous and
homozygous loss of Foxl2, at diﬀerent time points postnatally. Immunostaining
shows DAPI in blue and CFP in green. CFP expression was detected in Sertoli
cells in XY gonads (left panel) and in a potential subpopulation of theca cells
in XX TESCO:CFP; Foxl2LacZ=wt gonads from 4 weeks onwards (white arrows,
middle panel). De-repression of TESCO could be seen in XX TESCO:CFP;
Foxl2LacZ=LacZ gonads in cells surrounding the oocytes at all stages analysed (right
panel). Scale bar = 50m; inserts show 2.5x higher magniﬁcations.
1195.2.2 De-repression of SOX9 in Foxl2 mutant mice
To determine whether de-repression of TESCO activity coincided with de-repres-
sion of endogenous Sox9, the expression of Sox9 was analysed in Foxl2 mutant
gonads during embryonic development and after birth.
While Sox9 was expressed normally in the Sertoli cells of embryonic XY gonads,
no Sox9 expression could be detected in either XX TESCO:CFP; Foxl2LacZ=wt or
XX TESCO:CFP; Foxl2LacZ=LacZ gonads between 12.5 dpc and 18.5 dpc (data not
shown). After birth, Sox9 expression was found in the Sertoli cells of XY gonads
from P0 to 8 weeks of age and in a few cells in the ovaries of 4 and 8 week old
XX TESCO:CFP; Foxl2LacZ=wt mice, which might represent the sub-population of
theca cells as noted above (Notarnicola et al., 2006). However, endogenous SOX9
was detected in the ovaries of XX TESCO:CFP; Foxl2LacZ=LacZ mice from 7 dpp
to 8 weeks of age, in most of the residual cells surrounding the oocytes (Figure
5.5). Co-staining for nuclear SOX9 and cytoplasmic CFP revealed the expression
of both proteins in the same cells. Interestingly, whereas CFP expression was
found in ovaries of XX TESCO:CFP; Foxl2LacZ=LacZ mice from P0 (Figure 5.3),
SOX9 was not detected until later (Figure 5.5).
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Figure 5.5: Endogenous Sox9 expression in postnatal TESCO:CFP;
Foxl2LacZ=LacZ.
Cryosections of XY and XX gonads of TESCO:CFP mice with heterozygous and
homozygous loss of Foxl2 at diﬀerent time points postnatally. Immunostaining
shows DAPI in blue, CFP in green and SOX9 in red. Inserts show higher magniﬁ-
cations. CFP and SOX9 co-localised in Sertoli cells in the XY gonads (left panel),
in a possible subpopulation of theca cells in the XX TESCO:CFP; Foxl2LacZ=wt
gonads (middle panel) and in cells surrounding the oocytes in XX TESCO:CFP;
Foxl2LacZ=LacZ gonads (right panel). Scale bar = 50m; inserts show 2.5x higher
magniﬁcations.
121As mentioned above, expression from both TESCO and Sox9 could be seen in the
cells which surround the oocytes in a typical granulosa cell manner. To determine
whether indeed the remaining granulosa-like cells are the cells up-regulating Sox9,
the Foxl2 mutant gonads were analysed for the expression of LacZ, a reporter
gene inserted into the Foxl2 locus and therefore expressed under the control of the
endogenous Foxl2 promoter. In double immunostainings, the gonadal expression
of SOX9 and -galactosidase was analysed in 4 week old mice (Figure 5.6). XY
TESCO:CFP; Foxl2LacZ=wt gonads showed Sox9 expression in the Sertoli cells,
but no expression of -galactosidase. On the other hand, in XX TESCO:CFP;
Foxl2LacZ=wt gonads, -galactosidase could be found predominantly in the gran-
ulosa cells, but also in some interstitial cells (large white arrow). Although it
has been shown that Foxl2 is also expressed in a subpopulation of theca cells
(Uhlenhaut et al., 2009), in this analysis no -galactosidase activity could be de-
tected in any theca cells. As described before, Sox9 expression could be detected
in some cells of the XX TESCO:CFP; Foxl2LacZ=wt gonads that might represent
a subpopulation of theca cells (small white arrow). In the XX TESCO:CFP;
Foxl2LacZ=LacZ gonads, the cells surrounding the oocytes expressed both Sox9
and -galactosidase. However, some cells in the XX homozygous mutant gonad
were positive for -galactosidase but not for SOX9 and might correspond to the
interstitial cells which were also found in the XX Foxl2 heterozygous mutant
gonads.
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Figure 5.6: Co-localisation of SOX9 and -galactosidase.
Cryosections of XY and XX gonads of TESCO:CFP mice with heterozygous and
homozygous loss of Foxl2 at 4 weeks of age. Immunostaining shows DAPI in
blue, SOX9 in green and -galactosidase in red. In XY gonads, SOX9 but not -
galactosidase was expressed. In XX TESCO:CFP; Foxl2LacZ=wt gonads, SOX9 was
expressed in cells likely to represent a subpopulation of theca cells (small white
arrow) and -galactosidase was expressed in granulosa cells and some interstitial
cells (large white arrow). In XX TESCO:CFP; Foxl2LacZ=LacZ gonads, SOX9 and
-galactosidase co-localised in the cells surrounding the oocytes. Scale bar =
50m; inserts show 2.5x higher magniﬁcations.
5.2.3 The impact of oocyte depletion on the supporting
cell lineage
It has been suggested that oocytes are required for the maintenance of granulosa
cells and that the ovarian pathway is actually under the control of the germ
cells (Burgoyne, 1988; McLaren, 1991). If these cells are lost at the time of
folliculogenesis, testis-like structures form in cultured fetal rat ovaries (Pr´ epin
and Hida, 1989). The same eﬀect can be seen naturally in freemartin cattle,
where female embryos have a vascular connection to their male twins. Here, the
oocytes gradually degenerate and testicular cords form in the ovary, including
Sertoli cells which produce AMH and Leydig cells which produce testosterone
(McLaren, 1991). Other studies have shown that oocytes can interfere with the
organisation of testis cords and thus might be involved in antagonising testis
123diﬀerentiation (Yao et al., 2003). Based on this evidence it has been proposed
that the loss of oocytes could by itself cause the transdiﬀerentiation of granulosa
to Sertoli-like cells.
To investigate this possibility, oocytes were speciﬁcally depleted in neonatal mice
and Sox9 expression was analysed to determine whether the loss of oocytes could
result in a de-repression of Sox9. For this, mice carrying a conditionally expressed
gene for diphtheria toxin fragment A (DTA) in the ROSA26 locus were used
(R26DTA). These express the active DTA only upon Cre-mediated recombination
(Ivanova et al., 2005). Diphtheria toxin is secreted by the parasite Corynebac-
terium diphtheriae and consists of subunit A and B. Subunit B mediates the in-
ternalisation of the toxin by binding to its receptor, whereas subunit A terminates
protein synthesis and eventually leads to apoptosis of the cell (Maxwell et al.,
1986). The R26DTA mice were bred to mice carrying Cre-recombinase under the
control of the germ-line speciﬁc promoter of the zona pellucida 3 gene (Zp3:Cre),
which is speciﬁcally expressed in oocytes (De Vries et al., 2000). Zp3:Cre is active
in ovaries from 5 dpp onwards, in primary, secondary, and later follicular stages,
but not in adjacent somatic cells (Lan et al., 2004). Therefore, upon Zp3:Cre
mediated recombination, the DTA will be active exclusively in oocytes from the
primary follicular stage onwards, resulting in a global loss of oocytes.
To investigate the possible up-regulation of Sox9 expression upon oocyte loss,
gonads of XY Zp3:Cre; R26DTA, XX R26DTA and XX Zp3:Cre; R26DTA mice
were collected at diﬀerent time points after birth (P0 to 8 weeks). The gonads
were then sectioned and analysed for Sox9 expression. As expected, Sox9 expres-
124sion could be detected in Sertoli cells of XY Zp3:Cre; R26DTA gonads at all ages
between P0 and 8 weeks of age and in the putative subpopulation of theca cells of
four and eight week old XX Zp3:Cre-negative R26DTA gonads (white arrows). As
Zp3:Cre is not active at P0, ovaries of XX Zp3:Cre; R26DTA mice just after birth
were similar to ovaries of XX R26DTA mice, indicating that indeed the DTA had
no eﬀect in those ovaries yet. The ﬁrst morphological diﬀerences could be found
at 7 dpp and became more evident with age, resulting eventually in a complete
oocyte-depleted ovary at 4 and at 8 weeks of age. Adult XX Zp3:Cre; R26DTA
ovaries were drastically smaller compared to those of XX Zp3:Cre-negative litter-
mates. Despite the severely altered morphology, up-regulation of Sox9 expression
was not detected at any stage between P0 and 8 weeks of age in these XX Zp3:Cre;
R26DTA ovaries (Figure 5.7).
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Figure 5.7: Sox9 expression in gonads of Zp3:Cre; R26DTA mice.
Cryosections of XY and XX gonads of R26DTA mice with or without Zp3:Cre
at diﬀerent time points postnatally. Immunostaining shows DAPI in blue and
SOX9 in green. SOX9 could be detected in Sertoli cells of XY Zp3:Cre; R26DTA
gonads (left panel) and in a few cells in XX R26DTA gonads (white arrows,
middle panel). SOX9 was not detected in XX Zp3:Cre; R26DTA gonads (right
panel). Scale bar = 50m.
1265.3 Conclusions
In this chapter the eﬀect of Foxl2 on TESCO activity was analysed in vivo using
Foxl2LacZ mice crossed to TESCO:CFP reporter mice. Homozygous loss of Foxl2
did not have any eﬀect on either TESCO activity or endogenous Sox9 expres-
sion during embryogenesis. However, after birth homozygous loss of Foxl2 in XX
gonads resulted in the de-repression of TESCO activity and thus activation of
CFP expression from P0 onwards. Just after birth, very few CFP-positive cells
could be detected in the gonads of these XX TESCO:CFP; Foxl2LacZ=LacZ mice
and their number increased with age. From 4 weeks onwards, it was clear that
the cells which show de-repression of TESCO were mainly the cells surrounding
the oocytes. In addition, endogenous Sox9 expression was detected in ovaries
of Foxl2 homozygous, but not heterozygous, mutant mice. Sox9 expression co-
incided with CFP expression in the cells surrounding the oocytes. These cells
also expressed -galactosidase, which is largely speciﬁc to granulosa cells as it is
expressed under the endogenous Foxl2 promoter. All this evidence indicates that
indeed the remaining supporting cells which are surrounding the oocytes in the
XX Foxl2LacZ=LacZ gonads up-regulate Sox9 expression upon loss of Foxl2 and
thus switch their cell fate from the female supporting lineage to male Sertoli-like
cells.
Interestingly, TESCO and endogenous Sox9 became de-repressed at diﬀerent time
points in the XX Foxl2LacZ=LacZ gonads. While a few CFP-positive cells could
already be detected at P0, Sox9 was still repressed. There are several possible
explanations for these results: (i) endogenous Sox9 expression might be repressed
127via diﬀerent mechanisms compared to the TESCO element in XX gonads at the
time of birth, (ii) the fact that only very few CFP-positive cell could be found at
this time point suggests that other genes might be involved in the repression of
TESCO activity (and therefore Sox9 expression) around birth, (iii) TESCO:CFP
is a transgene and might be inserted at a more accessible position in the genome
than the endogenous Sox9 gene. Thus, it is possible that the diﬀerential de-
repression proﬁle of TESCO:CFP transgene and endogenous Sox9 might be due
to epigenetic diﬀerences.
Both TESCO and Sox9 became clearly de-repressed with increasing age in the
XX Foxl2LacZ=LacZ gonads, indicating that Foxl2 might be the important gene
in repressing Sox9 in the adult. These results match with the ﬁndings of our
collaborators in adult XX Foxl2∆=∆ mice, where endogenous Sox9 expression
could be detected after the complete loss of FOXL2. Moreover, when bred on
the TESCO:CFP background, CFP expression was also up-regulated in a typical
granulosa cell location of the adult ovary after Foxl2 deletion (Uhlenhaut et al.,
2009).
For a long time it had been proposed that oocytes are essential to maintain granu-
losa cell fate. In diﬀerent models the degeneration of oocytes was associated with
the appearance of testis cord like structure in XX gonads and the transdiﬀeren-
tiation of granulosa cells into Sertoli-like cells (McLaren, 1991). When 13.5 dpc
XX gonads were grafted to the kidney capsule of adult mice, they developed
cord like structures and started to express Sox9 (Morais da Silva et al., 1996).
However, the signals responsible for this testis development of the grafted XX
128gonads are not known. To determine whether the loss of oocytes could result in
a de-repression of Sox9, oocytes were speciﬁcally depleted by activating the DTA
upon Zp3:Cre mediated recombination. In the Zp3:Cre; R26DTA mice, the active
DTA caused apoptosis in oocytes from the primary follicular stage, resulting in a
much smaller, completely oocyte-depleted ovaries from 7 dpp onwards. Although
follicular growth was signiﬁcantly impaired, no Sox9 expression was detected in
these ovaries, indicating that the supporting cells in these oocyte-depleted ovaries
did not switch to Sertoli-like cells. These results are consistent with the data of
our collaborators, who generated Gdf9:Cre; R26DTA mice to analyse oocyte de-
pletion in the ovary. Gdf9 is expressed in oocytes from the primordial follicle
stage onwards at 3 dpp, whereas ZP3 expression starts at 5 dpp (Lan et al.,
2004). Analyses of these Gdf9:Cre; R26DTA mice showed similar results: no
Sox9 expression could be detected in the ovaries upon oocyte loss (Uhlenhaut
et al., 2009). These results diﬀer from the ones obtained in the analyses of the
Foxl2LacZ=LacZ mice which showed a postnatal de-repression of Sox9. Moreover,
when oocytes were depleted in adult female mice using an inducible form of the
human Diphtheria toxin receptor (hDTR), which only induces oocyte-speciﬁc
cell ablation after administration of diphtheria toxin (Gdf9:Cre; R26iDTR), Sox9
expression was also not detected (Uhlenhaut et al., 2009). Again these results
diﬀer from the ones obtained with the conditional adult XX Foxl2∆=∆ mice, which
showed an up-regulation of Sox9 expression at a comparable time after FOXL2
depletion.
Taken together, Sox9 de-repression could not be detected in XX gonads upon
oocyte depletion - it occurs only upon loss of Foxl2. Moreover, oocytes could
129still be found in the ovaries of both XX Foxl2LacZ=LacZ and Foxl2∆=∆ mice. These
results indicate that the de-repression of Sox9 in XX gonads is a consequence
of loss of Foxl2 expression, which results in a transdiﬀerentiation of granulosa
cells into Sertoli-like cells and that oocytes are not directly required to maintain
the granulosa cell fate at least during postnatal ovarian development. The loss
of oocytes in Foxl2 mutants might be a consequence of the granulosa cell trans-
diﬀerentiation to Sertoli-like cells rather than a cause. It is not surprising that
oocytes fail to survive in a testicular environment.
In summary, Foxl2 seems to be the only critical factor ensuring the maintenance
of the granulosa cell lineage in the adult ovary. It does so by repressing Sox9 ex-
pression via the TESCO element. However, these data also indicate that FOXL2
is not the primary factor to repress Sox9 expression during embryonic develop-
ment. Thus, other factors must be involved to ensure both the establishment and
maintenance of the female supporting precursor cell during embryogenesis.
130Chapter 6
The eﬀect of Wnt4 on TESCO
activity in vivo
6.1 Introduction
Loss of Foxl2 expression results in the de-repression of TESCO activity and
endogenous Sox9 expression after birth, indicating that FOXL2 is a critical factor
for maintaining granulosa cell fate postnatally (Chapter 5 and Uhlenhaut et al.
(2009)). However, Foxl2 does not seem to be the important factor to repress
both TESCO and Sox9 during embryogenesis. This raises the question which
factor(s) are responsible for the initial down-regulation of Sox9 expression in the
XX gonad at 11.5 dpc and maintenance of this repression throughout embryonic
development.
Wnt4 is a candidate to fulﬁl this role. In the mouse, Wnt4 is expressed in the in-
diﬀerent gonad from 10.5 dpc onwards in both sexes and becomes female-speciﬁc
due to its down-regulation in XY gonads at 11.5 dpc (Vainio et al., 1999). XX
131mice carrying a targeted null mutation of Wnt4 (Wnt4−=−) show partial mas-
culinisation of the gonad (which takes on a rounder shape, is unencapsulated and
develops closely associated with a fat body) and the developing gonadal duct has
a region resembling the epididymal region of the male Wolﬃan duct. Leydig-
like cells, expressing the two male steroidogenic genes 3HSD and P450c17 are
present in the mutant XX gonad and produce testosterone (Vainio et al., 1999).
Microarray studies revealed that several genes involved in testosterone synthesis
are up-regulated in XX Wnt4−=− gonads between 12.5 dpc and 14.5 dpc (Heikkil¨ a
et al., 2005). In these mice, steroidogenic adrenal precursors, derived from the
mesonephric region where the adrenal is forming, migrate into the gonad and
cluster in the area closest to the developing adrenal. This lead to the hypothesis
that during early gonadal development in XX mice, WNT4 represses the mi-
gration of steroidogenic cells from the mesonephros into the gonad (Jeays-Ward
et al., 2003). Moreover, mesonephric cells, which in XY gonads contribute to the
formation of the male-speciﬁc blood vessel, migrate into XX Wnt4−=− gonads
and an ectopic coelomic vessel develops. This suggests that Wnt4 is necessary to
prevent both migration of endothelial cells into the XX gonad as well as formation
of the vessel (Jeays-Ward et al., 2003). However, neither testis cord formation
nor masculinisation of the external genitalia could be observed in XX Wnt4−=−
mice. Moreover, while Sox9 expression could be detected transiently in these mu-
tant gonads at 11.5 dpc, it was already down-regulated by 12.5 dpc (Kim et al.,
2006b). Lack of Wnt4 expression also results in loss of germ cells by the time
of birth. While the early migration and proliferation of the germ cells seem to
be normal in XX Wnt4−=− mice, almost 90% of the germ cells undergo apopto-
132sis after 16.5 dpc (Yao et al., 2004), indicating a role for Wnt4 in maintaining
oocyte health. Interestingly, XY Wnt4−=− mice display defects in early testis
development, including reduced expression of Sox9, Dhh and Amh at 11.5 dpc
(Jeays-Ward et al., 2004). As Sry expression is unaﬀected, this data suggests that
Wnt4 is involved in Sertoli cell diﬀerentiation downstream of Sry but either up-
stream of or in parallel to Sox9. WNT4 has a mutually antagonistic relationship
with FGF9 (Kim et al., 2006b) and it is possible that precocious activity of the
latter leads to precocious development of testis cords with too few Sertoli-cells
dividing more slowly than pre-Sertoli cells. XY Wnt4−=− gonads also exhibit an
increase in the number of steroidogenic cells indicating that Wnt4 might play a
regulatory role in steroidogenesis in both XX and XY gonads (Jeays-Ward et al.,
2004).
XX mice carrying double homozygous mutations in Wnt4 and Foxl2 (Foxl2−=−,
Wnt4−=−) develop some seminiferous tubule-like structures at P0, which contain
oocytes as well as diﬀerentiated type A spermatogonia (Ottolenghi et al., 2007).
Several male-speciﬁc marker genes such as Sox9, Dmrt1, Amh, Ptgds, Hsd17b3
and Cyp26b1 are up-regulated in XX Foxl2−=−, Wnt4−=− gonads just after birth
(Ottolenghi et al., 2007).
In contrast to the data from WNT4 duplications in human patients, misexpres-
sion of either the human WNT4 gene with its endogenous regulatory sequences
or an Sf1:Wnt4 construct in XY transgenic mice does not cause male-to-female
sex reversal. In the XY Wnt4 transgenic gonads, the coelomic blood vessel de-
velops, although it is disorganised with multiple branches and fails to form one
133main vessel. This suggests that WNT4 is not suﬃcient to prevent the formation
of the coelomic blood vessel in XY gonads, although the level and timing of Wnt4
expression may not have been suﬃcient (Jeays-Ward et al., 2003; Jordan et al.,
2003). These data not only imply that additional Wnt4-independent pathways
must exist in XX gonads to prevent the initiation of vessel formation but also
that Wnt4 needs to be adequately down-regulated in XY gonads in order to form
normal vessels. While misexpression Sf1:Wnt4 in XY gonads does not aﬀect Ley-
dig cell diﬀerentiation (Jeays-Ward et al., 2003), the presence of human WNT4
results in reduced levels of testosterone due to a decreased expression of StAR,
which is involved in the rate-limiting step of steroidogenesis (Jordan et al., 2003).
In XY gonads, Fgf9 has been shown to be involved in the maintenance of Sox9
expression via the establishment of a feed-back loop between SOX9 and FGF9
(Kim et al., 2006b). In XY Fgf9−=− gonads, Wnt4 expression is not down-
regulated at 11.5 dpc as it normally occurs. However, both Sry and Sox9 are
initially expressed. Furthermore, addition of FGF9 to XX gonad cultures ex vivo
resulted in the down-regulation of Wnt4 expression (Kim et al., 2006b), while
Fgf9, which is normally expressed only in XY gonads after 11.5 dpc, was detected
in XX Wnt4−=− gonads at 12.5 dpc (Kim et al., 2006b). These results suggest an
antagonistic relationship between FGF9 and WNT4 signalling in the developing
gonad: the establishment of active FGF9 signalling in the XY gonad represses
Wnt4 expression and thereby ensures normal testis development, whereas the
establishment of WNT4 signalling represses Fgf9 activity in XX gonads to secure
normal ovarian development. In XX gonads with ectopic Sry expression induced
after the critical time window of sex determination, Sox9 expression could not
134be maintained. This was attributed to the fact that delayed Sry expression can
not result in suﬃciently high levels of Sox9 expression to enable the XX gonad
to activate FGF9 signalling. As the XX gonads did not switch from the female
WNT4 signalling to the male FGF9 signalling program, Sox9 expression could not
be maintained and therefore no female-to-male sex reversal occurred (Hiramatsu
et al., 2009). Taken together, the establishment of WNT4 signalling seems to be
crucial in tipping the balance of sex determination towards female development.
So far, a number of genes have been described as possible downstream targets
for WNT4 signalling. For example Dax1 expression is signiﬁcantly reduced in
Wnt4−=− mice (Mizusaki et al., 2003). Moreover, addition of WNT4 to cultured
mouse Leydig cells or Sertoli cells resulted in an up-regulation of endogenous
Dax1 expression (Jordan et al., 2001). Furthermore, both Fst and Bmp2 have
been suggested as downstream eﬀectors of WNT4 signalling. Fst encodes an ac-
tivin binding protein, which can antagonise members of the TGF superfamily.
It was originally identiﬁed as a potent inhibitor of pituitary FSH (Ueno et al.,
1987) and is involved in regulation of the hypothalamic-pituitary-gonadal axis
(Phillips and de Kretser, 1998). Fst is expressed exclusively in XX gonads from
11.5 dpc and decreases after 14.5 dpc (Yao et al., 2004). In XX Wnt4−=− mice,
no expression of Fst can be detected, whereas Wnt4 is expressed normally in
XX Fst−=− mice. This suggests that Fst is a downstream eﬀector of Wnt4 sig-
nalling (Yao et al., 2004). Moreover, XX Fst−=− mice form testis-speciﬁc coelomic
blood vessels and suﬀer germ cell depletion similar to the phenotypes observed in
Wnt4−=− mice (Yao et al., 2004). Testis diﬀerentiation was found to be normal
in XY Fst−=− mice. BMP2 belongs to the family of bone morphogenic proteins
135(Bmp), which are multifunctional regulators of cell growth and diﬀerentiation
and were originally identiﬁed in cartilage formation (Wozney et al., 1988). Bmp2
is expressed in the gonads of both sexes at 10.5 dpc and becomes female-speciﬁc
around 11.5 dpc, before its expression decreases after 14.5 dpc (Yao et al., 2004).
The expression is restricted to cells just under the coelomic epithelium. The go-
nadal phenotype of Bmp2−=− mice could not be analysed as the mice die before
10.5 dpc and thus prior to the time of sex determination (Zhang and Bradley,
1996). However, Bmp2 expression is absent in Wnt4−=− mice suggesting that it
is a downstream eﬀector of Wnt4 signalling (Yao et al., 2004).
In summary, WNT4 is an important anti-testis factor, implicated in opposing the
male pathway by repressing SOX9 and FGF9. This raises the question whether
Wnt4 could be involved in the regulation of Sox9 expression in vivo via the
TESCO enhancer element. To investigate this possibility, the eﬀect of Wnt4
deletion on TESCO activity was analysed in XX gonads by crossing Wnt4 mutant
mice to the TESCO:CFP reporter line. If WNT4 represses Sox9 expression via
the TESCO enhancer element in vivo, loss of Wnt4 in the XX gonad should result
in a de-repression of TESCO activity and therefore activation of CFP expression
in XX TESCO:CFP; Wnt4−=− ovaries.
1366.2 Results
6.2.1 The de-repression of TESCO in Wnt4 mutant mice
To test whether TESCO became de-repressed in the developing gonad upon loss
of Wnt4 expression, the TESCO:CFP reporter mice were bred to Wnt4 mutant
mice. The targeted deletion of Wnt4 was established by replacing the third and
fourth exon of Wnt4 with a selection cassette containing neomycin phosphotrans-
ferase resulting in a functional null allele (Stark et al., 1994).
Wnt4−=− mice die within 24 hours after birth due to kidney failure and there-
fore no analyses were possible after P0 (Vainio et al., 1999). XX TESCO:CFP;
Wnt4−=− gonads, as well as XY TESCO:CFP; Wnt4+=− and XX TESCO:CFP;
Wnt4+=− control gonads, were collected at diﬀerent time points during embry-
onic development (12.5 dpc to 18.5 dpc) and at birth (P0). Gonads were then
sectioned and analysed for CFP expression. CFP expression was detected in
XY TESCO:CFP; Wnt4+=− gonads in the Sertoli cells. In XX TESCO:CFP;
Wnt4+=− gonads, occasionally a few CFP-positive cells could be detected from
14.5 dpc onwards. In XX TESCO:CFP; Wnt4−=− gonads, few CFP expressing
cells were detected at 14.5 dpc, while more CFP-positive cells could be found
between 16.5 dpc and P0 (Figure 6.1).
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Figure 6.1: TESCO activity in TESCO:CFP; Wnt4−=− gonads during
embryogenesis.
Cryosections of XY and XX gonads of TESCO:CFP mice with heterozygous
and homozygous loss of Wnt4 at diﬀerent time points during embryogenesis and
just after birth (P0). Immunostaining shows DAPI in blue and CFP in green.
TESCO expression could be detected in the Sertoli cells in XY gonads (left panel).
Very few CFP-positive cells could be found in XX TESCO:CFP; Wnt4+=− gonads
(middle panel). De-repression of TESCO activity was found in XX TESCO:CFP;
Wnt4−=− from around 14.5 dpc to P0 (right panel). Scale bar = 50m.
138To determine whether the TESCO element was de-repressed in the granulosa cells
of XX TESCO:CFP; Wnt4−=− gonads, co-immunostainings of CFP and FOXL2
were analysed in 18.5 dpc gonads. As expected, XY TESCO:CFP; Wnt4+=−
gonads expressed CFP, as shown before, but no FOXL2. On the other hand, XX
TESCO:CFP; Wnt4+=− gonads showed expression of FOXL2 and occasionally
very few CFP-positive cells. Expression of both proteins was detected in XX
TESCO:CFP; Wnt4−=− gonads. Although both proteins were expressed, strong
signals for FOXL2 and CFP did not co-localise in the mutant XX gonads (Figure
6.2). Only occasionally a very weak cytoplasmic CFP signal could be found with
a strong nuclear FOXL2 signal and vice versa.
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Figure 6.2: FOXL2 and CFP do not co-localise in TESCO:CFP;
Wnt4−=− gonads.
Cryosections of XY and XX gonads of TESCO:CFP mice with heterozygous and
homozygous loss of Wnt4 at 18.5 dpc. Immunostaining showing DAPI in blue,
CFP in green and FOXL2 in red. CFP was detected in the Sertoli cells in the XY
gonads and occasionally in scattered cells in the XX TESCO:CFP; Wnt4+=− go-
nads, whereas FOXL2 was detected in XX TESCO:CFP; Wnt4+=− but not XY
gonads. XX TESCO:CFP; Wnt4−=− gonads showed cells which express either
CFP or FOXL2. Scale bar = 50m; inserts show 2.5x higher magniﬁcations.
1396.2.2 SOXE expression in Wnt4 mutant mice
Next, the expression pattern of endogenous Sox9 was analysed between 12.5 dpc
and P0 to determine if it coincided with the CFP expression. As expected, Sox9
expression was detected in Sertoli cells of XY TESCO:CFP; Wnt4+=− gonads,
while it could not be detected in control XX TESCO:CFP; Wnt4+=− gonads.
However, no Sox9 expression was found in XX TESCO:CFP; Wnt4−=− gonads
between 12.5 dpc and P0 (Figure 6.3). Thus, the cells which express TESCO:CFP
did not show a synchronous de-repression of endogenous Sox9 expression.
It has been described before that other members of the SoxE family also play an
important role in early testis development. Sox8 is expressed in Sertoli cells in
the XY gonad from 12.0 dpc onwards and has not been detected in XX gonads
(Schepers et al., 2003). Recently, it has also been reported that Sox10 is expressed
exclusively in the XY gonad at the time of sex determination (Polanco et al.,
2010). Both, Sox8 and Sox10 share a high sequence identity with Sox9 and it
has been proposed that at least SOX8 and SOX9 might act redundantly with
respect to each others function. To determine whether any SOXE signal could
be detected in XX TESCO:CFP; Wnt4−=− gonads, an antibody recognising all
three members of the SOXE proteins (SOX8, SOX9, SOX10) was used.
Since SOX9 expression is absent in XX Wnt4−=− gonads (Figure 6.3) any SOXE
signal identiﬁed would correspond to SOX8 or SOX10. As expected, SOXE ex-
pression was found in the Sertoli cells in XY TESCO:CFP; Wnt4+=− gonads
at all time points analysed, presumably representing the expression patterns of
both Sox8 and Sox9 (Figure 6.4). No SOXE signal was detected in control XX
140TESCO:CFP; Wnt4+=− gonads. In XX TESCO:CFP; Wnt4−=− gonads, some
occasional SOXE-positive cells could be found at 12.5 dpc, a few more cells at
14.5 dpc and more cells expressing SOXE were detected between 16.5 dpc and P0
(Figure 6.4), similar to the pattern of TESCO de-repression in XX TESCO:CFP;
Wnt4−=− gonads (Figure 6.1).
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Figure 6.3: Endogenous Sox9 expression in TESCO:CFP; Wnt4−=− go-
nads during embryogenesis.
Cryosections of XY and XX gonads of TESCO:CFP mice with heterozygous and
homozygous loss of Wnt4 at diﬀerent time points during embryogenesis and just
after birth (P0). Immunostaining shows DAPI in blue and SOX9 in green. SOX9
could be detected in Sertoli cells in the XY TESCO:CFP; Wnt4+=− gonads (left
panel) but not in XX TESCO:CFP; Wnt4+=− or XX TESCO:CFP; Wnt4−=− at
any time during embryogenesis (middle and right column, respectively). Scale
bar = 50m.
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Figure 6.4: Endogenous SoxE expression in TESCO:CFP; Wnt4−=− go-
nads during embryogenesis.
Cryosections of XY and XX gonads of TESCO:CFP mice with heterozygous and
homozygous loss of Wnt4 at diﬀerent time points during embryogenesis and at P0.
Immunostaining shows DAPI in blue and SOXE in green. SOXE signals could
be found in Sertoli cells in the XY TESCO:CFP; Wnt4+=− gonads (left panel)
but not in XX TESCO:CFP; Wnt4+=− gonads (middle panel). De-repression
of SOXE, presumably SOX8 and/or SOX10, was found in XX TESCO:CFP;
Wnt4−=− from around 14.5 dpc until birth (right panel). Scale bar = 50m.
1436.2.3 De-repression of TESCO and endogenous Sox9 ex-
pression in Foxl2/Wnt4 double mutant mice
Next, the eﬀect of the combined loss of both Foxl2 and Wnt4 on TESCO activity
was analysed in gonads of XX Foxl2/Wnt4 double mutant mice (Foxl2LacZ=LacZ;
Wnt4−=−) at birth (Figure 6.5). CFP expression could be detected normally in
Sertoli cells in XY Foxl2LacZ=LacZ; Wnt4−=− gonads, indicating that both Foxl2
and Wnt4 are not critical for Sertoli cell diﬀerentiation or testis cord formation.
Analyses of XX TESCO:CFP; Foxl2LacZ=LacZ; Wnt4+=− gonads showed similar
results to those of heterozygous XX TESCO:CFP; Wnt4+=− single mutants with
a few CFP-positive cells. However, XX TESCO:CFP; Foxl2LacZ=LacZ; Wnt4−=−
gonads showed an increase in the number of CFP-positive cells compared to each
single mutant, suggesting a stronger de-repression of TESCO activity at P0 in the
Foxl2LacZ=LacZ; Wnt4−=− double mutants. The CFP-positive cells in these gonads
are forming seminiferous tubule-like structures which resemble the ones seen in
XY gonads. Endogenous SOX9 expression could be found in the Sertoli cells of
XY Foxl2LacZ=LacZ; Wnt4−=− gonads, but not in the analysed XX TESCO:CFP;
Foxl2LacZ=LacZ; Wnt4+=− gonads. XX TESCO:CFP; Foxl2LacZ=LacZ; Wnt4−=− go-
nads showed endogenous Sox9 expression in a pattern similar to the TESCO:CFP
reporter. This was in contrast to each single mutant, where SOX9 was not de-
repressed at P0 (Figure 5.5 and Figure 6.3).
144D
A
P
I
C
F
P
/
P
0
D
A
P
I
S
O
X
9
/
P
0
XX TESCO:CFP,                Foxl2
LacZ/LacZ            XX TESCO:CFP,                Foxl2
LacZ/LacZ           −/−           
XY TESCO:CFP,               
+/−           
Wnt4 ,                ,                Wnt4 Foxl2
LacZ/LacZ            ,                Wnt4
−/−           
Figure 6.5: TESCO activity in TESCO:CFP; Foxl2LacZ=LacZ; Wnt4−=−
double mutant gonads at P0.
Cryosections of XY and XX gonads of TESCO:CFP mice with homozygous loss
of Foxl2 and heterozygous or homozygous loss of Wnt4 at P0. Immunostaining
shows DAPI in blue and CFP in green. TESCO expression could be detected
in the Sertoli cells in the XY TESCO:CFP; Foxl2LacZ=LacZ; Wnt4−=− gonads.
Very few CFP-positive cells could be found in XX TESCO:CFP; Foxl2LacZ=LacZ;
Wnt4+=− gonads. More CFP-positive cells were found in XX TESCO:CFP;
Foxl2LacZ=LacZ; Wnt4−=− gonads than in the single mutants. Scale bar = 50m.
1456.3 Conclusions
According to published data, Wnt4 is a candidate for an anti-testis or ovarian-
determining gene which could be involved in the repression of Sox9 in XX gonads
during embryonic development. As Wnt4 expression becomes female-speciﬁc co-
incidentally with the down-regulation of Sox9 at 11.5 dpc, it is possible that it is
the crucial gene to mediate the down-regulation of Sox9 expression in embryonic
XX gonads. In this chapter it was analysed whether Wnt4 can repress Sox9 ex-
pression in vivo and whether this repression is mediated via the TESCO enhancer
element. As homozygous Wnt4 mutant mice die within 24 h after birth due to
kidney failure, the gonadal phenotype of these mice could only be analysed up
until P0.
Homozygous loss of Wnt4 resulted in some de-repression of TESCO activity in
the XX gonad around 14.5 dpc. This result suggests that WNT4 signalling is
involved in the repression of TESCO activity from 14.5 dpc until after birth, but
not prior to 14.5 dpc. Interestingly, no Sox9 expression could be detected in
XX Wnt4−=− gonads at the time points analysed, either during embryogenesis or
at P0. This is consistent with results from Kim et al. (2006b), where transient
expression of Sox9 in XX Wnt4−=− gonads was detected only at 11.5 dpc and
then found to be down-regulated by 12.5 dpc. The time course of Sox9 expression
in XX TESCO:CFP; Wnt4−=− gonads shown here, demonstrates that the down-
regulation of Sox9 is maintained after 12.5 dpc until birth, although some cells
express the TESCO:CFP reporter from 14.5 dpc onwards. The fact that the
TESCO element became de-repressed upon loss of Wnt4 while Sox9 expression is
146not up-regulated suggests that the endogenous Sox9 gene is controlled in a more
complex manner, independently of the TESCO element in XX gonads during
embryonic development. The TESCO element is the critical 1.3 kb core region
of the endogenous 3.2 kb Sox9 enhancer TES and thus it might be possible
that the complete TES element contains relevant repressor binding sites outside
the TESCO region. In fact, when the larger TES element was cloned into the
luciferase vector and tested in co-transfection assays, the element could not be
activated by increasing amounts of SF1 and SOX9 (data not shown), suggesting
that TES might contain a strong repressor element outside TESCO. However,
as mentioned before, TESCO:CFP is a transgene and it is possible that the
diﬀerential de-repression proﬁle of TESCO:CFP transgene and endogenous Sox9
might be at least partially due to epigenetic diﬀerences and integration site.
Coinciding with the de-repression of TESCO in XX Wnt4−=− gonads, was the
activation of SOXE expression, that is SOX8 and/or SOX10, from 14.5 dpc until
P0. This result suggests that WNT4 represses Sox8 and/or Sox10 expression, in
addition to Sox9, in XX gonads during this time of embryonic development. Both,
Sox8 and Sox10 belong to the same group of SOXE proteins as Sox9 and the two
proteins share a high sequence homology. Studies in mice with double mutation of
both Sox8 and Sox9 have suggested that the two genes have redundant functions
during embryonic testis development (Chaboissier et al., 2004; Barrionuevo et al.,
2009).
Interestingly, the cells which showed a de-repression of TESCO activity in XX
Wnt4−=− gonads were not expressing FOXL2. This suggests that TESCO ac-
147tivity becomes de-repressed in a subset of granulosa cells which have lost Foxl2
expression, or in some undiﬀerentiated granulosa precursor cells in the gonads
of these mice. The result that expression of TESCO and FOXL2 are mutually
exclusive, once more indicates that FOXL2 antagonises TESCO activity. This
is consistent with the results in adult XX Foxl2∆=∆ mice, were the expression of
FOXL2 and SOX9 were found to be mutually exclusive (Uhlenhaut et al., 2009).
FOXL2 seems to be able to keep TESCO activity repressed in the granulosa
cell precursor cells in XX Wnt4−=− gonads during embryonic development. As
TESCO does not become up-regulated in XX Foxl2LacZ=LacZ gonads before birth,
it suggests that Wnt4 is the more important gene to repress TESCO during em-
bryogenesis, but in the absence of Wnt4, FOXL2 can still repress TESCO activity.
To determine whether Foxl2 and Wnt4 might be acting in redundant pathways
to secure repression of TESCO activity and endogenous Sox9 expression in the
developing XX gonad, mice carrying mutations of both genes were analysed. XX
Foxl2LacZ=LacZ, Wnt4+=− gonads were similar to those of Wnt4+=− mice with
very few CFP-positive cells. XX Foxl2LacZ=LacZ, Wnt4−=− gonads showed more
cells expressing CFP than in either of the single mutants. Moreover, cord-like
structures could be seen in the double mutant gonads and Sox9 expression was
de-repressed. This observation was diﬀerent from that in each single mutant
where neither XX Foxl2LacZ=LacZ nor XX Wnt4−=− gonads showed up-regulation
of Sox9 expression at P0 (Figure 6.6). These results indicate a synergistic eﬀect
of both Foxl2 and Wnt4 in repressing TESCO and Sox9 expression at birth.
Taken together these results indicate that WNT4 signalling is at least partially
involved in the repression of TESCO activity during embryonic development.
148However, the expression of endogenous Sox9 seems to be repressed by additional
factors independently from the TESCO element. Around the time of birth both
Wnt4 and Foxl2 seem to be working together to ensure the repression of TESCO
activity and Sox9 expression in the developing XX gonad.
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Figure 6.6: Summary of in vivo data.
In gonads of XX Wnt4−=− mice, TESCO:CFP and SOX8 are de-repressed from
14.5 dpc until P0, while Sox9 is still repressed (cross indicates that Wnt4−=− mice
die within 24h after birth). In gonads of XX Foxl2LacZ=LacZ mice, TESCO:CFP
becomes de-repressed at P0, whereas SOX9 ﬁrst appears at 7 dpp. In gonads of
XX double mutants, both TESCO:CFP and SOX9 can be detected at P0.
149Chapter 7
General Discussion
The decision whether a mammalian embryo develops as male or female depends
on the presence or absence of the Y chromosome. For some, the discovery of Sry
as the sex determining factor on the Y almost 20 years ago, strengthened the idea
that male development would be an active process whereas female development
would be merely a default pathway. However, due to the discovery of a number of
genes involved in both male and female sex determination, it has become evident
that it is not that simple. In both humans and mice, cases of XX female-to-male
sex reversal have been described that result from LoF mutations in several genes,
which are now considered to be ovarian-promoting or at least anti-testis genes as
they are playing important roles in the active repression of the male pathway.
Recently, it has been shown that Sox9 is the critical downstream target gene of
Sry in the developing XY gonad and that its testis-speciﬁc expression is regu-
lated via the 1.3 kb enhancer element TESCO (Sekido and Lovell-Badge, 2008).
A model has been proposed in which TESCO activity (and therefore Sox9 ex-
pression) in the XY supporting cell lineage is initiated by SF1 at 10.5 dpc, up-
150regulated by SRY by 11.5 dpc and maintained via a positive feedback loop in-
cluding SOX9 itself and other factors, such as FGF9 and PGD2 signalling (Sekido
and Lovell-Badge, 2008; Kim et al., 2006b; Wilhelm et al., 2005). SOX9 directs
the supporting cell lineage of the XY gonad to become Sertoli cells, which is the
crucial event in testis development. In contrast, in XX gonads, although Sox9
expression is initiated by SF1, it is then actively down-regulated by 11.5 dpc and
this repression is maintained in granulosa cells usually throughout life. Until now,
it has not been known which genes are responsible for the initial down-regulation
of Sox9 and the maintenance of Sox9 repression or whether this repression is
mediated via the TESCO element in XX gonads.
7.1 The ovarian-promoting genes Dax1, Sox4
and Foxl2 repress TESCO activity in vitro
Several genes have been proposed as ovarian promoting genes due to their diﬀer-
ential expression proﬁles in XX and XY gonads during the time of sex determi-
nation. These include Dax1, Sox4, Wnt4, Foxl2 and ER. To analyse whether
these candidate genes could be involved in the regulation of Sox9 expression via
the TESCO element, the 1.3 kb sequence was ﬁrst searched for putative binding
sites. The analysis revealed that the TESCO sequence is indeed full of potential
transcription factor binding sites. Amongst others, sites were found for GATA,
zinc ﬁnger transcription factors, LIM homeobox factors, TATA-binding factors,
SOX proteins, nuclear receptors, LEF/TCFs, forkhead factors and estrogen re-
sponse elements. This suggests the possibility that the listed ovarian promoting
151genes could be involved in the modulation of TESCO activity.
The potential of these genes to modulate Sox9 expression via the TESCO element
was then analysed in co-transfection assays in vitro. In this thesis, it has been
demonstrated that, while WNT eﬀectors did not signiﬁcantly aﬀect TESCO acti-
vation mediated by SF1 and SOX9/SRY, DAX1, SOX4 and FOXL2 were able to
repress TESCO activity in a dosage-dependent manner. Interestingly, ER on its
own did not have any eﬀect on TESCO activation, but acted synergistically with
FOXL2 resulting in an enhanced repression eﬀect which seems to be independent
from the amount of ER, at least at the levels tested.
The implication of WNT4 signalling on TESCO expression was analysed via its
downstream eﬀectors -catenin and LEF/TCFs. No eﬀect on TESCO activity
could be found by either -catenin on its own, either LEF1, TCF1, TCF3 or
TCF4, or by combinations of -catenin and any of the LEF/TCFs. This could
suggest that WNT4 signalling is not acting on Sox9 expression via the TESCO
element or that it acts on TESCO activity via a non-canonical pathway (for review
see Komiya and Habas, 2008). Another possibility is that the COS7 cell line that
was used might lack important co-factors which are crucial for WNT dependent
transcriptional regulation (like Groucho or CtBP). For more conclusive results
the experiments should be repeated in a more suitable cell line, e.g. in primary
cultures of granulosa cells. It is not known yet which LEF/TCFs are expressed in
the supporting cells of the gonad and therefore could be involved in any regulation
of sex determination. Thus, in future experiments, it should ﬁrstly be determined
which LEF/TCFs are indeed expressed in the granulosa cells in XX gonads during
152embryogenesis and postnatally, and thus could be involved in the regulation of
Sox9 expression. Moreover, ChIP assays are necessary to analyse which of these
factors, if any, are bound to the TESCO element in vivo and thus might indeed
be involved in its regulation. It is also possible that WNT4 signalling modulates
Sox9 expression not by transcriptional regulation but via a diﬀerent mechanism.
It has been reported in chondrocyte diﬀerentiation that SOX9 physically interacts
with -catenin which causes the degradation of both proteins via the proteosomal
machinery (Akiyama et al., 2004). It might be possible that the same is happening
in the gonad, thereby regulating the amount of available SOX9. Nevertheless,
reduced levels of SOX9 in the presence of -catenin should still cause a reduction
of TESCO activation in the co-transfection assays, as SOX9 is needed for TESCO
activation. However, the luciferase reporter assay might not be a suﬃcient system
to analyse any potential SOX9 degradation eﬀect. To determine the eﬀect of -
catenin on SOX9, diﬀerent amounts of -catenin and SOX9 could be transfected
into a cell line which does not endogenously express both genes and a possible
reduction of the two proteins could be monitored e.g. by western blotting analysis.
Finally, it is also possible that WNT4 is only involved in the regulation of Sox9
expression via activating its downstream target Dax1 (Mizusaki et al., 2003),
which is unlikely to happen in COS7 cells.
In the co-transfection assays, DAX1 was able to repress TESCO activation. It had
already been reported that DAX1 can form heterodimers with SF1 and decreases
SF1 activity (Ito et al., 1997; Crawford et al., 1998). As SF1 is needed for
TESCO activation, less SF1 activity could result in the observed repression eﬀect
on TESCO activity upon addition of DAX1. However, the precise mechanism as
153to how DAX1 represses TESCO activity remains to be investigated. In future
experiments it would be necessary to determine whether DAX1 directly binds to
the TESCO sequence, e.g. by ChIP assay. Moreover, it would also be interesting
to analyse the eﬀect of DAX1 on TESCO activity in vivo. If DAX1 is necessary
for the repression of TESCO activity, mice carrying a deletion of the Dax1 gene
crossed to the TESCO:CFP reporter line might show an up-regulation of CFP
expression in XX gonads. However, the role of Dax1 in sex determination is not
completely understood and the published Dax1 mutant mice are still a point of
controversy. Thus, it might be necessary to generate a targeted deletion of both
Dax1 exons or to establish a complete knock down of Dax1 expression via other
methods such as RNAi. These in vivo models might provide a more reliable
model to analyse the eﬀect of loss of Dax1 expression in general and on Sox9
expression and TESCO activation in particular.
SOX4 was also found to be able to repress TESCO activity in vitro, but only
when activated by combinations including SOX9 or SRY. The SOX4 protein
contains the highly conserved DNA binding domain (HMG-box) characteristic
of the SOX proteins and it is likely that it can bind to the same SOX binding
sites in the TESCO element as SOX9 and SRY. Thus, SOX4 could compete
with SOX9 and/or SRY for binding to the TESCO element and thereby prevent
the activation of TESCO. As SOX4 and SOX9 are members of diﬀerent groups
of SOX proteins it is also possible that SOX9 (belonging to the SOXE group)
acts as a transcriptional activator on TESCO and SOX4 (belonging to the SOXC
group) could act as a transcriptional repressor. Indeed, it has already been shown
that a prolonged expression of Sox4 in oligodendrocytes results in a reduction of
154myelin gene expression in vivo (Chew and Gallo, 2009). In future experiments,
such as EMSA or ChIP assays, it should be determined whether SOX4 is indeed
able to bind to the SOX binding sites in the TESCO element and whether this
might result in a competition for binding with SOX9. Furthermore, the eﬀect of
SOX4 on TESCO activity and endogenous Sox9 expression should be analysed
in vivo. For this, mice with a deletion of the Sox4 gene should be crossed to the
TESCO:CFP reporter line. If SOX4 is repressing TESCO activation, homozygous
loss of Sox4 might result in an up-regulation of CFP and possibly endogenous
Sox9 expression in XX gonads. However, Sox4−=− mice die at 14.5 dpc due
to heart malformation (Schilham et al., 1996) allowing only the analysis of a
possible role of SOX4 in the early repression of Sox9. To further determine the
involvement of SOX4 in Sox9 repression after 14.5 dpc, a conditional mutation
of Sox4 would be required.
The most interesting eﬀect seen in the co-transfection assays in vitro was the
repression of TESCO by FOXL2. This eﬀect was dosage-dependent and provides
the ﬁrst evidence of a direct link between Foxl2 and the regulation of Sox9,
suggesting that this regulation could be mediated via the TESCO element.
7.2 FOXL2 represses TESCO activity synergis-
tically with ER
FOXL2 and ER were able to synergistically repress TESCO activation in vitro.
While FOXL2 belongs to the forkhead family of transcription factors which can
bind to DNA at the consensus binding site (A/G)(C/T)(A/C)AA(A/T)A (Kauf-
155mann et al., 1995), ER can bind to EREs (palindromes of GGTCA) (Klinge,
2001), both of which are present in the TESCO element. ChIP analysis in adult
ovaries have revealed that both FOXL2 and ER are indeed binding to the
TESCO sequence and co-immunoprecipitation assays have demonstrated that
FOXL2 and ER physically interact (Uhlenhaut et al., 2009). Moreover, it has
been shown in this thesis that mutation of all identiﬁed FOX and ERE sites in the
TESCO sequence resulted in a loss of the synergistic repression eﬀect mediated
by ER in vitro, though the repressive eﬀect of FOXL2 was persisting. Analyses
of the same mutations in the TESCO element in vivo showed a de-repression of
TESCO:CFP in the adult ovary (Uhlenhaut et al., 2009). These data suggest
that a potential FOXL2/ER complex might bind to either FOX or ERE sites
in the TESCO element and that Sox9 repression is mediated via these sites in
the TESCO element in the adult ovary. A possible explanation for the diﬀering
results in vitro and in vivo could be the presence of some minor interaction sites
for FOXL2 in the mutated TESCO sequence. These might not play a crucial
role in vivo and TESCO activity becomes de-repressed upon loss of the major
FOX and ERE sites. However, in the in vitro co-transfection assays these minor
sites might still mediate the repression of TESCO activity due to the excessive
amount of available FOXL2. Although the conclusions which can be drawn from
the in vitro assays should be regarded carefully due to the limitations of this
artiﬁcial system, the results stress the same trend seen in vivo: the importance
of the synergistic repressive eﬀect of FOXL2 and ER on TESCO activity
In contrast to the adult ovary, FOXL2 seems not to be the crucial factor for
TESCO repression during embryogenesis as loss of Foxl2 does not result in the
156up-regulation of TESCO activity or Sox9 expression before birth. In mice, no
steroidogenesis takes place during XX embryonic development (Pannetier et al.,
2006a), thus no production of estrogens occurs during this time period. It is
possible that, due to the lack of estrogen signalling, ER is not translocated into
the nucleus and thus cannot interact with FOXL2 which results in the inability
of FOXL2 to repress TESCO. To understand this mechanism better, it should be
analysed via ChIP assays whether FOXL2 is able to bind to the TESCO element
in the absence of ER during embryogenesis. In contrast to mice, production of
estrogens has been found during early ovarian development in the goat. It has
been shown that FOXL2 activates Cyp19a1 expression in goat (Pannetier et al.,
2006a), indicating that loss of Foxl2 expression in XX goats with female-to-male
sex reversal (PIS mutation) might also result in the additional absence of es-
trogens during embryonic development. The phenotype in PIS mutant goats is
evident much earlier than in Foxl2 mutant mice, suggesting that indeed estro-
gens play an important role in repressing the testis pathway during embryonic
development in the goat. Loss of Foxl2 therefore seems to be the primary cause
of the XX sex reversal in PIS animals.
In XX mice however, double mutations of both ER and ER (ERKO) result
in mostly normal pre-pubertal ovaries (Couse et al., 1999). In such mice, the
early diﬀerentiation of the reproductive tract occurs normally and all M¨ ullerian
duct-derived structures are developed. However, the pre-pubertal ovaries pos-
sess adult-like follicles indicating a precocious maturation of the ovary. In con-
trast, ovaries of adult ERKO mice show the appearance of some seminiferous
tubule like structures and Sertoli-like cells. Moreover, Sox9 expression becomes
157up-regulated, resulting in an adult sex-reversed phenotype similar to the one
described in adult Foxl2∆=∆ mice (Uhlenhaut et al., 2009), although less pro-
nounced. While the phenotype of ERKO mice ﬁrst becomes evident after
puberty, the phenotype of Foxl2LacZ=LacZ mice is visible as early as 7 dpp. These
diﬀerences in timing indicate that FOXL2 cannot just depend on an interaction
with ERs to regulate female sex determination.
7.3 FOXL2 interferes with SF1-mediated acti-
vation of TESCO in vitro
In this thesis it has been demonstrated that FOXL2 interacts directly with SF1.
It was also shown that mutation of all putative FOX sites in the TESCO element
did not result in a loss of TESCO repression mediated by FOXL2, suggesting that
FOXL2 does not act, at least not exclusively, via these predicted binding sites.
Moreover, the data suggests that FOXL2 can bind to DNA at the SF1 binding
site and might be competing with SF1 for binding to the TESCO sequence.
Recently a paper was published which postulated a new FOXL2-speciﬁc DNA
binding site GTCAAGG(T/C)CA (Benayoun et al., 2008). This new binding site
resembles very closely the SF1 binding site (T/C)(T/C)AAGG(T/C)C(G/A).
Taken together, these data allows to hypothesise several ways by which FOXL2
could interact with SF1 to regulate TESCO activity (Figure 7.1): (i) FOXL2
(possibly together with ER) might physically interact with SF1 and thereby
reduce the amount of SF1 available to activate TESCO, (ii) FOXL2 (possibly
together with ER) might interact with DNA-bound SF1, thereby inhibiting its
158transcriptional activation capability, (iii) FOXL2 might be competing with SF1
for binding to the TESCO element, resulting in a repression of TESCO rather
than an activation. In future experiments, the exact binding sites for FOXL2
in the TESCO element should be analysed e.g. by in vivo footprinting assays,
to determine if FOXL2 is indeed able to bind to SF1 binding sites or if it could
possibly bind to other sites which diﬀers from the consensus forkhead factor
binding site. Further structural analyses should also determine the interaction
between FOXL2/ER and FOXL2/SF1 in more detail to ﬁnd out which domains
might be involved in protein-protein interactions and how they might bind to
DNA as protein complexes.
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Figure 7.1: Model of possible interactions between FOXL2 and SF1 to
regulate Sox9 expression in XX gonads.
SF1 initiates low expression of Sox9 in the XX gonad, but this is then down-
regulated and it is maintained in a repressed state in the granulosa cells through-
out life. It is likely that the repression is mediated via the TESCO element, and
FOXL2 (and ER) could contribute to this in the embryo and then become solely
responsible after birth, in several ways: (i) FOXL2 (+ ER?) could interact with
SF1, preventing the latter from binding DNA, (ii) FOXL2 (+ ER?) could in-
teract with DNA-bound SF1, interfering with its ability to activate transcription
or actively recruit co-repressors (iii) FOXL2 interacts with ER and the complex
might bind to TESCO at FOX sites, EREs or possibly at SF1 binding sites and
directly mediate repression.
1597.4 FOXL2 represses TESCO activity and en-
dogenous Sox9 expression postnatally
The in vivo analyses conducted in this thesis, showed that loss of Foxl2 ex-
pression resulted in an up-regulation of TESCO activity in XX TESCO:CFP;
Foxl2LacZ=LacZ gonads. This indicates that FOXL2 is repressing TESCO activa-
tion in vivo as well as in vitro. However, the de-repression of TESCO activity
was only seen postnatally and not at any of the time points analysed during
embryogenesis. Endogenous Sox9 expression was also up-regulated postnatally
in the same cells as CFP, in cells surrounding oocytes. These cells are likely to
have been granulosa cells as they also express -galactosidase, a marker expressed
under the control of the endogenous Foxl2 promoter. Thus, it seems that the de-
repression of both TESCO activity and endogenous Sox9 expression occurs in
granulosa cells which then take on Sertoli-like properties. In Foxl2 mutant mice,
these cells are organised in only one or two layers around the oocyte, in contrast
to several layers of granulosa cells in wild-type ovaries. This seems to be due
to a failure in proliferation (Uda et al., 2004) as might be expected if they are
Sertoli cells. The up-regulation of Sox9 expression in this layer of supporting cells
indicates a switch from the female to a male fate. A similar result was obtained
in the conditional Foxl2∆=∆ mice where, upon loss of Foxl2 in the adult ovary,
both TESCO:CFP and Sox9 became expressed in the layer of granulosa cells
surrounding the oocytes (Uhlenhaut et al., 2009). Taken together, these results
indicate that FOXL2 is indeed necessary to repress Sox9 postnatally and that
this regulation is accomplished via the TESCO element in vivo.
160However, it is also possible that the loss of FOXL2 results in a de-repression of
endogenous Sox9 independent of the TESCO element. The de-repressed endoge-
nous SOX9 could then act back on the TESCO element in a positive feedback
loop in the same way that SOX9 contributes to its own regulation during early
testis diﬀerentiation (Sekido and Lovell-Badge, 2008). It is thought that SOX9
levels need to reach a critical threshold ﬁrst before such a feedback loop can be
established. Thus, if loss of Foxl2 indeed resulted in a de-repression of Sox9 ex-
pression before activation of the TESCO element, there might be a detectable
delay between the onset of endogenous Sox9 expression and activation of CFP
in XX TESCO:CFP; Foxl2LacZ=LacZ gonads. However, CFP activation preceded
the de-repression of Sox9 expression in such gonads. While a few CFP positive
cells could already be found, endogenous Sox9 expression was not detectable at
P0, but it could be seen at 7 dpp. This is concordant with the ﬁnding that XX
Foxl2LacZ=LacZ ovaries are indistinguishable from wild-type ovaries at birth but
phenotypic diﬀerences were detected at 7 dpp (Schmidt et al., 2004; Uda et al.,
2004). In future experiments, the timing and relationship between TESCO:CFP
and SOX9 should be analysed in more detail and a closer look should be taken at
the expression proﬁle of the two proteins between P0 and 1 week of age. Also, the
conditional Foxl2 mutant mice (Foxl2fl=fl) could be used to further analyse the
de-repression of both TESCO activity and Sox9 expression in the mutant ovaries.
By crossing them with the TESCO:CFP reporter line it would be possible to ana-
lyse the exact timing between the loss of FOXL2 and the ﬁrst appearance of CFP
or SOX9. It would also be interesting to analyse the eﬀect of loss of Foxl2 on
TESCO activity in the context of a Sox9 null background, using the conditional
161Sox9 null allele (Sox9fl=fl) (Chaboissier et al., 2004). In this background, any de-
repression of TESCO:CFP would have to be independent from endogenous SOX9
and instead directly due to the loss of FOXL2-mediated repression on the TESCO
element. A diﬀerent approach would be to ﬁrst determine whether the TESCO
element is the only regulatory element necessary to control Sox9 expression in
the gonad by generating a targeted deletion of the TESCO enhancer (TESCO∆).
The deletion of the TESCO element in vivo should result in a complete loss of
gonadal Sox9 expression. The TESCO:CFP reporter and the Foxl2LacZ allele
could then be bred onto the TESCO∆ background, where any de-repression of
TESCO:CFP would be SOX9 independent.
Both TESCO and Sox9 become robustly de-repressed with increasing age in the
XX TESCO:CFP; Foxl2LacZ=LacZ gonads, suggesting that Foxl2 becomes the only
important gene to maintain Sox9 repression in the adult. These ﬁndings were
substantiated in the conditional Foxl2∆=∆ mice, where deletion of Foxl2 in 8 week
old females resulted in the de-repression of Sox9 and the transdiﬀerentiation of
granulosa cells into Sertoli cells (Uhlenhaut et al., 2009). Taken together these
data indicate that FOXL2 is indeed a only critical factor needed to repress Sox9
expression in the adult ovary. Interestingly, de-repression of Sox9 starts from 1
week of age in XX TESCO:CFP; Foxl2LacZ=LacZ gonads, suggesting that FOXL2
becomes important for repression of Sox9 expression at this time. In future exper-
iments, Foxl2 should be deleted at diﬀerent time points around and after birth,
using the conditional Foxl2fl=fl mice, to determine the exact time point from
which Foxl2 acts as the only critical factor required to repress Sox9 expression
postnatally. Moreover, using the conditional Foxl2fl=fl mice, it would be inter-
162esting to analyse whether deletion of Foxl2 just before birth (i.e. Foxl2 would be
expressed during most of the embryonic development) results in the same postna-
tal phenotype as seen in the Foxl2LacZ=LacZ mice (where Foxl2 is never expressed).
It is possible that loss of Foxl2 from the early stages of embryogenesis results in
the activation of redundant pathways to ensure proper ovarian development.
In future experiments, the eﬀect of Foxl2 misexpression in XY gonads should
also be addressed. It has already been shown that misexpression of transgenic
Foxl2 under the control of an ubiquitous heat-shock inducible promoter in XY
gonads resulted in disorganised tubules and ovotestis-like structures at 13.5 dpc
(Ottolenghi et al., 2007). However, no further analyses have been carried out
in the gonads of these mice. It would be interesting to analyse both endoge-
nous Sox9 expression and TESCO:CFP reporter expression upon misexpression
of Foxl2 in XY gonads. If FOXL2 is indeed repressing Sox9 via TESCO, mis-
expressed Foxl2 should result in the down-regulation of both TESCO:CFP and
endogenous Sox9 in these gonads. To test this hypothesis, a construct for condi-
tional misexpression of Foxl2 has already been designed (IZ/Foxl2) and injected
into fertilised mouse eggs. Mice carrying this transgene will express the LacZ
gene ubiquitously and, upon cre-mediated recombination, HA-tagged Foxl2 will
be expressed from a CMV promoter (Figure 7.2). These mice will be crossed
to the TESCO:CFP line and to mice expressing a gonad-speciﬁc cre-recombinase
(e.g. Sf1:Cre, Amh:Cre) to analyse the eﬀect of Foxl2 expression on both TESCO
activity and Sox9 expression in the XY gonad . Another approach could be to
analyse the eﬀect of Foxl2 transfection into cultured Sertoli cells in vitro. Un-
fortunately, in the supposed Sertoli cell line TM4, SOX9 protein could not be
163detected either by immunohistochemistry or by Western blot analysis (data not
shown and Beverdam et al., 2003). Therefore these cell line could not be used to
analyse the potential eﬀect of FOXL2 on Sox9 expression in vitro. In future ex-
periments, primary cultures of Sertoli cells from the TESCO:CFP reporter mouse
line could be employed to analyse the eﬀect of misexpression of Foxl2 on both
TESCO activity and endogenous Sox9 expression in vitro.
pA Foxl2 HA
pA Foxl2 HA
LacZ
Cre recombination: CAGS promoter
CAGS promoter
Figure 7.2: IZ/Foxl2: A construct for conditional misexpression of Foxl2.
Mice carrying this transgene will express -galactosidase ubiquitously. Upon cre-
mediated recombination the two loxP sites (pink triangles) will recombine and
Foxl2, which is N-terminally tagged with a HA-epitope, will be expressed.
7.5 Sox9 expression is not up-regulated in oocyte-
depleted ovaries
For a long time it had been proposed that oocytes are essential to maintain gran-
ulosa cell fate and that the loss of oocytes could cause a switch from granulosa
cells to Sertoli cells (McLaren, 1991). In this thesis the question was addressed
whether the loss of oocytes resulted in a postnatal up-regulation of Sox9 expres-
sion comparable to the de-repression seen in XX TESCO:CFP; Foxl2LacZ=LacZ
mice. When oocytes were speciﬁcally depleted by activation of a conditional form
164of the diphtheria toxin fragment A (DTA) (Ivanova et al., 2005) using ZP3:Cre,
no postnatal Sox9 expression was detected in these ovaries at any of the postna-
tal time points analysed. Similar results were obtained using Gdf9:Cre as well as
an inducible approach which allowed the deletion of oocytes in the adult ovary
(Uhlenhaut et al., 2009). These results, compared to the analyses in the XX
TESCO:CFP; Foxl2LacZ=LacZ and XX Foxl2∆=∆ mice, show that it is not the loss
of oocytes, but the loss of a sole gene, Foxl2, which leads to up-regulation of Sox9
expression in granulosa cells, resulting in their transdiﬀerentiation to Sertoli cells.
Interestingly, it has also been shown in neonatal rats, that depletion of oocytes
by -irradiation resulted in a survival of granulosa cells which developed mor-
phological characteristics of Sertoli cells, but did not up-regulate Sox9 expression
(Guigon et al., 2005). However, these experiments were not conclusive as not
all oocytes were eliminated. In further experiments, the oocyte-depleted ovaries
(ZP3:Cre, R26DTA) should be analysed in more detail regarding their morpho-
logical characteristics as well as further marker analyses to establish which cell
types are still present upon loss of oocytes and how the granulosa cells are ef-
fected in terms of cellular and molecular properties. However, it remains possible
that oocytes are required during late fetal stages to prevent a fate change from
follicle to Sertoli cells. To analyse this hypothesis, oocytes have to be depleted
during embryonic development, e.g. by disrupting the progress of meiosis.
1657.6 WNT4 signalling partially represses TESCO
activity during embryonic development
It has been shown that Wnt4, when expressed at high levels, or stabilised -
catenin can antagonise the FGF9/FGFR2 feedback loop (Kim et al., 2006b) and
prevent the maintenance of Sox9 expression (Figure 7.3). This suggests an an-
tagonism between the two signalling pathways, such that FGF9 tips the balance
towards testis development and WNT4 towards ovarian development. This thesis
presents the ﬁrst evidence that Wnt4 is also involved in the repression of TESCO
activity and Sox8/Sox10 expression during embryonic development.
Homozygous loss of Wnt4 resulted in de-repression of TESCO from 14.5 dpc
onwards, suggesting that Wnt4 is at least partially responsible for TESCO re-
pression during embryonic development. However, although TESCO:CFP was
de-repressed in those gonads, no endogenous Sox9 could be detected, indicating
that additional factors are still repressing Sox9 during this time.
Moreover, as TESCO activity in XX TESCO:CFP; Wnt4−=− gonads becomes
de-repressed only from 14.5 dpc, WNT4 cannot be the critical factor responsible
for its repression prior to this point. It is possible that other Wnts which are
expressed in the gonad compensate for the loss of Wnt4. However, other factors
could also be involved in the early repression of TESCO activity (and Sox9 ex-
pression). R-spondin1 is one possible candidate (Figure 7.3). RSPO1 was ﬁrst
identiﬁed to play a role in sex determination in human patients which display
XX female-to-male sex reversal due to homozygous LoF mutations of R-SPO1
(Parma et al., 2006). In the mouse, Rspo1 is expressed in somatic cells of the
166indiﬀerent gonad in both sexes at 10.5 dpc and then becomes female-speciﬁc
around 12.5 dpc (Parma et al., 2006). Mice with a targeted null mutation of
Rspo1 (Rspo1−=−) show partial XX female-to-male sex reversal (Chassot et al.,
2008; Tomizuka et al., 2008). Rspo1 is still expressed in XX Wnt4−=− gonads
(Chassot et al., 2008). Thus it is possible that Rspo1 might be responsible for
the repression of TESCO prior to 14.5 dpc in the XX TESCO:CFP; Wnt4−=−
gonads. In future experiments, the eﬀect of loss of Rspo1 expression on both
TESCO activity and endogenous Sox9 expression should be determined in XX
gonads from 11.5 dpc onwards.
As homozygous Wnt4 mutant mice die within 24 h after birth due to kidney
failure, the gonadal phenotype of those mice could only be analysed until P0.
Recently, a conditional Wnt4 mutant mouse line has been described (Wnt4fl=fl),
which upon cre-mediated deletion during early embryogenesis, displays a pheno-
type consistent with the Wnt4−=− mice (Shan et al., 2009). It would be very
interesting to analyse the eﬀect of later loss of Wnt4 expression on both TESCO
activity and Sox9 expression. If FOXL2 is indeed the only critical factor repress-
ing TESCO activity after birth, postnatal loss of Wnt4 should not result in a
de-repression of either TESCO activity or Sox9 expression.
Although CFP expression was detected in XX gonads of both TESCO:CFP;
Wnt4−=− and TESCO:CFP; Foxl2−=− mice at P0, no de-repression of Sox9 could
be found in either single mutant. Interestingly, XX gonads of mice with double
homozygous mutations in Foxl2 and Wnt4 not only show a stronger de-repression
of TESCO activity at P0, but also up-regulation of endogenous Sox9 expression.
167Moreover, XX gonads of double mutant mice show a much more severe phenotype
than the single mutants including the formation of seminiferous tubule-like struc-
tures. This suggests that both FOXL2 and WNT4 are necessary to repress Sox9
expression in XX gonads around the time of birth. However, more detailed ana-
lyses of de-repression of both TESCO activity and endogenous Sox9 during the
time of embryonic development are necessary in the gonads of XX TESCO:CFP;
Foxl2LacZ=LacZ; Wnt4−=− mice to better understand the synergistic eﬀect of the
two genes.
7.7 Sox8 and/or Sox10 expression is de-repressed
in embryonic Wnt4 mutant XX gonads
The de-repression of TESCO in XX TESCO:CFP; Wnt4−=− gonads coincides
with the activation of the expression of SoxE genes from 14.5 dpc until P0. The
SOXE group of proteins comprises SOX8, SOX9 and SOX10, which share high
sequence homology even outside the HMG box. Like Sox9, both Sox8 and Sox10
are known to be expressed in the XY gonad around the time of sex determination
(Schepers et al., 2003; Polanco et al., 2010).
Studies in mice with double mutations of both Sox8 and Sox9 have suggested
that the two genes might be involved in redundant pathways immediate after
Sox9 up-regulation and during subsequent testis development (Chaboissier et al.,
2004; Barrionuevo et al., 2009). It has been shown that Sox9 is essential for the
initiation of testis diﬀerentiation as the homozygous deletion of Sox9 prior or at
the time of sex determination causes XY sex reversal (Chaboissier et al., 2004).
168Moreover, conditional deletion of Sox9 at 14.5 dpc, after the successful initiation
of testis diﬀerentiation, results in normal embryonic and early postnatal testis
development. These mice show a late sterility around 7 months of age due to a
loss of spermatogonial stem cells and subsequent abrogation of spermatogenesis
(Barrionuevo et al., 2009). On the other hand, homozygous loss of Sox8 leads to
an 80% sterility in male mice, while XY Sox8+=− and XX Sox8−=− mice are repro-
ductively normal with no sex reversal. However, about 20% of XY Sox8−=− mice
are able to produce a reduced number of oﬀspring before they become sterile at 5
months of age (O’Bryan et al., 2008). Mice carrying a heterozygous conditional
mutation of Sox9 on a Sox8 null background (Sox8−=−, Sox9∆=−) display a more
severe phenotype than single Sox8−=− or Sox9∆=− mice. XY Sox8−=−, Sox9∆=−
gonads show abnormally shaped testis cords and defects in the formation of the
coelomic vessel. Moreover, these gonads have a reduced number of seminiferous
tubules and show partial sex reversal with areas resembling ovarian structures
and lacking Amh expression at 15.5 dpc (Chaboissier et al., 2004). Homozygous
double mutations of the two genes after 14.5 dpc using the Sox9 conditional allele
and Amh:Cre (Sox8−=−, Sox9∆=∆) result in progressive testis cord degradation
with reduced numbers of testis cords containing a large amount of apoptotic cells.
At 2 months of age, the testes of such mice completely lack any tubular structures
and are mainly composed of Leydig cells resulting in a primary infertility. More-
over, some XY mice with a homozygous double mutation in both genes displayed
a residual uterus in addition to testicular structures, the formation of which is at-
tributed to an almost complete down-regulation of Amh expression (Barrionuevo
et al., 2009). All this data indicates that Sox8 and Sox9 act redundantly during
169testis diﬀerentiation as both are important for proper Sertoli cell speciﬁcation
and maintenance of Amh expression.
Although a targeted mutation of Sox10 has been described (Britsch et al., 2001),
the eﬀect of loss of Sox10 in the gonad has not yet been determined. Recently, it
has been demonstrated that misexpression of Sox10 in XX mice under the control
of the Wt1 regulatory region, causes XX female-to-male sex reversal at 13.5 dpc
(Polanco et al., 2010).
Since SOX9 is still repressed in the XX TESCO:CFP; Wnt4−=− gonads analysed
in this thesis, the detected SOXE signal must be due to SOX8 and/or SOX10.
In future experiments, it will be necessary to determine by in situ hybridisation
which of the two genes, if not both, are expressed in the mutant gonads. The
de-repression of the SoxE gene(s) in XX TESCO:CFP; Wnt4−=− gonads suggests
that Sox8 and/or Sox10 might normally be repressed by WNT4 signalling in XX
gonads during this time of embryonic development. It might therefore be possible,
that the up-regulation of Sox8 and/or Sox10 expression could be involved in
causing the masculinisation described in XX Wnt4−=− gonads (Vainio et al., 1999)
in the absence of Sox9. Furthermore, it would be interesting to know whether
Sox8 misexpression can cause XX sex reversal similar to Sox9 and Sox10.
Recently, it has been shown that both SOX8 and SOX10 in combination with
SF1 can activate TESCO in vitro, although not as strongly as SF1 and SOX9
(Polanco et al., 2010). According to this data, it might also be possible that
loss of Wnt4 in XX gonads results in a de-repression of endogenous Sox8 and/or
Sox10 which then in turn activates the TESCO:CFP reporter. To further analyse
170this possibility, the TESCO:CFP; Wnt4 mutant mice could be crossed to the
Sox8 null background, the Sox8/Sox9 double null background and the Sox10 null
background. On the other hand, no gonad-speciﬁc regulatory elements for Sox8
and Sox10 have been described. As Sox8 and/or Sox10 de-repression temporally
coincides with TESCO up-regulation in XX TESCO:CFP; Wnt4−=− gonads, it
is reasonable to speculate that a gonadal Sox8 and/or Sox10 enhancer might be
regulated similarly to the TESCO element.
7.8 Additional factors must be involved in re-
pressing Sox9 in embryonic XX gonads
While TESCO:CFP became de-repressed in XX TESCO:CFP; Wnt4−=− gonads
at 14.5 dpc, endogenous Sox9 was still repressed. This may indicate that other
factors are involved in repressing Sox9 expression during embryogenesis (Figure
7.3), independently of the TESCO element, although it is also possible that the
latter is integrated in a site more favourable for expression, e.g. next to an ac-
tive gene. Both RSPO1 and WNT4 act by stabilising -catenin (Komiya and
Habas, 2008; Chassot et al., 2008). It has already been shown that expression
of a stabilised form of -catenin in XY gonads at 11.5 dpc led to male-to-female
sex reversal (Maatouk et al., 2008). Both Sox9 and Amh expression were dra-
matically reduced in the XY gonads of these mice after 12.5 dpc, suggesting that
-catenin is indeed able to antagonise Sox9 expression in the gonad, although
the mechanism is still unknown. In future experiments, it would be interesting to
analyse the eﬀect of gonadal loss of -catenin on Sox9 expression and TESCO ac-
171tivity by crossing conditional -catenin null mutant mice (Huelsken et al., 2001)
to mice expressing a gonad-speciﬁc cre-recombinase (e.g. Sf1:Cre, Amh:Cre) and
also to the TESCO:CFP reporter mice.
In future analyses it will be necessary to search for additional factors which are
involved in the repression of Sox9 in the XX gonad during embryogenesis. This
search could be performed via diﬀerent approaches, e.g. by comparing diﬀer-
ences in gene expression between XX and XY gonads during diﬀerent time points
around sex determination, as done by Nef et al. (2005), Beverdam and Koopman
(2006) and Bouma et al. (2007). Another possible approach would be forward
genetic screening, such as ENU mutagenesis as performed by Bogani et al. (2009).
Subsequently, mutations of identiﬁed candidate genes should be analysed in vivo.
However, mutations in genes which are important in early embryonic develop-
ment could result in embryonic lethality prior to the time of sex determination
and therefore conditional approaches might be necessary. As an alternative to the
classical expression-base screens, more global genomic approaches have recently
been applied. In these studies, diﬀerences in gene expression proﬁles are mapped
to chromosomal regions in the genome (eQTL). Recently, an eQTL analysis com-
pared the gene expression levels in the developing gonad between a mouse strain
sensitive to XY male-to-female sex reversal (C57BL/6J) versus a non-sensitive
strain (129S1/SvImJ) at 11.5 dpc and found a number of novel genes and chromo-
somal loci which might be involved in the regulation of sex-related genes (Munger
et al., 2009). This approach can be used to identify genetic network interactions
on a global scale, as well as ﬁnding new regulators in sex determination, including
both protein-coding and non-protein coding genes.
172Non-protein coding genes, e.g. micro RNAs (miRNAs), are known to play impor-
tant roles in the regulation of gene expression and it is possible that they account
for the unknown factor regulating Sox9 expression in the XX gonad. Micro RNAs
are small non-coding RNAs of 21-23 nucleotides, which alter the expression of tar-
get genes by post-transcriptional inhibition or degradation of mRNA sequences
to which they are complementary (for review see Bartel, 2004). Analyses in the
adult subventricular zone of the central nervous system have shown that Sox9 is
a direct target of miR-124 (Cheng et al., 2009). It is possible that miR-124 might
also be involved in the degradation of Sox9 transcripts in the early XX gonad
(Figure 7.3), resulting in the persistent repression of endogenous SOX9 in the
XX TESCO:CFP; Wnt4−=− gonads while TESCO:CFP is de-repressed. More-
over, the brief burst of Sox9 expression seen early in XX Wnt4−=− gonads (Kim
et al., 2006b) could fail to establish the positive autoregulatory loop because miR-
124 has become up-regulated and prevents further translation of SOX9. However,
it is not known yet whether miR-124 is indeed expressed in the supporting cell
precursors of the XX gonad at the right time to be involved in the repression of
Sox9. Thus, in future experiments, the precise expression pattern of miR-124 in
the gonad should be investigated at diﬀerent time points during embryonic de-
velopment. Furthermore, the eﬀect of miR-124 misexpression on Sox9 expression
could be analysed in XY gonads or the eﬀect of anti-miR (miRNA inhibitors)
designed for miR-124 could be examined in XX gonads.
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Figure 7.3: Model of genetic interactions during ovarian development.
Possible genetic interactions in the XX gonad, including diﬀerent mechanisms
which could be involved in the down-regulation of Sox9 in the female granulosa
cell lineage.
1747.9 Summary
In this thesis, it has been shown that the genes Dax1, Sox4 and Foxl2 (alone
or in combination with ER) have the potential to repress TESCO activity in
vitro. It has also been demonstrated that the loss of Foxl2 results in a postnatal
de-repression of TESCO activity and endogenous Sox9 expression in XX gonads,
which is most evident in the adult. The de-repression of both TESCO and Sox9
occurs in cells derived from granulosa cells, indicating a transdiﬀerentiation of
the female supporting cells to Sertoli cells. These data indicate that FOXL2 is
the crucial factor to repress Sox9 expression in the adult ovary and that this
repression is mediated via the TESCO element (Figure 7.4). On the other hand,
Foxl2 is not critical for the repression of either TESCO or Sox9 during embryonic
development. Moreover, it has been shown in this thesis that WNT4 signalling
could be partially responsible for Sox9 repression during embryonic development
from 14.5 dpc onwards via the TESCO element. As Sox9 is still repressed in
XX Wnt4 mutant gonads, additional factors (e.g. Rspo1 or miR-124) must be
involved in its initial down-regulation at 11.5 dpc and persisting repression during
embryonic development. Interestingly, both FOXL2 and WNT4 seem to play a
role in the repression of Sox9 around the time of birth, possibly via the TESCO
element (Figure 7.4).
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176Chapter 8
Appendices
1778.1 Plasmid maps
8.1.1 pcDNA-Foxl2
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A-150228 There is an ATG upstream
of the Xba I site.
EcoRI XhoI
Foxl2 cDNA
1788.1.2 pcDNA-Dax1
T7 promoter/priming site: bases 863-882
Multiple cloning site: bases 895-1010
pcDNA3.1/BGH reverse priming site: bases 1022-1039
BGH polyadenylation sequence: bases 1028-1252
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1798.1.3 pcDNA-Sox4
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of the Xba I site.
BamHI XhoI
Sox4 cDNA
1808.2 PCR-protocols
8.2.1 CFP PCR
Primer
Forward: 5’-GACCCTGAAGTTCATCTGCAC-3’
Reverse: 5’-GTGGCTGATGTAGTTGTACTC-3’
Size: 300 bp
PCR Protocol
H2O 19.0 l
10X buﬀer 2.5 l
MgCl2 [25mM] 1.25 l
DMSO 1.0 l
dNTP [25mM] 0.2 l
primer for [50mM] 0.125l
primer rev [50mM] 0.125l
Taq DNA polymerase 0.125l
DNA 0.5 l
PCR Program
94◦C 3 min
94◦C 45 sec
53◦C 45 sec
72◦C 1 min
72◦C 7 min
9
> > > =
> > > ;
30x
1818.2.2 Foxl2 PCR
Primer
FWB3: 5’-CAGATGATGGCCAGCTACCCCGAGC-3’
FWB4: 5’-GTTGTGGCGGATGCTATTCTGCCAGCC-3’
FWB5: 5’-GTAGATGGGCGCATCGTAACCGTGC-3’
Size: wild-type = 200 bp, mutant = 500 bp
PCR Protocol
H2O 16.45l
10X buﬀer 2.5 l
MgCl2 [25mM] 2.0 l
DMSO 1.25 l
dNTP [25mM] 0.2 l
primer FWB3 [10mM] 0.5 l
primer FWB4 [10mM] 0.5 l
primer FWB5 [10mM] 0.5 l
Taq DNA polymerase 0.1 l
DNA 1.0 l
PCR Program
94◦C 3 min
94◦C 30 sec
58◦C 30 sec
72◦C 45 sec
72◦C 5 min
9
> > > =
> > > ;
35x
1828.2.3 Wnt4 PCR
Primer
Wnt4-E3for: 5’-CTTCACAACAACGAGGCTGGCAGG-3’
Wnt4-E4rev: 5’-CACCCGCATGTGTGTCAAGATGG-3’
Wnt4-neo-rev: 5’-GCATTGTCTGAGTAGGTGTCATTC-3’
Size: wild-type = 700 bp, mutant = 400 bp
PCR Protocol
H2O 17.05l
10X CAT-buﬀer 2.5 l
dNTP [25mM] 0.25 l
primer E3for [20mM] 1.0 l
primer E4rev [20mM] 1.0 l
primer neo-rev [20mM] 1.0 l
Taq DNA polymerase 0.2 l
DNA 2.0 l
PCR Program
94◦C 4 min
94◦C 1 min
65◦C 30 sec
72◦C 30 sec
72◦C 5 min
9
> > > =
> > > ;
45x
1838.2.4 Cre PCR
Primer
Forward: 5’-GGCGGATCCGAAAAGAAAA-3’
Reverse: 5’-CAGGGCGCGAGTTAGTAGC-3’
Size: 400 bp
PCR Protocol
H2O 17.62l
10X buﬀer 2.5 l
MgCl2 [25mM] 1.5 l
DMSO 1.25 l
dNTP [25mM] 0.2 l
primer for [50mM] 0.31 l
primer rev [50mM] 0.31 l
Taq DNA polymerase 0.31 l
DNA 1.0 l
PCR Program
94◦C 3 min
94◦C 45 sec
54◦C 45 sec
72◦C 45 sec
72◦C 7 min
9
> > > =
> > > ;
35x
1848.3 TESCO sequence alignment
CLUSTAL 2.0.12 multiple sequence alignment 
SeqA Name          Len(nt)  SeqB Name          Len(nt)  Score 
=============================================================
1    TESCO_human   1389     2    TESCO_dog     1502     78 
1    TESCO_human   1389     3    TESCO_mouse   1293     62 
1    TESCO_human   1389     4    TESCO_rat     1378     60 
2    TESCO_dog     1502     3    TESCO_mouse   1293     42 
2    TESCO_dog     1502     4    TESCO_rat     1378     43 
3    TESCO_mouse   1293     4    TESCO_rat     1378     86 
=============================================================
Result:
TESCO_mouse      CATATGTCACATACCTAAGGTGAAAATATACGAGCCCTGTCTAAATCGGAACTCCAACCA 60 
TESCO_rat        CATATGTCCCATACCTAAGGTGTAAATATACTAGCCTTGTG------GGAACTCCAACTA 54 
TESCO_human      ----------ACATCACTGATGTAAATATACTAGACCTGTCTAAATCTAAACTCCAACTA 50 
TESCO_dog        -------CAGACATCATGGATGTAAATATACTAGACCTGTCGAAATCTGAACTCCAAGTA 53 
                           * * *   * ** ******** ** * ***         ********  * 
TESCO_mouse      TGTACCATTTTC-CTTA------------AGGCCCCACAGGAAGAAAAAGGGAAAAAGAG 107 
TESCO_rat        CGTACCATTTTTTCTTA------------AGCCCCCACAGGAAGAAATGGGGAAAATGAA 102 
TESCO_human      CACACGAATTTTTTTA-------------ACGCTCCACAAAAAAGAAAATGAGAAAAGCA 97 
TESCO_dog        TGCATCCTTTTTTTTTTTTTTTTTTTTTCAGGCTCCACCAAAAGAAAAAGAGGAAAAGGA 113 
                    *    ***   *              *  * ****   **  **      *** *
TESCO_mouse      AG------------------AGAGACCGA--------CTCTATTGTTGAATTACTGTTAG 141 
TESCO_rat        AGCCTGGA--ACCCCGTATAGGAGTCAGGTAGCCTTTCTCCCTTGTCAACTAACTATTAG 160 
TESCO_human      AAACTCAACAACACCCTAAAGGAGTCAGATCCTCTTTCTATATTGTCAGGTAATTGTTAG 157 
TESCO_dog        AAACTCAACAAGCCCCTAAAGGAGTCAGATCCCCCT-CTATATTGTCAGGTAATTGTTAG 172 
                 *                    *** * *         **   ****    * * * **** 
TESCO_mouse      CAGAACTCAGCTGTAATACAGAACCATTTGAAAGGAATGCCAATTGAGTTCTGCCCAGCC 201 
TESCO_rat        CAGAAATTGGCTGTAATACAGAGGCACTTTAAAGGAATGTCAATTGAGTTCTGCCCAGCC 220 
TESCO_human      CAGAAATCAGCTGTAATAACAAGCCATTTTAAAGGAATGCCAATTCCATTCTATCCTGCT 217 
TESCO_dog        CAGAAATGGGCTGTAATAACAAGCCATTTTAAAGGAATGTCAATTCAATTCTGTCTTGCT 232 
                 ***** *  *********   *  ** ** ********* *****   ****  *  **
TESCO_mouse      TGAAGAAGACCCAGCCTC-GGCCTTTGTTCCTAACCTGGGCGG-TTTTCACAAAATAACA 259 
TESCO_rat        TGAAGAAGACCCAGCCTCTGGCTTTTGTTCCTAACCTGGGCGGGTTTTCACAAAATAACA 280 
TESCO_human      TAAAGAAGATCCAGAATC-TGCCTTTGTTCCTAACCTGGGCAG-TATGGAGAAAATAACA 275 
TESCO_dog        TAAAGAAGATCCAGAGTC-TGCCTTTGTTCCTAACCTGAGCAG-TTTTGAGGAAATA--- 287 
                 * ******* ****  **  ** *************** ** * * *  *  *****
TESCO_mouse ATGCCTTCTTTCAGAAACTTTAGG-GCTAAGAAAGAGAAGACTCCA-CTCTCGCAGATAA 317 
TESCO_rat ATACCTTCTTTCAGAACCTTTGGG-ACTAAGAAAGGTACAAATCCT-CTCTCCCAGATAA 338 
TESCO_human ATACCTTCTTTCAGAAACTGTGGGGAATCTGAAAGGTAGGATTCCTGCTCTCCCAGATAA 335 
TESCO_dog ATACCTTCTTTCAGAAACTGTGGGGAATTTGCAAGGTAGGGCTCCTGCTTTCCCAGATAA 347 
                 ** ************* ** * **   *  * ***  *    ***  ** ** ******* 
TESCO_mouse      GGGCTGGCAGAAGAGGTGGCAGATACCAACTACAGGGAGGTGGC-----TGCAGGAGTT- 371 
TESCO_rat        GGGCTGGCAGAAGAGAAGGCAGCTACCAACTACAGGAAGGTAGC-----TACAGAAGTT- 392 
TESCO_human      GAGCTGGCAGGAGAGGTGGCAGCTGTCAA--GGGGGAGGCTTGTGTGAGCCCTGGGGTCA 393 
TESCO_dog        GCACGGGCAGGAGTGGGGACTGCTGGCCA--GGAGGAGGCTAGC-----TCTGGGGGTCA 400 
                 *  * ***** ** *  * * * *  * *     **  * * *          *  **
TESCO_mouse      -----------CCCAGGGTCA-----AACACAAGTGCCTGGCTTCTTGGTGAGAGG--AA 413 
TESCO_rat        -----------CCCGGGGCCA-----ACCACAAGTGCCTGGCTTCTTGGTGACAGG--CA 434 
TESCO_human      GCCAGGAGCACCCTGGAGAGAAGACCAGGACCATCAGAAGGGAGCAAAGTAAGAGGTGCT 453 
TESCO_dog        GCCAGCA----CCCAGGGAGAGGGCCAAC-CCAGCCACAGGGAGCGAGGTGAGGGG-GCG 454 
                            **  * *  *     *   * *      **   *   ** *  **
185TESCO_mouse TTAGACAAGGAAGGGCCTTGCTCCCAGGAACTGAAAACCCCCCACCCCCACTCCC----- 468
TESCO_rat TCAGGTA-GAAAGGGCCTTGCTCCCAGGAACTTAAAAAGTCCTAACCCCACTCCC----- 488
TESCO_human TCAGGGA-GAAAGTGCTTTGCTTTCCGAAACTTAAAAAGGATCTCCACTCCTCAG----- 507
TESCO_dog GCAGGAA-GCCAGTGCCTTGCTTTCAGAAACTTATAAAGGATCTCTCCTCCTCCTCCTCC 513
** * * ** ** ***** * * **** * ** * ***
TESCO_mouse ----------------------------TG-----------------------TGCCCAT 477
TESCO_rat ----------------------------TGCTGGTGTATGCAGGGAGACTTCTTGCCCAA 520
TESCO_human ----------------------------TGTGGACTTGTGTGCAGCCAAGGCCTCCAGAG 539
TESCO_dog TCCTCCTCCTCCTCCTCCTCCTCTTCCCTGTGGACTCG---GCAGCCAAGGCCTCCCCAG 570
** * * *
TESCO_mouse ACAGAAGAAGTCCAAGGATCTCTGAAAACATCTCCTTCACATTCTG-------GGTATGT 530
TESCO_rat GCAGAAGAAGCCCCAGTGTCTCTGGAAACATCTCCTTCGCCATCTG-------GGTATGT 573
TESCO_human ACTGCAGAACCACCAGTCTCT--GGAAACGTCTCCTTCGTCGTCCTGGCTGACGGCATGT 597
TESCO_dog -TGGCAGAACCACCAGTCTCTTAGGCAACGTGTCCTTCGCCCTCCCTGCTGACGGCATGT 629
* **** * ** *** * *** * ****** ** ** ****
TESCO_mouse TTGCAGTTGGGGGCTATCTC-TACAGCTGACTTCTTCCAAGACTCTGCGGTTTAGAGTTT 589
TESCO_rat TTGCAGTTTGAGACTATCTC-TACAGCTGACTTCTTCCAAGACTCTGAGGTTTAGAGTTA 632
TESCO_human TTGCAGTTTGGGACTGTTTTATGCAGCTGATTCTTTCCAAGAGTCTGAGGTTTAGGGTTT 657
TESCO_dog TTGCAGTCTGGGACGCTTTCGTGCAGCTGCGTCTTTCCAAGAGCCTGAGGTTTAGGGTTT 689
******* * * * * * * ****** * ******** *** ******* ***
TESCO_mouse GAGTGAGCTTGGTGGCTGGC-------------------------------CTTTCTCTC 618
TESCO_rat GAGTGAGCTTGGTGACTGCCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTC 692
TESCO_human GGGTGAGCTTGCTGCTTAGCCTTT--------------------------------CCCC 685
TESCO_dog GGGTGAGCTTGGTGGTTCGCTTTTTTT------------------------TTTTCCTCC 725
* ********* ** * * *
TESCO_mouse TCTTACCTTTTTATTCAAAGTTTCCAACACACAAAGCGCTTGAGAGTATCCATGGAAACT 678
TESCO_rat TCTCACCTTTTTATTCAAACTTTCCAACACACAAAGCACTTTGGAGTATCCATGGAAACT 752
TESCO_human CCTTACCTTTTTATTCACAGTTTCCGACACACAAAGCACTTTAAATTATCCATGGAAACC 745
TESCO_dog CCCTACCTTTTTATTCACAGTTTCCAATACACAAAGCACTTTACAACATCCATGGAAACC 785
* ************* * ***** * ********* *** * ************
TESCO_mouse TCCATAGCCACGGACTCAGAATGAGGCTGTGAGCAA-----------AGTGTCAGC---A 724
TESCO_rat TCTATAGCCACGGGCTCAGAATGAGGCTGTGAATGAGGCTGTGAGCAAGTGTCAGC---A 809
TESCO_human TTTGTGACCACAGACTTAGAACACAGCTATGACCAA------------GTGTCAG----A 789
TESCO_dog TCTGTGGCCACAGACTTAGAAAAAGACAATGACGGA------------GCGTCAGCCACA 833
* * **** * ** **** *  *** * * ***** *
TESCO_mouse GCCTGGAAGTCACCCCAAGAGCATCAAGTCCCGGTGGCATGAATGTGTCACTTTCTCTTT 784
TESCO_rat GCCTGGAAGTCACCCCAAGAGCCTCGAGTCCTGGTGGCATGAATGTGTCACTTTCTCTTT 869
TESCO_human AACAGGGAAGGCATCCGCGAATGTCCAGCTATG-TGGCATGAATGTGTTGCTTTCTCTTT 848
TESCO_dog CACGGGGAAGGAATATGGGAGTGTCCACTTATG-TGGCATGGTTGTGTTGCTTTCTCTTT 892
* ** * ** ** * * ******* ***** **********
TESCO_mouse TTCTAATGGGG-CCACGGGGTGCCATTT----------------------CTTTGCAAA- 820
TESCO_rat TTCTAGTGGAG-CCACAAAGTGCCAATT----------------------CTTCACCAA- 905
TESCO_human TCCTAATCAGGTCCCAAAAGTGGCATTT----------------------CTTTGCAAA- 885
TESCO_dog TGCTAATCGGGTCCCCAAAGCAGTGTTTGTTTTACTTTTTGTTTTTTTTTTTTTTTTAAT 952
* *** * * ** * ** ** **
TESCO_mouse --------GGACCACACCGACATGA-------------------------GCCCAGCTAA 847
TESCO_rat --------GGACCACACCGATATGA-------------------------GCCCAGCTAA 932
TESCO_human --------GGGCTACACAGACAAGG------------------------GCTTTAGCTAG 913
TESCO_dog TTTTGTCTGTGTTTTATTTCCGGGGTTCTTGTTGTTGTCGTTTGGTTTTGTTTTAGTTGT 1012
* * * ** *
TESCO_mouse --------------------AAAGGG------GGTAGCTACTG----------ATAGGAT 871
TESCO_rat --------------------AAAGTA------GGTAGCTACTG----------ATAGGAT 956
TESCO_human --------------------AAAAGC-------ACCACTGCCT---------GACATGCT 937
TESCO_dog TTGTTGTTGTTGTTTTCACTAAAGGCCAGAATGACAAGGGCTTTAGAGCAAAGACATGAT 1072
*** * * * * *
186TESCO_mouse GAAC-TCGGACTGCGGTTGCATTTGGACTGGTAAATGTGGTCAGTCACATAGCAAGG--- 927
TESCO_rat GAGT-TTGGACTGTGGTTGCATTTGGGCTAGTAAATGTGGCCAGCCCCA-AGCGAGG--- 1011
TESCO_human GAAT-TAAGAATGAAGTTGCCCTTGGGTTGGTAAATTTGGGTAGTCGGATAGCACGC--- 993
TESCO_dog GGATGTAAAAATGCCATTGCCCTTGAGCTGGTCCATGTGGGTAGTTGTACAGCACGGCGG 1132
* * * ** **** *** * ** ** *** ** * *** *
TESCO_mouse ---CAGGACTC----AGACACT---------------GCAGAAATGCACTGCCCTTGCTT 965
TESCO_rat ---CAGGACTC----AGACACT---------------GCAAAAATGCACCACCCTTGCTT 1049
TESCO_human AGCCAGGCCTCTCCTAGCCGTTCAAGAAATGTTTGTGGAATGAATGTGCACTGCTTGTTT 1053
TESCO_dog AGCCAGGCCTCTCGTTGACATTCGTGAAATGTTTGTGGAATGAATGTGTGCCACTTCTTT 1192
**** *** * * * * * **** *** **
TESCO_mouse GAAGGCCTTGTTGACCCTGATAAAGCTTGTGG---CCCTTCTAGAAG-AGGTGT------ 1015
TESCO_rat AAAGGCCTTGTTGACGCTGATAAAGCTCATGGG--CTTTTCTAGAGG-AGGAGT------ 1100
TESCO_human AAAGAGCACGCTGTCATTGTTAGAACACACTGGACGCTTCCCA-AGGCAGGAGTTTTAAC 1112
TESCO_dog AAAGAGCTCTGTGTCATTGTTAGAACATACGGGAAGCTTCTTAGAGGCGAGAGTCCTAAC 1252
*** * ** * ** ** * * * * * * * * **
TESCO_mouse ATCC----TTGTCCCACCTCCCACCT-----------CCAGCCTTCCTGGCTT-CCTGAG 1059
TESCO_rat ATTT----TTGCCCCACCTCCCACCT-----------CCAGCCTTCCTGGCTT-TCTGAG 1144
TESCO_human ATTTAAATTTTTCATTGTTCTTGCCCTCCCACTCCCCTCAGCCTTCCTAGCTCCCTGGAG 1172
TESCO_dog ATTTGAAGTCGTCATCATTCCTGTGC--------CCAGTAGGTTCCCTGGCTCACCTGAG 1304
** * * ** ** * *** *** ***
TESCO_mouse AGCAATCTGTGCTCAGGGCCAGTCCACACAGTGTGCTACTGAGTTGAATGACCTT-GTC- 1117
TESCO_rat AGCAATCTGAGCTCAGGGCCAGTCAGCACAGTGTGCGACTGAATCGAATGACCTT-GTC- 1202
TESCO_human AGGGGCCTGAGCTCAGGGAAAGTCAATAAAATATATTCTTGAACTGACTGATCTTTGTCA 1232
TESCO_dog AGGGATCTGAGCTCAGGGGACCACAATTAAATG---------------TGACCTTTGTC- 1348
** *** ******** *  * * *** *** ***
TESCO_mouse --CTCTCGAACTCCCCTGTCCCCATTCAGTACACCATTGTTCTGCAATCTCCACCAGCAT 1175
TESCO_rat --CTCTTGAACTCTCCTGTCCCCATTCTGTACACCATTGTTCTTCAGTATCCACCAGCAT 1260
TESCO_human TTTTCATGAAGTCCCCTGTCCTCATTCTGTCTAT-ATTCACTGGAGTCAATACTTAGCAA 1291
TESCO_dog --CTCTGGAAATCTGCTGTCCTTATTCTGT--AT-ATTCTCTGGAGACAGTCCTTGGCAA 1403
** *** ** ****** **** ** * *** ***
TESCO_mouse TGGTTCAAGGACCCTCTATAGCTACAAAAGTCCAGGGACACCCAAGTCTCATATAAAACA 1235
TESCO_rat TGGTTCAAGGACCCTCCATAGCGACAAAAATCCAGAGACGCCCAAGTCGCATAGAAAACA 1320
TESCO_human T-GCCCTCACCCCATCCAT-----------TCCA----TTCTCTAACCAATTATACAG-- 1333
TESCO_dog TCGCATTTACCCCCACTTT-----------TCCACC--TCTTCCAACCAATTATACAG-- 1448
* * ** * * **** * * * ** * *
TESCO_mouse GCATGGTGTGTGCACAGAACTAA--TGATAATTCCCAT-GTGGTGTTAATTGTCTGTTAA 1292
TESCO_rat GAATGGTGTGCGCACAGAACTAA--AGACAGTTCCCAC-GTGTTGCTAATCGTCTGTCAC 1377
TESCO_human GAATAAT---TGCCAAAAATTAAAAGACTAACCCCAATTGAATTGGAATCTGGCTGTTT- 1389
TESCO_dog GAATAAT---TGCCAAAAATTAA--GACTGAGACCCATTGAATTCTAAACTGACTCTTT- 1502
* ** * ** * ** *** ** * * * * * ** *
TESCO_mouse C 1293
TESCO_rat G 1378
TESCO_human -
TESCO_dog -
1878.4 TESCO deletion constructs
 TESCO deletion constructs
        1 CATATGTCAC ATACCTAAGG TGAAAATATA CGAGCCCTGT CTAAATCGGA ACTCCAACCA 
       61 TGTACCATTT TCCTTAAGGC CCCACAGGAA GAAAAAGGGA AAAAGAGAGA GAGACCGACT ∆C4    .
      121 CTATTGTTGA ATTACTGTTA GCAGAACTCA GCTGTAATAC AGAACCATTT GAAAGGAATG
      181 CCAATTGAGT TCTGCCCAGC CTGAAGAAGA CCCAGCCTCG GCCTTTGTTC CTAACCTGGG 
      241 CGGTTTTCAC AAAATAACAA TGCCTTCTTT CAGAAACTTT AGGGCTAAGA AAGAGAAGAC 
      301 TCCACTCTCG CAGATAAGGG CTGGCAGAAG AGGTGGCAGA TACCAACTAC AGGGAGGTGG ∆C5    .
      361 CTGCAGGAGT TCCCAGGGTC AAACACAAGT GCCTGGCTTC TTGGTGAGAG GAATTAGACA
      421 AGGAAGGGCC TTGCTCCCAG GAACTGAAAA CCCCCCACCC CCACTCCCTG TGCCCATACA 
      481 GAAGAAGTCC AAGGATCTCT GAAAACATCT CCTTCACATT CTGGGTATGT TTGCAGTTGG 
      541 GGGCTATCTC TACAGCTGAC TTCTTCCAAG ACTCTGCGGT TTAGAGTTTG AGTGAGCTTG ∆C6    .
      601 GTGGCTGGCC TTTCTCTCTC TTACCTTTTT ATTCAAAGTT TCCAACACAC AAAGCGCTTG 
      661 AGAGTATCCA TGGAAACTTC CATAGCCACG GACTCAGAAT GAGGCTGTGA GCAAAGTGTC 
      721 AGCAGCCTGG AAGTCACCCC AAGAGCATCA AGTCCCGGTG GCATGAATGT GTCACTTTCT 
      781 CTTTTTCTAA TGGGGCCACG GGGTGCCATT TCTTTGCAAA GGACCACACC GACATGAGCC 
      841 CAGCTAAAAA GGGGGTAGCT ACTGATAGGA TGAACTCGGA CTGCGGTTGC ATTTGGACTG ∆C7    .
      901 GTAAATGTGG TCAGTCACAT AGCAAGGCAG GACTCAGACA CTGCAGAAAT GCACTGCCCT
      961 TGCTTGAAGG CCTTGTTGAC CCTGATAAAG CTTGTGGCCC TTCTAGAAGA GGTGTATCCT 
     1021 TGTCCCACCT CCCACCTCCA GCCTTCCTGG CTTCCTGAGA GCAATCTGTG CTCAGGGCCA  1.0kb  .
     1081 GTCCACACAG TGTGCTACTG AGTTGAATGA CCTTGTCCTC TCGAACTCCC CTGTCCCCAT 
     1141 TCAGTACACC ATTGTTCTGC AATCTCCACC AGCATTGGTT CAAGGACCCT CTATAGCTAC 
     1201 AAAAGTCCAG GGACACCCAA GTCTCATATA AAACAGCATG GTGTGTGCAC AGAACTAATG 
     1261 ATAATTCCCA TGTGGTGTTA ATTGTCTGTT AAC
XXX SF1 binding sites T/C A A G G T/C C G/A 
XXX SOX binding sites A G A A C A A T G G
XXX FOXL2 core binding site G/A T/C C/A A A C/T A 
188Bibliography
Adams, I. R. and McLaren, A. (2002). Sexually dimorphic development of mouse
primordial germ cells: switching from oogenesis to spermatogenesis. Develop-
ment, 129(5):1155–1164.
Akiyama, H., Lyons, J. P., Mori-Akiyama, Y., Yang, X., Zhang, R., Zhang, Z.,
Deng, J. M., Taketo, M. M., Nakamura, T., Behringer, R. R., McCrea, P. D.,
and de Crombrugghe, B. (2004). Interactions between Sox9 and beta-catenin
control chondrocyte diﬀerentiation. Genes Dev, 18(9):1072–1087.
Albrecht, K. H. and Eicher, E. M. (2001). Evidence that Sry is expressed in
pre-Sertoli cells and Sertoli and granulosa cells have a common precursor. Dev
Biol, 240(1):92–107.
Bagheri-Fam, S., Sim, H., Bernard, P., Jayakody, I., Taketo, M. M., Scherer, G.,
and Harley, V. R. (2008). Loss of Fgfr2 leads to partial XY sex reversal. Dev
Biol, 314(1):71–83.
Bardoni, B., Zanaria, E., Guioli, S., Floridia, G., Worley, K. C., Tonini, G.,
Ferrante, E., Chiumello, G., McCabe, E. R., and Fraccaro, M. (1994). A
dosage sensitive locus at chromosome Xp21 is involved in male to female sex
reversal. Nat Genet, 7(4):497–501.
Barnett, K. R., Schilling, C., Greenfeld, C. R., Tomic, D., and Flaws, J. A.
(2006). Ovarian follicle development and transgenic mouse models. Hum Re-
prod Update, 12(5):537–555.
Baron, D., Cocquet, J., Xia, X., Fellous, M., Guiguen, Y., and Veitia, R. A.
(2004). An evolutionary and functional analysis of FoxL2 in rainbow trout
gonad diﬀerentiation. J Mol Endocrinol, 33(3):705–715.
Barrionuevo, F., Bagheri-Fam, S., Klattig, J., Kist, R., Taketo, M. M., Englert,
C., and Scherer, G. (2006). Homozygous inactivation of Sox9 causes complete
XY sex reversal in mice. Biol Reprod, 74(1):195–201.
Barrionuevo, F., Georg, I., Scherthan, H., L´ ecureuil, C., Guillou, F., Wegner, M.,
and Scherer, G. (2009). Testis cord diﬀerentiation after the sex determination
stage is independent of Sox9 but fails in the combined absence of Sox9 and
Sox8. Dev Biol, 327(2):301–312.
Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and func-
tion. Cell, 116(2):281–297.
189Batista, F., Vaiman, D., Dausset, J., Fellous, M., and Veitia, R. A. (2007). Po-
tential targets of FOXL2, a transcription factor involved in craniofacial and
follicular development, identiﬁed by transcriptomics. Proc Natl Acad Sci U S
A, 104(9):3330–3335.
Bell, D. M., Leung, K. K., Wheatley, S. C., Ng, L. J., Zhou, S., Ling, K. W.,
Sham, M. H., Koopman, P., Tam, P. P., and Cheah, K. S. (1997). SOX9
directly regulates the type-II collagen gene. Nat Genet, 16(2):174–178.
Benayoun, B. A., Caburet, S., Dipietromaria, A., Bailly-Bechet, M., Batista,
F., Fellous, M., Vaiman, D., and Veitia, R. A. (2008). The identiﬁcation
and characterization of a FOXL2 response element provides insights into the
pathogenesis of mutant alleles. Hum Mol Genet, 17(20):3118–3127.
Bernard, P., Sim, H., Knower, K., Vilain, E., and Harley, V. (2008). Human
SRY inhibits beta-catenin-mediated transcription. Int J Biochem Cell Biol,
40(12):2889–2900.
Beverdam, A. and Koopman, P. (2006). Expression proﬁling of puriﬁed mouse
gonadal somatic cells during the critical time window of sex determination
reveals novel candidate genes for human sexual dysgenesis syndromes. Hum
Mol Genet, 15(3):417–431.
Beverdam, A., Wilhelm, D., and Koopman, P. (2003). Molecular characterization
of three gonad cell lines. Cytogenet Genome Res, 101(3-4):242–249.
Bi, W., Huang, W., Whitworth, D. J., Deng, J. M., Zhang, Z., Behringer, R. R.,
and de Crombrugghe, B. (2001). Haploinsuﬃciency of Sox9 results in defective
cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci
U S A, 98(12):6698–6703.
Biason-Lauber, A., Konrad, D., Meyer, M., DeBeaufort, C., and Schoenle, E.
(2009). Ovaries and female phenotype in a girl with 46,XY karyotype and
mutations in the CBX2 gene. Am J Hum Genet., 84:658–663.
Biason-Lauber, A., Konrad, D., Navratil, F., and Schoenle, E. J. (2004). A
WNT4 mutation associated with M¨ ullerian-duct regression and virilization in
a 46,XX woman. N Engl J Med, 351(8):792–798.
Birk, O. S., Casiano, D. E., Wassif, C. A., Cogliati, T., Zhao, L., Zhao, Y.,
Grinberg, A., Huang, S., Kreidberg, J. A., Parker, K. L., Porter, F. D., and
Westphal, H. (2000). The LIM homeobox gene Lhx9 is essential for mouse
gonad formation. Nature, 403(6772):909–913.
Bishop, C. E., Whitworth, D. J., Qin, Y., Agoulnik, A. I., Agoulnik, I. U., Har-
rison, W. R., Behringer, R. R., and Overbeek, P. A. (2000). A transgenic
insertion upstream of sox9 is associated with dominant XX sex reversal in the
mouse. Nat Genet, 26(4):490–494.
Blount, A. L., Schmidt, K., Justice, N. J., Vale, W. W., Fischer, W. H., and
Bilezikjian, L. M. (2009). FoxL2 and Smad3 coordinately regulate follistatin
gene transcription. J Biol Chem, 284(12):7631–7645.
190Bogani, D., Siggers, P., Brixey, R., Warr, N., Beddow, S., Edwards, J., Williams,
D., Wilhelm, D., Koopman, P., Flavell, R. A., Chi, H., Ostrer, H., Wells, S.,
Cheeseman, M., and Greenﬁeld, A. (2009). Loss of mitogen-activated protein
kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling
in mouse sex determination. PLoS Biol, 7(9):e1000196.
Bor, Y., Swartz, J., Morrison, A., Rekosh, D., Ladomery, M., and Hammarskj¨ old,
M.-L. (2006). The Wilms’ tumor 1 (WT1) gene (+KTS isoform) functions with
a CTE to enhance translation from an unspliced RNA with a retained intron.
Genes Dev, 20(12):1597–1608.
Bouma, G. J., Aﬀourtit, J. P., Bult, C. J., and Eicher, E. M. (2007). Tran-
scriptional proﬁle of mouse pre-granulosa and Sertoli cells isolated from early-
diﬀerentiated fetal gonads. Gene Expr Patterns, 7(1-2):113–123.
Bouma, G. J., Albrecht, K. H., Washburn, L. L., Recknagel, A. K., Churchill,
G. A., and Eicher, E. M. (2005). Gonadal sex reversal in mutant Dax1 XY mice:
a failure to upregulate Sox9 in pre-Sertoli cells. Development, 132(13):3045–
3054.
Bowles, J., Cooper, L., Berkman, J., and Koopman, P. (1999). Sry requires a
CAG repeat domain for male sex determination in Mus musculus. Nat Genet,
22(4):405–408.
Bowles, J., Knight, D., Smith, C., Wilhelm, D., Richman, J., Mamiya, S.,
Yashiro, K., Chawengsaksophak, K., Wilson, M. J., Rossant, J., Hamada, H.,
and Koopman, P. (2006). Retinoid signaling determines germ cell fate in mice.
Science, 312(5773):596–600.
Bradford, S. T., Wilhelm, D., Bandiera, R., Vidal, V., Schedl, A., and Koopman,
P. (2009). A cell-autonomous role for WT1 in regulating Sry in vivo. Hum Mol
Genet, 18(18):3429–3438.
Brennan, J., Karl, J., and Capel, B. (2002). Divergent vascular mechanisms
downstream of Sry establish the arterial system in the XY gonad. Dev Biol,
244(2):418–428.
Brennan, J., Tilmann, C., and Capel, B. (2003). Pdgfr-alpha mediates testis cord
organization and fetal Leydig cell development in the XY gonad. Genes Dev,
17(6):800–810.
Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I., Rossner, M., Nave,
K. A., Birchmeier, C., and Wegner, M. (2001). The transcription factor Sox10
is a key regulator of peripheral glial development. Genes Dev, 15(1):66–78.
Bullejos, M. and Koopman, P. (2004). Germ cells enter meiosis in a rostro-caudal
wave during development of the mouse ovary. Mol Reprod Dev, 68(4):422–428.
Burgoyne, P. and Thornhill, A. (1993). Sex Chromosomes and Sex-Determining
Genes, chapter The genetic basis of XX-XY diﬀerences present before goadal
sex diﬀerentiation in mice., pages 369–372. Harwood Academic.
191Burgoyne, P. S. (1988). Role of mammalian Y chromosome in sex determination.
Philos Trans R Soc Lond B Biol Sci, 322(1208):63–72.
Capel, B. (1998). Sex in the 90s: SRY and the switch to the male pathway. Annu
Rev Physiol, 60:497–523.
Carlsson, P. and Mahlapuu, M. (2002). Forkhead transcription factors: key
players in development and metabolism. Dev Biol, 250(1):1–23.
Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J.,
Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R., Fox, E. A.,
Silver, P. A., and Brown, M. (2005). Chromosome-wide mapping of estrogen
receptor binding reveals long-range regulation requiring the forkhead protein
FoxA1. Cell, 122(1):33–43.
Chaboissier, M.-C., Kobayashi, A., Vidal, V. I. P., L¨ utzkendorf, S., van de Kant,
H. J. G., Wegner, M., de Rooij, D. G., Behringer, R. R., and Schedl, A. (2004).
Functional analysis of Sox8 and Sox9 during sex determination in the mouse.
Development, 131(9):1891–1901.
Chang, H., Gao, F., Guillou, F., Taketo, M. M., Huﬀ, V., and Behringer, R. R.
(2008). Wt1 negatively regulates beta-catenin signaling during testis develop-
ment. Development, 135(10):1875–1885.
Chassot, A.-A., Ranc, F., Gregoire, E. P., Roepers-Gajadien, H. L., Taketo,
M. M., Camerino, G., de Rooij, D. G., Schedl, A., and Chaboissier, M.-C.
(2008). Activation of beta-catenin signaling by Rspo1 controls diﬀerentiation
of the mammalian ovary. Hum Mol Genet, 17(9):1264–1277.
Cheng, L.-C., Pastrana, E., Tavazoie, M., and Doetsch, F. (2009). miR-124
regulates adult neurogenesis in the subventricular zone stem cell niche. Nat
Neurosci, 12(4):399–408.
Chew, L.-J. and Gallo, V. (2009). The Yin and Yang of Sox proteins: Activation
and repression in development and disease. J Neurosci Res, 87(15):3277–3287.
Colvin, J. S., Green, R. P., Schmahl, J., Capel, B., and Ornitz, D. M. (2001).
Male-to-female sex reversal in mice lacking ﬁbroblast growth factor 9. Cell,
104(6):875–889.
Combes, A. N., Wilhelm, D., Davidson, T., Dejana, E., Harley, V., Sinclair,
A., and Koopman, P. (2009). Endothelial cell migration directs testis cord
formation. Dev Biol, 326(1):112–120.
Cool, J., Carmona, F. D., Szucsik, J. C., and Capel, B. (2008). Peritubular myoid
cells are not the migrating population required for testis cord formation in the
XY gonad. Sex Dev, 2(3):128–133.
Couse, J. F., Hewitt, S. C., Bunch, D. O., Sar, M., Walker, V. R., Davis, B. J.,
and Korach, K. S. (1999). Postnatal sex reversal of the ovaries in mice lacking
estrogen receptors alpha and beta. Science, 286(5448):2328–2331.
192Coveney, D., Cool, J., Oliver, T., and Capel, B. (2008). Four-dimensional analysis
of vascularization during primary development of an organ, the gonad. Proc
Natl Acad Sci U S A, 105(20):7212–7217.
Crawford, P. A., Dorn, C., Sadovsky, Y., and Milbrandt, J. (1998). Nuclear
receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic
factor 1. Mol Cell Biol, 18(5):2949–2956.
Crisponi, L., Deiana, M., Loi, A., Chiappe, F., Uda, M., Amati, P., Bisceglia,
L., Zelante, L., Nagaraja, R., Porcu, S., Ristaldi, M. S., Marzella, R., Roc-
chi, M., Nicolino, M., Lienhardt-Roussie, A., Nivelon, A., Verloes, A., Sch-
lessinger, D., Gasparini, P., Bonneau, D., Cao, A., and Pilia, G. (2001). The
putative forkhead transcription factor FOXL2 is mutated in blepharophimo-
sis/ptosis/epicanthus inversus syndrome. Nat Genet, 27(2):159–166.
Daneau, I., Ethier, J. F., Lussier, J. G., and Silversides, D. W. (1996). Porcine
SRY gene locus and genital ridge expression. Biol Reprod, 55(1):47–53.
Davidoﬀ, M. S., Middendorﬀ, R., Enikolopov, G., Riethmacher, D., Holstein,
A. F., and M¨ uller, D. (2004). Progenitor cells of the testosterone-producing
Leydig cells revealed. J Cell Biol, 167(5):935–944.
De Santa Barbara, P., Bonneaud, N., Boizet, B., Desclozeaux, M., Moniot, B.,
Sudbeck, P., Scherer, G., Poulat, F., and Berta, P. (1998). Direct interaction
of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription
of the human anti-M¨ ullerian hormone gene. Mol Cell Biol, 18(11):6653–6665.
de Santa Barbara, P., M´ ejean, C., Moniot, B., Malcl` es, M. H., Berta, P., and
Boizet-Bonhoure, B. (2001). Steroidogenic factor-1 contributes to the cyclic-
adenosine monophosphate down-regulation of human SRY gene expression.
Biol Reprod, 64(3):775–783.
De Vries, W. N., Binns, L. T., Fancher, K. S., Dean, J., Moore, R., Kemler, R.,
and Knowles, B. B. (2000). Expression of Cre recombinase in mouse oocytes:
a means to study maternal eﬀect genes. Genesis, 26(2):110–112.
Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P., and Mark, M.
(2000). Eﬀect of single and compound knockouts of estrogen receptors alpha
(ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Develop-
ment, 127(19):4277–4291.
Eicher, E. M., Washburn, L. L., Whitney, J. B., and Morrow, K. E. (1982).
Mus poschiavinus Y chromosome in the C57BL/6J murine genome causes sex
reversal. Science, 217(4559):535–537.
Ellsworth, B. S., Burns, A. T., Escudero, K. W., Duval, D. L., Nelson, S. E., and
Clay, C. M. (2003). The gonadotropin releasing hormone (GnRH) receptor
activating sequence (GRAS) is a composite regulatory element that interacts
with multiple classes of transcription factors including Smads, AP-1 and a
forkhead DNA binding protein. Mol Cell Endocrinol, 206(1-2):93–111.
193Ferrari, S., Harley, V. R., Pontiggia, A., Goodfellow, P. N., Lovell-Badge, R.,
and Bianchi, M. E. (1992). SRY, like HMG1, recognizes sharp angles in DNA.
EMBO J, 11(12):4497–4506.
Fitzpatrick, S. L., Funkhouser, J. M., Sindoni, D. M., Stevis, P. E., Deecher,
D. C., Bapat, A. R., Merchenthaler, I., and Frail, D. E. (1999). Expression
of estrogen receptor-beta protein in rodent ovary. Endocrinology, 140(6):2581–
2591.
Ford, C. E., Jones, K. W., Polani, P. E., Almeida, J. C. D., and Briggs, J. H.
(1959). A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner’s
syndrome). Lancet, 1(7075):711–713.
Foster, J. W., Dominguez-Steglich, M. A., Guioli, S., Kwok, C., Weller, P. A.,
M. Stevanovic, M., Weissenbach, J., Mansour, S., Young, I. D., and Goodfellow,
P. N. (1994). Campomelic dysplasia and autosomal sex reversal caused by
mutations in an SRY-related gene. Nature, 372(6506):525–530.
Gersak, K., Harris, S. E., Smale, W. J., and Shelling, A. N. (2004). A novel 30 bp
deletion in the FOXL2 gene in a phenotypically normal woman with primary
amenorrhoea: case report. Hum Reprod, 19(12):2767–2770.
Giese, K., Pagel, J., and Grosschedl, R. (1994). Distinct DNA-binding properties
of the high mobility group domain of murine and human SRY sex-determining
factors. Proc Natl Acad Sci U S A, 91(8):3368–3372.
Gilbert, S. F. (2006). Developmental Biology. Sinauer Associates.
Ginsburg, M., Snow, M. H., and McLaren, A. (1990). Primordial germ cells in
the mouse embryo during gastrulation. Development, 110(2):521–528.
Gomperts, M., Garcia-Castro, M., Wylie, C., and Heasman, J. (1994). Inter-
actions between primordial germ cells play a role in their migration in mouse
embryos. Development, 120(1):135–141.
Gruenwald (1941). The relation of the growing M¨ ullerian Duct to the Wolﬃan
Duct and its importance for the genesis of malformations. Anat. Rec., 81:1–19.
Gubbay, J., Collignon, J., Koopman, P., Capel, B., Economou, A., M¨ unsterberg,
A., Vivian, N., Goodfellow, P., and Lovell-Badge, R. (1990). A gene mapping
to the sex-determining region of the mouse Y chromosome is a member of a
novel family of embryonically expressed genes. Nature, 346(6281):245–250.
Gubler, M. C., Yang, Y., Jeanpierre, C., Barbaux, S., and Niaudet, P. (1999).
WT1, renal development, and glomerulopathies. Adv Nephrol Necker Hosp,
29:299–315.
Guigon, C. J., Coudouel, N., Mazaud-Guittot, S., Forest, M. G., and Magre,
S. (2005). Follicular cells acquire sertoli cell characteristics after oocyte loss.
Endocrinology, 146(7):2992–3004.
194Habert, R., Lejeune, H., and Saez, J. M. (2001). Origin, diﬀerentiation and
regulation of fetal and adult Leydig cells. Mol Cell Endocrinol, 179(1-2):47–74.
Hammes, A., Guo, J. K., Lutsch, G., Leheste, J. R., Landrock, D., Ziegler, U.,
Gubler, M. C., and Schedl, A. (2001). Two splice variants of the Wilms’ tumor
1 gene have distinct functions during sex determination and nephron formation.
Cell, 106(3):319–329.
Hanley, N. A., Hagan, D. M., Clement-Jones, M., Ball, S. G., Strachan, T., Salas-
Cort´ es, L., McElreavey, K., Lindsay, S., Robson, S., Bullen, P., Ostrer, H., and
Wilson, D. I. (2000). SRY, SOX9, and DAX1 expression patterns during human
sex determination and gonadal development. Mech Dev, 91(1-2):403–407.
Harris, S. E., Chand, A. L., Winship, I. M., Gersak, K., Aittom¨ aki, K., and
Shelling, A. N. (2002). Identiﬁcation of novel mutations in FOXL2 associated
with premature ovarian failure. Mol Hum Reprod, 8(8):729–733.
Heikkil¨ a, M., Prunskaite, R., Naillat, F., It¨ aranta, P., Vuoristo, J., Lepp¨ aluoto,
J., Peltoketo, H., and Vainio, S. (2005). The partial female to male sex reversal
in Wnt-4-deﬁcient females involves induced expression of testosterone biosyn-
thetic genes and testosterone production, and depends on androgen action.
Endocrinology, 146(9):4016–4023.
Hiramatsu, R., Matoba, S., Kanai-Azuma, M., Tsunekawa, N., Katoh-Fukui, Y.,
Kurohmaru, M., Morohashi, K.-I., Wilhelm, D., Koopman, P., and Kanai, Y.
(2009). A critical time window of Sry action in gonadal sex determination in
mice. Development, 136:129–138.
Hirshﬁeld, A. N. (1991). Development of follicles in the mammalian ovary. Int
Rev Cytol, 124:43–101.
Hoogeboom, D., Essers, M. A. G., Polderman, P. E., Voets, E., Smits, L. M. M.,
and Burgering, B. M. T. (2008). Interaction of FOXO with beta-catenin inhibits
beta-catenin/T cell factor activity. J Biol Chem, 283(14):9224–9230.
Hoyle, C., Narvaez, V., Alldus, G., Lovell-Badge, R., and Swain, A. (2002). Dax1
expression is dependent on steroidogenic factor 1 in the developing gonad. Mol
Endocrinol, 16(4):747–756.
Huang, B., Wang, S., Ning, Y., Lamb, A. N., and Bartley, J. (1999). Autosomal
XX sex reversal caused by duplication of SOX9. Am J Med Genet, 87(4):349–
353.
Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G., and Birchmeier, W. (2001).
beta-Catenin controls hair follicle morphogenesis and stem cell diﬀerentiation
in the skin. Cell, 105(4):533–545.
Ijiri, S., Kaneko, H., Kobayashi, T., Wang, D.-S., Sakai, F., Paul-Prasanth, B.,
Nakamura, M., and Nagahama, Y. (2008). Sexual dimorphic expression of
genes in gonads during early diﬀerentiation of a teleost ﬁsh, the Nile tilapia
Oreochromis niloticus. Biol Reprod, 78(2):333–341.
195Ito, M., Yu, R., and Jameson, J. L. (1997). DAX-1 inhibits SF-1-mediated trans-
activation via a carboxy-terminal domain that is deleted in adrenal hypoplasia
congenita. Mol Cell Biol, 17(3):1476–1483.
Ivanova, A., Signore, M., Caro, N., Greene, N. D. E., Copp, A. J., and Martinez-
Barbera, J. P. (2005). In vivo genetic ablation by Cre-mediated expression of
diphtheria toxin fragment A. Genesis, 43(3):129–135.
Jacobs, P. A. and Strong, J. A. (1959). A case of human intersexuality having a
possible XXY sex-determining mechanism. Nature, 183(4657):302–303.
Jeays-Ward, K., Dandonneau, M., and Swain, A. (2004). Wnt4 is required for
proper male as well as female sexual development. Dev Biol, 276(2):431–440.
Jeays-Ward, K., Hoyle, C., Brennan, J., Dandonneau, M., Alldus, G., Capel,
B., and Swain, A. (2003). Endothelial and steroidogenic cell migration are
regulated by WNT4 in the developing mammalian gonad. Development,
130(16):3663–3670.
Jepsen, K., Gleiberman, A. S., Shi, C., Simon, D. I., and Rosenfeld, M. G.
(2008). Cooperative regulation in development by SMRT and FOXP1. Genes
Dev, 22(6):740–745.
J¨ ager, R. J., Anvret, M., Hall, K., and Scherer, G. (1990). A human XY female
with a frame shift mutation in the candidate testis-determining gene SRY.
Nature, 348(6300):452–454.
Jordan, B. K., Mohammed, M., Ching, S. T., D´ elot, E., Chen, X. N., Dewing,
P., Swain, A., Rao, P. N., Elejalde, B. R., and Vilain, E. (2001). Up-regulation
of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am J Hum
Genet, 68(5):1102–1109.
Jordan, B. K., Shen, J. H.-C., Olaso, R., Ingraham, H. A., and Vilain, E. (2003).
Wnt4 overexpression disrupts normal testicular vasculature and inhibits testos-
terone synthesis by repressing steroidogenic factor 1/beta-catenin synergy. Proc
Natl Acad Sci U S A, 100(19):10866–10871.
Jost, A. (1952). Investigation of hormonal control of genesis of the sex organs
in rabbit and notes on certain malformations of the genital apparatus in man.
Ginecol Obstet Mex., 7:477–492.
Karl, J. and Capel, B. (1998). Sertoli cells of the mouse testis originate from the
coelomic epithelium. Dev Biol, 203(2):323–333.
Katoh-Fukui, Y., Owaki, A., Toyama, Y., Kusaka, M., Shinohara, Y., Maekawa,
M., Toshimori, K., and Morohashi, K.-I. (2005). Mouse Polycomb M33 is
required for splenic vascular and adrenal gland formation through regulating
Ad4BP/SF1 expression. Blood, 106(5):1612–1620.
Katoh-Fukui, Y., Tsuchiya, R., Shiroishi, T., Nakahara, Y., Hashimoto, N.,
Noguchi, K., and Higashinakagawa, T. (1998). Male-to-female sex reversal
in M33 mutant mice. Nature, 393(6686):688–692.
196Kaufmann, E., M¨ uller, D., and Kn¨ ochel, W. (1995). DNA recognition site analysis
of Xenopus winged helix proteins. J Mol Biol, 248(2):239–254.
Kazanskaya, O., Glinka, A., del Barco Barrantes, I., Stannek, P., Niehrs, C.,
and Wu, W. (2004). R-Spondin2 is a secreted activator of Wnt/beta-catenin
signaling and is required for Xenopus myogenesis. Dev Cell, 7(4):525–534.
Kidokoro, T., Matoba, S., Hiramatsu, R., Fujisawa, M., Kanai-Azuma, M., Taya,
C., Kurohmaru, M., Kawakami, H., Hayashi, Y., Kanai, Y., and Yonekawa, H.
(2005). Inﬂuence on spatiotemporal patterns of a male-speciﬁc Sox9 activation
by ectopic Sry expression during early phases of testis diﬀerentiation in mice.
Dev Biol, 278(2):511–525.
Kim, K.-A., Zhao, J., Andarmani, S., Kakitani, M., Oshima, T., Binnerts, M. E.,
Abo, A., Tomizuka, K., and Funk, W. D. (2006a). R-Spondin proteins: a novel
link to beta-catenin activation. Cell Cycle, 5(1):23–26.
Kim, S.-Y., Weiss, J., Tong, M., Laronda, M. M., Lee, E.-J., and Jameson, J. L.
(2009). Foxl2, a forkhead transcription factor, modulates nonclassical activity
of the estrogen receptor-alpha. Endocrinology, 150(11):5085–5093.
Kim, Y., Bingham, N., Sekido, R., Parker, K. L., Lovell-Badge, R., and Capel, B.
(2007). Fibroblast growth factor receptor 2 regulates proliferation and Sertoli
diﬀerentiation during male sex determination. Proc Natl Acad Sci U S A,
104(42):16558–16563.
Kim, Y., Kobayashi, A., Sekido, R., DiNapoli, L., Brennan, J., Chaboissier, M.-
C., Poulat, F., Behringer, R. R., Lovell-Badge, R., and Capel, B. (2006b). Fgf9
and Wnt4 act as antagonistic signals to regulate mammalian sex determination.
PLoS Biol, 4(6):e187.
Klinge, C. M. (2001). Estrogen receptor interaction with estrogen response ele-
ments. Nucleic Acids Res, 29(14):2905–2919.
Komiya, Y. and Habas, R. (2008). Wnt signal transduction pathways. Organo-
genesis, 4(2):68–75.
Koopman, P., Gubbay, J., Vivian, N., Goodfellow, P., and Lovell-Badge, R.
(1991). Male development of chromosomally female mice transgenic for Sry.
Nature, 351(6322):117–121.
Koopman, P., M¨ unsterberg, A., Capel, B., Vivian, N., and Lovell-Badge, R.
(1990). Expression of a candidate sex-determining gene during mouse testis
diﬀerentiation. Nature, 348(6300):450–452.
Koubova, J., Menke, D. B., Zhou, Q., Capel, B., Griswold, M. D., and Page,
D. C. (2006). Retinoic acid regulates sex-speciﬁc timing of meiotic initiation
in mice. Proc Natl Acad Sci U S A, 103(8):2474–2479.
Krege, J. H., Hodgin, J. B., Couse, J. F., Enmark, E., Warner, M., Mahler, J. F.,
Sar, M., Korach, K. S., Gustafsson, J. A., and Smithies, O. (1998). Generation
197and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl
Acad Sci U S A, 95(26):15677–15682.
Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman,
D., and Jaenisch, R. (1993). WT-1 is required for early kidney development.
Cell, 74(4):679–691.
Kuo, F.-T., Bentsi-Barnes, I. K., Barlow, G. M., Bae, J., and Pisarska, M. D.
(2009). Sumoylation of forkhead L2 by Ubc9 is required for its activity as
a transcriptional repressor of the Steroidogenic Acute Regulatory gene. Cell
Signal, 21(12):1935–1944.
Laity, J. H., Dyson, H. J., and Wright, P. E. (2000). Molecular basis for modula-
tion of biological function by alternate splicing of the Wilms’ tumor suppressor
protein. Proc Natl Acad Sci U S A, 97(22):11932–11935.
Lalli, E., Ohe, K., Hindelang, C., and Sassone-Corsi, P. (2000). Orphan receptor
DAX-1 is a shuttling RNA binding protein associated with polyribosomes via
mRNA. Mol Cell Biol, 20(13):4910–4921.
Lan, Z.-J., Xu, X., and Cooney, A. J. (2004). Diﬀerential oocyte-speciﬁc ex-
pression of Cre recombinase activity in GDF-9-iCre, Zp3cre, and Msx2Cre
transgenic mice. Biol Reprod, 71(5):1469–1474.
Lee, K., Pisarska, M. D., Ko, J.-J., Kang, Y., Yoon, S., Ryou, S.-M., Cha, K.-Y.,
and Bae, J. (2005). Transcriptional factor FOXL2 interacts with DP103 and
induces apoptosis. Biochem Biophys Res Commun, 336(3):876–881.
Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N., and de Crombrugghe,
B. (1997). SOX9 is a potent activator of the chondrocyte-speciﬁc enhancer of
the pro alpha1(II) collagen gene. Mol Cell Biol, 17(4):2336–2346.
Lei, N., Karpova, T., Hornbaker, K. I., Rice, D. A., and Heckert, L. L. (2009). Dis-
tinct transcriptional mechanisms direct expression of the rat Dmrt1 promoter
in sertoli cells and germ cells of transgenic mice. Biol Reprod, 81(1):118–125.
Lin, L. and Achermann, J. C. (2008). Steroidogenic factor-1 (SF-1, Ad4BP,
NR5A1) and disorders of testis development. Sex Dev, 2(4-5):200–209.
Liu, C.-F., Bingham, N., Parker, K., and Yao, H. H.-C. (2009). Sex-speciﬁc roles
of beta-catenin in mouse gonadal development. Hum Mol Genet, 18(3):405–
417.
Loﬄer, K. A., Zarkower, D., and Koopman, P. (2003). Etiology of ovarian failure
in blepharophimosis ptosis epicanthus inversus syndrome: FOXL2 is a con-
served, early-acting gene in vertebrate ovarian development. Endocrinology,
144(7):3237–3243.
Lovell-Badge, R., Canning, C., and Sekido, R. (2002). The Genetics and Bi-
ology of Sex Determination, chapter Sex-determining genes in mice: building
pathways., pages 4–22. Wiley.
198Lubahn, D. B., Moyer, J. S., Golding, T. S., Couse, J. F., Korach, K. S., and
Smithies, O. (1993). Alteration of reproductive function but not prenatal sexual
development after insertional disruption of the mouse estrogen receptor gene.
Proc Natl Acad Sci U S A, 90(23):11162–11166.
Ludbrook, L. M. and Harley, V. R. (2004). Sex determination: a ’window’ of
DAX1 activity. Trends Endocrinol Metab, 15(3):116–121.
Luo, X., Ikeda, Y., and Parker, K. L. (1994). A cell-speciﬁc nuclear receptor is
essential for adrenal and gonadal development and sexual diﬀerentiation. Cell,
77(4):481–490.
Maatouk, D. M., DiNapoli, L., Alvers, A., Parker, K. L., Taketo, M. M., and
Capel, B. (2008). Stabilization of beta-catenin in XY gonads causes male-to-
female sex-reversal. Hum Mol Genet, 17(19):2949–2955.
Magoﬃn, D. A. (2005). Ovarian theca cell. Int J Biochem Cell Biol, 37(7):1344–
1349.
Maxwell, I. H., Maxwell, F., and Glode, L. M. (1986). Regulated expression of a
diphtheria toxin A-chain gene transfected into human cells: possible strategy
for inducing cancer cell suicide. Cancer Res, 46(9):4660–4664.
Mazet, F., Yu, J. K., Liberles, D. A., Holland, L. Z., and Shimeld, S. M. (2003).
Phylogenetic relationships of the Fox (Forkhead) gene family in the Bilateria.
Gene, 316:79–89.
McElreavey, K., Vilain, E., Abbas, N., Herskowitz, I., and Fellous, M. (1993).
A regulatory cascade hypothesis for mammalian sex determination: SRY re-
presses a negative regulator of male development. Proc Natl Acad Sci U S A,
90(8):3368–3372.
McLaren, A. (1984). Meiosis and diﬀerentiation of mouse germ cells. Symp Soc
Exp Biol, 38:7–23.
McLaren, A. (1991). Development of the mammalian gonad: the fate of the
supporting cell lineage. Bioessays, 13(4):151–156.
McLaren, A. and Southee, D. (1997). Entry of mouse embryonic germ cells into
meiosis. Dev Biol, 187(1):107–113.
Meeks, J. J., Weiss, J., and Jameson, J. L. (2003). Dax1 is required for testis
determination. Nat Genet, 34(1):32–33.
Menke, D. B., Koubova, J., and Page, D. C. (2003). Sexual diﬀerentiation of
germ cells in XX mouse gonads occurs in an anterior-to-posterior wave. Dev
Biol, 262(2):303–312.
Merchant-Larios, H. and Moreno-Mendoza, N. (1998). Mesonephric stromal
cells diﬀerentiate into Leydig cells in the mouse fetal testis. Exp Cell Res,
244(1):230–238.
199Merrill, B. J., Pasolli, H. A., Polak, L., Rendl, M., Garc´ ıa-Garc´ ıa, M. J., An-
derson, K. V., and Fuchs, E. (2004). Tcf3: a transcriptional regulator of axis
induction in the early embryo. Development, 131(2):263–274.
Micali, G., Nasca, M. R., Innocenzi, D., Frasin, L. A., Radi, O., Parma, P.,
Camerino, G., and Schwartz, R. A. (2005). Association of palmoplantar kera-
toderma, cutaneous squamous cell carcinoma, dental anomalies, and hypogen-
italism in four siblings with 46,XX karyotype: a new syndrome. J Am Acad
Dermatol, 53(5 Suppl 1):S234–S239.
Miyamoto, N., Yoshida, M., Kuratani, S., Matsuo, I., and Aizawa, S. (1997).
Defects of urogenital development in mice lacking Emx2. Development,
124(9):1653–1664.
Miyamoto, Y., Taniguchi, H., Hamel, F., Silversides, D. W., and Viger, R. S.
(2008). A GATA4/WT1 cooperation regulates transcription of genes required
for mammalian sex determination and diﬀerentiation. BMC Mol Biol, 9:44.
Mizusaki, H., Kawabe, K., Mukai, T., Ariyoshi, E., Kasahara, M., Yoshioka, H.,
Swain, A., and Morohashi, K.-I. (2003). Dax-1 (dosage-sensitive sex reversal-
adrenal hypoplasia congenita critical region on the X chromosome, gene 1)
gene transcription is regulated by wnt4 in the female developing gonad. Mol
Endocrinol, 17(4):507–519.
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., God-
save, S., Korinek, V., Roose, J., Destr´ ee, O., and Clevers, H. (1996). XTcf-3
transcription factor mediates beta-catenin-induced axis formation in Xenopus
embryos. Cell, 86(3):391–399.
Molkentin, J. D., Lin, Q., Duncan, S. A., and Olson, E. N. (1997). Require-
ment of the transcription factor GATA4 for heart tube formation and ventral
morphogenesis. Genes Dev, 11(8):1061–1072.
Moniot, B., Declosmenil, F., Barrionuevo, F., Scherer, G., Aritake, K., Malki,
S., Marzi, L., Cohen-Solal, A., Georg, I., Klattig, J., Englert, C., Kim, Y.,
Capel, B., Eguchi, N., Urade, Y., Boizet-Bonhoure, B., and Poulat, F. (2009).
The PGD2 pathway, independently of FGF9, ampliﬁes SOX9 activity in Sertoli
cells during male sexual diﬀerentiation. Development, 136(11):1813–1821.
Morais da Silva, S., Hacker, A., Harley, V., Goodfellow, P., Swain, A., and Lovell-
Badge, R. (1996). Sox9 expression during gonadal development implies a con-
served role for the gene in testis diﬀerentiation in mammals and birds. Nat
Genet, 14(1):62–68.
Morohashi, K., Honda, S., Inomata, Y., Handa, H., and Omura, T. (1992). A
common trans-acting factor, Ad4-binding protein, to the promoters of steroido-
genic P-450s. J Biol Chem, 267(25):17913–17919.
Moumn´ e, L., Dipietromaria, A., Batista, F., Kocer, A., Fellous, M., Pailhoux, E.,
and Veitia, R. A. (2008). Diﬀerential aggregation and functional impairment
induced by polyalanine expansions in FOXL2, a transcription factor involved
in cranio-facial and ovarian development. Hum Mol Genet, 17(7):1010–1019.
200Munger, S. C., Aylor, D. L., Syed, H. A., Magwene, P. M., Threadgill, D. W.,
and Capel, B. (2009). Elucidation of the transcription network governing mam-
malian sex determination by exploiting strain-speciﬁc susceptibility to sex re-
versal. Genes Dev, 23(21):2521–2536.
Muscatelli, F., Strom, T. M., Walker, A. P., Zanaria, E., R´ ecan, D., Meindl,
A., Bardoni, B., Guioli, S., Zehetner, G., and Rabl, W. (1994). Mutations in
the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and
hypogonadotropic hypogonadism. Nature, 372(6507):672–676.
Nef, S., Schaad, O., Stallings, N. R., Cederroth, C. R., Pitetti, J.-L., Schaer, G.,
Malki, S., Dubois-Dauphin, M., Boizet-Bonhoure, B., Descombes, P., Parker,
K. L., and Vassalli, J.-D. (2005). Gene expression during sex determination
reveals a robust female genetic program at the onset of ovarian development.
Dev Biol, 287(2):361–377.
Nef, S., Verma-Kurvari, S., Merenmies, J., Vassalli, J.-D., Efstratiadis, A., Accili,
D., and Parada, L. F. (2003). Testis determination requires insulin receptor
family function in mice. Nature, 426(6964):291–295.
Notarnicola, C., Malki, S., Berta, P., Poulat, F., and Boizet-Bonhoure, B. (2006).
Transient expression of SOX9 protein during follicular development in the adult
mouse ovary. Gene Expr Patterns, 6(7):695–702.
Obendorf, M., Meyer, R., Henning, K., Mitev, Y. A., Schr¨ oder, J., Patchev, V. K.,
and Wolf, S. S. (2007). FoxG1, a member of the forkhead family, is a corepressor
of the androgen receptor. J Steroid Biochem Mol Biol, 104(3-5):195–207.
O’Bryan, M. K., Takada, S., Kennedy, C. L., Scott, G., ichi Harada, S., Ray,
M. K., Dai, Q., Wilhelm, D., de Kretser, D. M., Eddy, E. M., Koopman, P.,
and Mishina, Y. (2008). Sox8 is a critical regulator of adult Sertoli cell function
and male fertility. Dev Biol, 316(2):359–370.
Oh, H. J., Li, Y., and Lau, Y.-F. C. (2005). Sry associates with the heterochro-
matin protein 1 complex by interacting with a KRAB domain protein. Biol
Reprod, 72(2):407–415.
Okada, E., Yoshimoto, S., Ikeda, N., Kanda, H., Tamura, K., Shiba, T., Taka-
matsu, N., and Ito, M. (2009). Xenopus W-linked DM-W induces Foxl2 and
Cyp19 expression during ovary formation. Sex Dev, 3(1):38–42.
Orth, J. M. (1982). Proliferation of Sertoli cells in fetal and postnatal rats: a
quantitative autoradiographic study. Anat Rec, 203(4):485–492.
Orvis, G. D. and Behringer, R. R. (2007). Cellular mechanisms of M¨ ullerian duct
formation in the mouse. Dev Biol, 306(2):493–504.
Ottolenghi, C., Omari, S., Garcia-Ortiz, J. E., Uda, M., Crisponi, L., Forabosco,
A., Pilia, G., and Schlessinger, D. (2005). Foxl2 is required for commitment to
ovary diﬀerentiation. Hum Mol Genet, 14(14):2053–2062.
201Ottolenghi, C., Pelosi, E., Tran, J., Colombino, M., Douglass, E., Nedorezov, T.,
Cao, A., Forabosco, A., and Schlessinger, D. (2007). Loss of Wnt4 and Foxl2
leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet,
16(23):2795–2804.
Pailhoux, E., Vigier, B., Chaﬀaux, S., Servel, N., Taourit, S., Furet, J. P., Fellous,
M., Grosclaude, F., Cribiu, E. P., Cotinot, C., and Vaiman, D. (2001). A
11.7-kb deletion triggers intersexuality and polledness in goats. Nat Genet,
29(4):453–458.
Palmer, S. J. and Burgoyne, P. S. (1991a). In situ analysis of fetal, prepuberal
and adult XX—-XY chimaeric mouse testes: Sertoli cells are predominantly,
but not exclusively, XY. Development, 112(1):265–268.
Palmer, S. J. and Burgoyne, P. S. (1991b). The Mus musculus domesticus Tdy
allele acts later than the Mus musculus musculus Tdy allele: a basis for XY
sex-reversal in C57BL/6-YPOS mice. Development, 113(2):709–714.
Pannetier, M., Fabre, S., Batista, F., Kocer, A., Jolivet, L. R. G., Mandon-P´ epin,
B., Cotinot, C., Veitia, R., and Pailhoux, E. (2006a). FOXL2 activates P450
aromatase gene transcription: towards a better characterization of the early
steps of mammalian ovarian development. J Mol Endocrinol., 36:399–413.
Pannetier, M., Tilly, G., Kocer, A., Hudrisier, M., Renault, L., Chesnais, N.,
Costa, J., Provost, F. L., Vaiman, D., Vilotte, J.-L., and Pailhoux, E. (2006b).
Goat SRY induces testis development in XX transgenic mice. FEBS Lett,
580(15):3715–3720.
Parakh, T. N., Hernandez, J. A., Grammer, J. C., Weck, J., Hunzicker-Dunn, M.,
Zeleznik, A. J., and Nilson, J. H. (2006). Follicle-stimulating hormone/cAMP
regulation of aromatase gene expression requires beta-catenin. Proc Natl Acad
Sci U S A, 103(33):12435–12440.
Parker, K. L. and Schimmer, B. P. (1997). Steroidogenic factor 1: a key deter-
minant of endocrine development and function. Endocr Rev, 18(3):361–377.
Parma, P., Radi, O., Vidal, V., Chaboissier, M. C., Dellambra, E., Valentini, S.,
Guerra, L., Schedl, A., and Camerino, G. (2006). R-spondin1 is essential in sex
determination, skin diﬀerentiation and malignancy. Nat Genet, 38(11):1304–
1309.
Pearce, J. J., Singh, P. B., and Gaunt, S. J. (1992). The mouse has a Polycomb-
like chromobox gene. Development, 114(4):921–929.
Pepling, M. E. and Spradling, A. C. (2001). Mouse ovarian germ cell cysts undergo
programmed breakdown to form primordial follicles. Dev Biol, 234(2):339–351.
Phillips, D. J. and de Kretser, D. M. (1998). Follistatin: a multifunctional regu-
latory protein. Front Neuroendocrinol, 19(4):287–322.
202Pieau, C., Dorizzi, M., and Richard-Mercier, N. (1999). Temperature-dependent
sex determination and gonadal diﬀerentiation in reptiles. Cell Mol Life Sci,
55(6-7):887–900.
Pierrou, S., Hellqvist, M., Samuelsson, L., Enerb¨ ack, S., and Carlsson, P. (1994).
Cloning and characterization of seven human forkhead proteins: binding site
speciﬁcity and DNA bending. EMBO J, 13(20):5002–5012.
Pilon, N., Daneau, I., Paradis, V., Hamel, F., Lussier, J. G., Viger, R. S., and
Silversides, D. W. (2003). Porcine SRY promoter is a target for steroidogenic
factor 1. Biol Reprod, 68(4):1098–1106.
Pisarska, M. D., Bae, J., Klein, C., and Hsueh, A. J. W. (2004). Forkhead l2 is
expressed in the ovary and represses the promoter activity of the steroidogenic
acute regulatory gene. Endocrinology, 145(7):3424–3433.
Polanco, J. C., Wilhelm, D., Davidson, T.-L., Knight, D., and Koopman, P.
(2010). Sox10 gain-of-function causes XX sex reversal in mice: implications for
human 22q-linked disorders of sex development. Hum Mol Genet, 19(3):506–
516.
Polanco, J. C., Wilhelm, D., Mizusaki, H., Jackson, A., Browne, C., Davidson,
T., Harley, V., Sinclair, A., and Koopman, P. (2009). Functional analysis of the
SRY-KRAB interaction in mouse sex determination. Biol Cell, 101(1):55–67.
Poulat, F., de Santa Barbara, P., Desclozeaux, M., Soullier, S., Moniot, B.,
Bonneaud, N., Boizet, B., and Berta, P. (1997). The human testis determining
factor SRY binds a nuclear factor containing PDZ protein interaction domains.
J Biol Chem, 272(11):7167–7172.
Pr´ epin, J. and Hida, N. (1989). Inﬂuence of age and medium on formation of
epithelial cords in the rat fetal ovary in vitro. J Reprod Fertil, 87(1):375–382.
Quandt, K., Frech, K., Karas, H., Wingender, E., and Werner, T. (1995). MatInd
and MatInspector: new fast and versatile tools for detection of consensus
matches in nucleotide sequence data. Nucleic Acids Res, 23(23):4878–4884.
Reddy, J. C. and Licht, J. D. (1996). The WT1 Wilms’ tumor suppressor gene:
how much do we really know? Biochim Biophys Acta, 1287(1):1–28.
Roose, J., Molenaar, M., Peterson, J., Hurenkamp, J., Brantjes, H., Moerer,
P., van de Wetering, M., Destr´ ee, O., and Clevers, H. (1998). The Xenopus
Wnt eﬀector XTcf-3 interacts with Groucho-related transcriptional repressors.
Nature, 395(6702):608–612.
Ross, A. J. and Capel, B. (2005). Signaling at the crossroads of gonad develop-
ment. Trends Endocrinol Metab, 16(1):19–25.
Ross, D. G. F., Bowles, J., Koopman, P., and Lehnert, S. (2008). New insights
into SRY regulation through identiﬁcation of 5’ conserved sequences. BMC
Mol Biol, 9:85.
203Saitou, M., Barton, S. C., and Surani, M. A. (2002). A molecular programme for
the speciﬁcation of germ cell fate in mice. Nature, 418(6895):293–300.
Schepers, G., Wilson, M., Wilhelm, D., and Koopman, P. (2003). SOX8 is ex-
pressed during testis diﬀerentiation in mice and synergizes with SF1 to activate
the Amh promoter in vitro. J Biol Chem, 278(30):28101–28108.
Schilham, M. W., Oosterwegel, M. A., Moerer, P., Ya, J., de Boer, P. A., van de
Wetering, M., Verbeek, S., Lamers, W. H., Kruisbeek, A. M., Cumano, A.,
and Clevers, H. (1996). Defects in cardiac outﬂow tract formation and pro-B-
lymphocyte expansion in mice lacking Sox-4. Nature, 380(6576):711–714.
Schmahl, J., Eicher, E. M., Washburn, L. L., and Capel, B. (2000). Sry induces
cell proliferation in the mouse gonad. Development, 127(1):65–73.
Schmahl, J., Rizzolo, K., and Soriano, P. (2008). The PDGF signaling pathway
controls multiple steroid-producing lineages. Genes Dev, 22(23):3255–3267.
Schmidt, D., Ovitt, C. E., Anlag, K., Fehsenfeld, S., Gredsted, L., Treier, A.-C.,
and Treier, M. (2004). The murine winged-helix transcription factor Foxl2 is
required for granulosa cell diﬀerentiation and ovary maintenance. Development,
131(4):933–942.
S¨ udbeck, P., Schmitz, M. L., Baeuerle, P. A., and Scherer, G. (1996). Sex reversal
by loss of the C-terminal transactivation domain of human SOX9. Nat Genet,
13(2):230–232.
Sekido, R. (2010). SRY: A transcriptional activator of mammalian testis deter-
mination. Int J Biochem Cell Biol, 42(3):417–420.
Sekido, R., Bar, I., Narv´ aez, V., Penny, G., and Lovell-Badge, R. (2004). SOX9
is up-regulated by the transient expression of SRY speciﬁcally in Sertoli cell
precursors. Dev Biol, 274(2):271–279.
Sekido, R. and Lovell-Badge, R. (2008). Sex determination involves synergistic
action of SRY and SF1 on a speciﬁc Sox9 enhancer. Nature, 453(7197):930–934.
Shahid, M., Dhillion, V. S., Jain, N., Hedau, S., Diwakar, S., Sachdeva, P., Batra,
S., Das, B. C., and Husain, S. A. (2004). Two new novel point mutations
localized upstream and downstream of the HMG box region of the SRY gene
in three Indian 46,XY females with sex reversal and gonadal tumour formation.
Mol Hum Reprod, 10(7):521–526.
Shan, J., Jokela, T., Peltoketo, H., and Vainio, S. (2009). Generation of an
allele to inactivate Wnt4 gene function conditionally in the mouse. Genesis,
47(11):782–788.
Sharma, P. M., Bowman, M., Madden, S. L., Rauscher, F. J., and Sukumar, S.
(1994). RNA editing in the Wilms’ tumor susceptibility gene, WT1. Genes
Dev, 8(6):720–731.
204Simeone, A., Gulisano, M., Acampora, D., Stornaiuolo, A., Rambaldi, M., and
Boncinelli, E. (1992). Two vertebrate homeobox genes related to the Drosophila
empty spiracles gene are expressed in the embryonic cerebral cortex. EMBO
J, 11(7):2541–2550.
Sinclair, A. H., Berta, P., Palmer, M. S., Hawkins, J. R., Griﬃths, B. L., Smith,
M. J., Foster, J. W., Frischauf, A. M., Lovell-Badge, R., and 280, P. N. G. .
(1990). A gene from the human sex-determining region encodes a protein with
homology to a conserved DNA-binding motif. Nature, 346(6281):240–244.
Sinner, D., Kordich, J. J., Spence, J. R., Opoka, R., Rankin, S., Lin, S.-C. J.,
Jonatan, D., Zorn, A. M., and Wells, J. M. (2007). Sox17 and Sox4 diﬀerentially
regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma
cells. Mol Cell Biol, 27(22):7802–7815.
Smith, C. A., Roeszler, K. N., Ohnesorg, T., Cummins, D. M., Farlie, P. G.,
Doran, T. J., and Sinclair, A. H. (2009). The avian Z-linked gene DMRT1 is
required for male sex determination in the chicken. Nature, 461(7261):267–271.
Soyal, S. M., Amleh, A., and Dean, J. (2000). FIGalpha, a germ cell-speciﬁc
transcription factor required for ovarian follicle formation. Development,
127(21):4645–4654.
Stark, K., Vainio, S., Vassileva, G., and McMahon, A. P. (1994). Epithelial
transformation of metanephric mesenchyme in the developing kidney regulated
by Wnt-4. Nature, 372(6507):679–683.
Suemori, H., Kadodawa, Y., Goto, K., Araki, I., Kondoh, H., and Nakatsuji, N.
(1990). A mouse embryonic stem cell line showing pluripotency of diﬀerentia-
tion in early embryos and ubiquitous beta-galactosidase expression. Cell Diﬀer
Dev, 29(3):181–186.
Swain, A., Narvaez, V., Burgoyne, P., Camerino, G., and Lovell-Badge, R.
(1998). Dax1 antagonizes Sry action in mammalian sex determination. Nature,
391(6669):761–767.
Swain, A., Zanaria, E., Hacker, A., Lovell-Badge, R., and Camerino, G. (1996).
Mouse Dax1 expression is consistent with a role in sex determination as well
as in adrenal and hypothalamus function. Nat Genet, 12(4):404–409.
Tamashiro, D. A. A., Alarc´ on, V. B., and Marikawa, Y. (2008). Ectopic expression
of mouse Sry interferes with Wnt/beta-catenin signaling in mouse embryonal
carcinoma cell lines. Biochim Biophys Acta, 1780(12):1395–1402.
Tang, H., Brennan, J., Karl, J., Hamada, Y., Raetzman, L., and Capel, B.
(2008). Notch signaling maintains Leydig progenitor cells in the mouse testis.
Development, 135(22):3745–3753.
Tevosian, S. G., Albrecht, K. H., Crispino, J. D., Fujiwara, Y., Eicher, E. M.,
and Orkin, S. H. (2002). Gonadal diﬀerentiation, sex determination and normal
Sry expression in mice require direct interaction between transcription partners
GATA4 and FOG2. Development, 129(19):4627–4634.
205Thevenet, L., Albrecht, K. H., Malki, S., Berta, P., Boizet-Bonhoure, B., and
Poulat, F. (2005). NHERF2/SIP-1 interacts with mouse SRY via a diﬀerent
mechanism than human SRY. J Biol Chem, 280(46):38625–38630.
Tomizuka, K., Horikoshi, K., Kitada, R., Sugawara, Y., Iba, Y., Kojima, A.,
Yoshitome, A., Yamawaki, K., Amagai, M., Inoue, A., Oshima, T., and Kak-
itani, M. (2008). R-spondin1 plays an essential role in ovarian development
through positively regulating Wnt-4 signaling. Hum Mol Genet, 17(9):1278–
1291.
Uda, M., Ottolenghi, C., Crisponi, L., Garcia, J. E., Deiana, M., Kimber, W.,
Forabosco, A., Cao, A., Schlessinger, D., and Pilia, G. (2004). Foxl2 disruption
causes mouse ovarian failure by pervasive blockage of follicle development. Hum
Mol Genet, 13(11):1171–1181.
Ueno, N., Ling, N., Ying, S. Y., Esch, F., Shimasaki, S., and Guillemin, R. (1987).
Isolation and partial characterization of follistatin: a single-chain Mr 35,000
monomeric protein that inhibits the release of follicle-stimulating hormone.
Proc Natl Acad Sci U S A, 84(23):8282–8286.
Uhlenhaut, N., Jakob, S., Anlag, K. E., T., Sekido, R., Kress, J., Treier, A.-C.,
C., K., C., K., Holter, N., Riethmacher, D., Sch¨ utz, G., Cooney, A., Lovell-
Badge, R., and Treier, M. (2009). Somatic sex reprogramming of adult ovaries
to testes by FOXL2 ablation. Cell, 139(6):1130–1142.
Uhlenhaut, N. H. and Treier, M. (2006). Foxl2 function in ovarian development.
Mol Genet Metab, 88(3):225–234.
Vaiman, D., Schibler, L., Bourgeois, F., Oustry, A., Amigues, Y., and Cribiu,
E. P. (1996). A genetic linkage map of the male goat genome. Genetics,
144(1):279–305.
Vainio, S., Heikkil¨ a, M., Kispert, A., Chin, N., and McMahon, A. P. (1999).
Female development in mammals is regulated by Wnt-4 signalling. Nature,
397(6718):405–409.
van de Wetering, M., Oosterwegel, M., van Norren, K., and Clevers, H. (1993).
Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lympho-
cytes. EMBO J, 12(10):3847–3854.
Vidal, V. P., Chaboissier, M. C., de Rooij, D. G., and Schedl, A. (2001). Sox9
induces testis development in XX transgenic mice. Nat Genet, 28(3):216–217.
Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J.,
Bricarelli, F. D., Keutel, J., and Hustert, E. (1994). Autosomal sex reversal and
campomelic dysplasia are caused by mutations in and around the SRY-related
gene SOX9. Cell, 79(6):1111–1120.
Wang, D.-S., Kobayashi, T., Zhou, L.-Y., Paul-Prasanth, B., Ijiri, S., Sakai,
F., Okubo, K., ichirou Morohashi, K., and Nagahama, Y. (2007). Foxl2 up-
regulates aromatase gene transcription in a female-speciﬁc manner by binding
206to the promoter as well as interacting with ad4 binding protein/steroidogenic
factor 1. Mol Endocrinol, 21(3):712–725.
Welshons, W. J. and Russell, L. B. (1959). THE Y-CHROMOSOME AS THE
BEARER OF MALE DETERMINING FACTORS IN THE MOUSE. Proc
Natl Acad Sci U S A, 45(4):560–566.
Wieacker, P., Missbach, D., Jakubiczka, S., Borgmann, S., and Albers, N. (1996).
Sex reversal in a child with the karyotype 46,XY, dup (1) (p22.3p32.3). Clin
Genet, 49(5):271–273.
Wilhelm, D. and Englert, C. (2002). The Wilms tumor suppressor WT1 regulates
early gonad development by activation of Sf1. Genes Dev, 16(14):1839–1851.
Wilhelm, D., Martinson, F., Bradford, S., Wilson, M. J., Combes, A. N., Bever-
dam, A., Bowles, J., Mizusaki, H., and Koopman, P. (2005). Sertoli cell
diﬀerentiation is induced both cell-autonomously and through prostaglandin
signaling during mammalian sex determination. Dev Biol, 287(1):111–124.
Wilkie, A. O., Campbell, F. M., Daubeney, P., Grant, D. B., Daniels, R. J.,
Mullarkey, M., Aﬀara, N. A., Fitchett, M., and Huson, S. M. (1993). Complete
and partial XY sex reversal associated with terminal deletion of 10q: report of
2 cases and literature review. Am J Med Genet, 46(5):597–600.
Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz,
R. W., Hewick, R. M., and Wang, E. A. (1988). Novel regulators of bone
formation: molecular clones and activities. Science, 242(4885):1528–1534.
Yao, H. H.-C., DiNapoli, L., and Capel, B. (2003). Meiotic germ cells antag-
onize mesonephric cell migration and testis cord formation in mouse gonads.
Development, 130(24):5895–5902.
Yao, H. H. C., Matzuk, M. M., Jorgez, C. J., Menke, D. B., Page, D. C., Swain, A.,
and Capel, B. (2004). Follistatin operates downstream of Wnt4 in mammalian
ovary organogenesis. Dev Dyn, 230(2):210–215.
Yao, H. H.-C., Whoriskey, W., and Capel, B. (2002). Desert Hedgehog/Patched
1 signaling speciﬁes fetal Leydig cell fate in testis organogenesis. Genes Dev,
16(11):1433–1440.
Yoshioka, H., Ishimaru, Y., Sugiyama, N., Tsunekawa, N., Noce, T., Kasahara,
M., and ichirou Morohashi, K. (2005). Mesonephric FGF signaling is associ-
ated with the development of sexually indiﬀerent gonadal primordium in chick
embryos. Dev Biol, 280(1):150–161.
Zanaria, E., Muscatelli, F., Bardoni, B., Strom, T. M., Guioli, S., Guo, W., Lalli,
E., Moser, C., Walker, A. P., and McCabe, E. R. (1994). An unusual member
of the nuclear hormone receptor superfamily responsible for X-linked adrenal
hypoplasia congenita. Nature, 372(6507):635–641.
207Zazopoulos, E., Lalli, E., Stocco, D. M., and Sassone-Corsi, P. (1997). DNA bind-
ing and transcriptional repression by DAX-1 blocks steroidogenesis. Nature,
390(6657):311–315.
Zhang, H. and Bradley, A. (1996). Mice deﬁcient for BMP2 are nonviable
and have defects in amnion/chorion and cardiac development. Development,
122(10):2977–2986.
208